<SEC-DOCUMENT>0001493152-22-000935.txt : 20220111
<SEC-HEADER>0001493152-22-000935.hdr.sgml : 20220111
<ACCEPTANCE-DATETIME>20220111160527
ACCESSION NUMBER:		0001493152-22-000935
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		23
CONFORMED PERIOD OF REPORT:	20220110
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220111
DATE AS OF CHANGE:		20220111

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Celsion CORP
		CENTRAL INDEX KEY:			0000749647
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				521256615
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15911
		FILM NUMBER:		22523921

	BUSINESS ADDRESS:	
		STREET 1:		997 LENOX DRIVE
		STREET 2:		SUITE 100
		CITY:			LAWRENCEVILLE
		STATE:			NJ
		ZIP:			08648
		BUSINESS PHONE:		(609) 896-9100

	MAIL ADDRESS:	
		STREET 1:		997 LENOX DRIVE
		STREET 2:		SUITE 100
		CITY:			LAWRENCEVILLE
		STATE:			NJ
		ZIP:			08648

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELSION CORP
		DATE OF NAME CHANGE:	19980515

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEUNG LABORATORIES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:CLSN="http://celsion.com/20220110">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_CLSN_celsion.com_20220110 -->
<!-- Field: Set; Name: xdx; ID: xdx_043_20220110_20220110 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0000749647 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-01-10to2022-01-10" name="dei:EntityCentralIndexKey">0000749647</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-10to2022-01-10" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-10to2022-01-10" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="clsn-20220110.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-01-10to2022-01-10">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-10</xbrli:startDate>
        <xbrli:endDate>2022-01-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_900_edei--DocumentType_c20220110__20220110_zcCyhvZKo2N7"><ix:nonNumeric contextRef="From2022-01-10to2022-01-10" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
of report (Date of earliest event reported): <span id="xdx_904_edei--DocumentPeriodEndDate_c20220110__20220110_zim0WkWpXLb7"><ix:nonNumeric contextRef="From2022-01-10to2022-01-10" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">January 10, 2022</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90C_edei--EntityRegistrantName_c20220110__20220110_zMmUegwu5Smb" style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><ix:nonNumeric contextRef="From2022-01-10to2022-01-10" name="dei:EntityRegistrantName">Celsion
Corporation</ix:nonNumeric></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Exact
Name of Registrant as Specified in Charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20220110__20220110_zbzkCkfg4zdc"><ix:nonNumeric contextRef="From2022-01-10to2022-01-10" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--EntityFileNumber_c20220110__20220110_zODtGSxa0Bc4"><ix:nonNumeric contextRef="From2022-01-10to2022-01-10" name="dei:EntityFileNumber">001-15911</ix:nonNumeric></span>
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityTaxIdentificationNumber_c20220110__20220110_zzDgt46PFKbe"><ix:nonNumeric contextRef="From2022-01-10to2022-01-10" name="dei:EntityTaxIdentificationNumber">52-1256615</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or Other Jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    Incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
    Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>



<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; width: 49%"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityAddressAddressLine1_c20220110__20220110_z5wlYCWAcPH4"><ix:nonNumeric contextRef="From2022-01-10to2022-01-10" name="dei:EntityAddressAddressLine1">997 Lenox Drive</ix:nonNumeric></span>, <span id="xdx_90E_edei--EntityAddressAddressLine2_c20220110__20220110_zK8gygQ8a7nf"><ix:nonNumeric contextRef="From2022-01-10to2022-01-10" name="dei:EntityAddressAddressLine2">Suite 100</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressCityOrTown_c20220110__20220110_zZ3fRbNNmEi5"><ix:nonNumeric contextRef="From2022-01-10to2022-01-10" name="dei:EntityAddressCityOrTown">Lawrenceville</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressStateOrProvince_c20220110__20220110_zpF9cOWAoL68"><ix:nonNumeric contextRef="From2022-01-10to2022-01-10" name="dei:EntityAddressStateOrProvince">NJ</ix:nonNumeric></span> </b></span></td>
    <td style="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; width: 49%"><span style="font-size: 10pt"><b><span id="xdx_901_edei--EntityAddressPostalZipCode_c20220110__20220110_zdVYE5N31Is7"><ix:nonNumeric contextRef="From2022-01-10to2022-01-10" name="dei:EntityAddressPostalZipCode">08648</ix:nonNumeric></span></b></span></td>
    </tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">(Address of Principal Executive Offices) </span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(Zip Code)</span></td>
    </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--CityAreaCode_c20220110__20220110_zSBbFdx6ijC6"><ix:nonNumeric contextRef="From2022-01-10to2022-01-10" name="dei:CityAreaCode">(609)</ix:nonNumeric></span>
<span id="xdx_90E_edei--LocalPhoneNumber_c20220110__20220110_zyiKcE8uVCAa"><ix:nonNumeric contextRef="From2022-01-10to2022-01-10" name="dei:LocalPhoneNumber">896-9100</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
Telephone Number, Including Area Code</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>N/A</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
Name or Former Address, if Changed Since Last Report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (<span style="text-decoration: underline">see</span> General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--WrittenCommunications_c20220110__20220110_zOnuBSjX1NTk"><ix:nonNumeric contextRef="From2022-01-10to2022-01-10" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--SolicitingMaterial_c20220110__20220110_zeBEqhaPR0r9"><ix:nonNumeric contextRef="From2022-01-10to2022-01-10" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--PreCommencementTenderOffer_c20220110__20220110_z4WpjGR1MJr"><ix:nonNumeric contextRef="From2022-01-10to2022-01-10" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--PreCommencementIssuerTenderOffer_c20220110__20220110_zNPDJhgQTYLg"><ix:nonNumeric contextRef="From2022-01-10to2022-01-10" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--Security12bTitle_c20220110__20220110_zAdK4yLmhmT3"><ix:nonNumeric contextRef="From2022-01-10to2022-01-10" name="dei:Security12bTitle">Common
    stock, par value $0.01 per share</ix:nonNumeric></span> </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--TradingSymbol_c20220110__20220110_z3r8aKZTB4vb"><ix:nonNumeric contextRef="From2022-01-10to2022-01-10" name="dei:TradingSymbol">CLSN</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--SecurityExchangeName_c20220110__20220110_zgiaYrLmikt1"><ix:nonNumeric contextRef="From2022-01-10to2022-01-10" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span>
    Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90B_edei--EntityEmergingGrowthCompany_c20220110__20220110_zaRNy5yGkiY"><ix:nonNumeric contextRef="From2022-01-10to2022-01-10" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br />
<b>Item 1.01 Entry into a Material Definitive Agreement</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
January 10, 2022, Celsion Corporation, a Delaware Corporation (the &#8220;Company&#8221;), entered into a Securities Purchase Agreement
(the &#8220;Purchase Agreement&#8221;) with several institutional investors, pursuant to which the Company agreed to issue and sell,
in concurrent registered direct offerings (the &#8220;Offerings&#8221;), (i) 50,000 shares of the Company&#8217;s Series A Convertible
Redeemable Preferred Stock, par value $0.01 per share (the &#8220;Series A Preferred Stock&#8221;), and (ii) 50,000 shares of the Company&#8217;s
Series B Convertible Redeemable Preferred Stock, par value $0.01 per share (the &#8220;Series B Preferred Stock&#8221; and together with
the Series A Preferred Stock, the &#8220;Preferred Stock&#8221;), in each case at an offering price of $285 per share, representing a
5% original issue discount to the stated value of $300 per share, for gross proceeds of each Offering of $14.25 million, or approximately
$28.50 million in the aggregate for the Offerings, before the deduction of the Placement Agent&#8217;s (as defined below) fee and offering
expenses. The shares of Series A Preferred Stock will have a stated value of $300 per share and will be convertible, at a conversion
price of $0.91 per share, into 16,483,516 shares of common stock (subject in certain circumstances to adjustments). The shares of Series
B Preferred Stock will have a stated value of $300 per share and will be convertible, at a conversion price of $1.00 per share, into
15,000,000 shares of common stock (subject in certain circumstances to adjustments). The Series A Preferred Stock and the Series B Preferred
Stock are being offered by the Company pursuant to a registration statement on Form S-3 (File No. <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-254515<span style="background-color: white">)
(the &#8220;Registration Statement&#8221;) filed under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). The
Purchase Agreement contains customary representations, warranties and agreements by the Company and customary conditions to closing.
The closing of the Offerings is expected to occur on January 13, 2022.</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company intends to call a special meeting of stockholders to consider an amendment (the &#8220;Amendment&#8221;) to the Company&#8217;s
Certificate of Incorporation, as amended (the &#8220;Charter&#8221;), to effect a reverse stock split of the outstanding shares of common
stock (&#8220;Common Stock&#8221;)</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by a ratio
to be determined by the Board of Directors of the Company (the &#8220;Reverse Stock Split&#8221;), ranging from 7-to-1
to, 10-to-1, 12-to-1 or 15-to-1.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investors
have agreed in the Purchase Agreement to not transfer, offer, sell, contract to sell, hypothecate, pledge or otherwise dispose of the
shares of the Preferred Stock until the Reverse Stock Split, to vote the shares of the Series A Preferred Stock purchased in the Offerings
in favor of such Amendment and to vote the shares of the Series B Preferred Stock purchased in the Offerings in a manner that &#8220;mirrors&#8221;
the proportions on which the shares of Common Stock (excluding any shares of Common Stock that are not voted) and Series A Preferred
Stock are voted on the Reverse Stock Split and the Amendment. The Amendment requires the approval of the majority of the votes associated
with our outstanding stock entitled to vote on the proposal. Since the Series B Preferred Stock will mirror only votes cast, abstentions
or broker non-votes by common stockholders, which would ordinarily have the effect of a no vote, will not have any effect on the outcome
of the vote.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Purchase Agreement, the Company will file two certificates of designation (the &#8220;Certificates of Designation&#8221;) with
the Secretary of the State of Delaware designating the rights, preferences and limitations of the shares of Preferred Stock. The Certificates
of Designation will provide, in particular, that the Preferred Stock will have no voting rights, other than the right to vote as a class
on certain specified matters, except that (i) each share of Series A Preferred Stock will have the right to vote, on an as converted
basis, on the Reverse Stock Split (together with the Company&#8217;s Common Stock and the Series B Preferred Stock as a single class),
and (ii) each share of Series B Preferred Stock will have the right to cast 45,000 votes per share of Series B Preferred Stock on the
Reverse Stock Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holder of Preferred Stock will be entitled to dividends, on an as-if converted basis, equal to dividends actually paid, if any, on shares
of Common Stock. The Preferred Stock is convertible into shares of Common Stock at a rate of $0.91 per share for the Series A Preferred
Stock and $1.00 per share for the Series B Preferred Stock. The conversion price can be adjusted pursuant to the Certificate of Designation
for stock dividends and stock splits, subsequent rights offerings, pro rata distributions of dividends or the occurrence of a fundamental
transaction (as defined in the applicable Certificate of Designation). The Preferred Stock can be converted at the option of the holder
at any time after the Company has received stockholder approval for the Reverse Stock Split and filed the requisite Amendment with the
Delaware Secretary of State&#8217;s office to effectuate the Reverse Stock Split (the &#8220;Reverse Stock Split Date&#8221;), subject
to beneficial ownership limitations set forth in the applicable Certificate of Designation. In addition, on or after the Reverse Stock
Split Date, and subject to the satisfaction of certain conditions, the Company can cause the holder of the Preferred Stock to convert
their shares of Preferred Stock, subject to such beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
holder of the Preferred Stock shall have the right to cause the Company to redeem all or part of their shares of the Preferred Stock
from the earlier of receipt of stockholder approval of the reverse stock split or of 90 days following the original issue date until
120 days following the original issue date, the &#8220;Redemption Date,&#8221; in cash at a redemption price equal to 105% of the stated
value plus an amount equal to accumulated but unpaid dividends, if any, on such shares (whether or not earned or declared, but excluding
interest on such dividends) up to, but excluding, the Redemption Date. The proceeds of the Offerings will be held in an escrow account
until the expiration of the redemption period for the Series A Preferred Stock or the Series B Preferred Stock, as applicable, subject
to the earlier payment to redeeming holders. Upon expiration of the redemption period, any proceeds remaining in escrow will be disbursed
to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
connection with the Offerings, the Company entered into a placement agent agreement (the &#8220;Placement Agent Agreement&#8221;) with
A.G.P./Alliance Global Partners, as placement agent (&#8220;AGP,&#8221; or the &#8220;Placement Agent&#8221;) pursuant to which the Company
agreed to pay the Placement Agents an aggregate cash fee equal to $1,000,000 and reimburse the Placement Agent for certain of their expenses
in an amount not to exceed $110,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Placement Agent Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing,
indemnification obligations of the Company and the Placement Agent, including for liabilities under the Securities Act, other obligations
of the parties and termination provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Under
the Placement Agent Agreement, the Company and its subsidiaries are prohibited, for a period of 90 days after the closing from issuing,
entering into any agreement to issue or announcing any issuance or proposed issuance of common stock, preferred stock or common stock
equivalents, subject to limited exceptions for exempted issuances as defined in the Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
addition, under the Purchase Agreement, to the extent shares of Preferred Stock are outstanding, for a period of 30 days from the date
of the Purchase Agreement, the Company and its subsidiaries are prohibited from (i) issuing entering into any agreement to issue or announce
the issuance or proposed issuance of any shares of common stock or common stock equivalents or (ii) filing any registration statement
or amendment or supplement thereto, other than the Prospectus Supplements for the Offerings (other than a registration statement or amendment
or supplement thereto relating to the issuance or resale of the common stock issuable or issued on conversion of shares of Preferred
Stock). Additionally, to the extent shares of Preferred Stock are outstanding, from the closing date of the Purchase Agreement until
the date that is 120 days thereafter, neither the Company nor any of its subsidiaries may issue any shares of Preferred Stock or other
securities having rights senior to or <i>pari passu</i> with the Preferred Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Further,
from the date of the Purchase Agreement until one year following the Reverse Stock Split Date, the Company is be prohibited from effecting
or entering into an agreement to effect any issuance by the Company or any of its subsidiaries of common stock or common stock equivalents
(or a combination of units thereof) involving a Variable Rate Transaction, as defined in the Purchase Agreement. Also, until the Reverse
Stock Split Date, neither the Company nor any subsidiary may make any issuance whatsoever of common stock or common stock equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
above limitations on issuances of stock under the Purchase Agreement do not apply to exempt issuances as defined in the Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
foregoing summaries of the Purchase Agreement and the Placement Agent Agreement do not purport to be complete and are subject to, and
qualified in their entirety by, such documents attached as Exhibits 10.1 and 1.1, respectively, to this Current Report on Form 8-K, which
are incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
representations, warranties and covenants contained in the Purchase Agreement and the Placement Agent Agreement were made only for purposes
of such agreement and as of specific dates, were solely for the benefit of the parties to the such agreements and are subject to limitations
agreed upon by the contracting parties. Accordingly, the Purchase Agreement and the Placement Agent Agreement are incorporated herein
by reference only to provide investors with information regarding the terms of the Purchase Agreement and the Placement Agent Agreement
and not to provide investors with any other factual information regarding the Company or its business, and should be read in conjunction
with the disclosures in the Company&#8217;s periodic reports and other filings with the Securities and Exchange Commission.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
legal opinions, including the related consent, of Baker &amp; McKenzie LLP relating to the issuance and sale of Series A Preferred Stock
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(and the shares of Common Stock issuable upon conversion
of the Series A Preferred Stock) <span style="background-color: white">and the Series B Preferred Stock (</span>and the shares of Common
Stock issuable upon conversion of the Series B Preferred Stock) <span style="background-color: white">are filed as Exhibit 5.1 and Exhibit
5.2, respectively, hereto.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 3.03.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Material Modifications to Rights of Security Holders.</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
disclosure required by this Item and included in Item 1.01 of this Current Report is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 5.03</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
disclosure required by this Item and included in Item 1.01 of this Current Report is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 8.01</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other Events</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company issued a press release announcing the Offering on January 10, 2022. A copy of the press release is attached hereto as Exhibit
99.1, and is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 9.01</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial Statements and Exhibits.</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Not Applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Not Applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Not Applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    Number</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex1-1.htm">Placement Agent Agreement, dated January 10, 2022, between Celsion Corporation and A.G.P./Alliance Global Partners</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex3-1.htm">Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Redeemable Preferred Stock</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex3-2.htm">Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Redeemable Preferred Stock</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex5-1.htm">Opinion of Baker &amp; McKenzie LLP with respect to validity of the Series A Preferred Stock (and the shares of Common Stock issuable upon conversion of the Series A Preferred Stock)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex5-2.htm">Opinion of Baker &amp; McKenzie LLP with respect to validity of the Series B Preferred Stock (and the shares of Common Stock issuable upon conversion of the Series B Preferred Stock)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">Form of Securities Purchase Agreement between Celsion Corporation and the investors therein, dated January 10, 2022</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex5-1.htm">Consent of Baker &amp; McKenzie LLP (included in Exhibit 5.1)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex5-2.htm">Consent of Baker &amp; McKenzie LLP (included in Exhibit 5.2)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press Release of Celsion Corporation dated January 10, 2022 announcing the pricing of the Offering</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">104</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CELSION
    CORPORATION</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    January 11, 2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Jeffrey W. Church</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
    W. Church</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Vice President</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
    Chief Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5LpoEROyjRUWsIkXE12BXCbbZskn9OZK3NLaIy8KyzHwzQqRiRUtbI8NpXhZwwKatTUAo8YKM7ozRka83GcRb4tX6wMaF/v2BOUUGIzMZKWWi0Fvv1mOVgVRjJcdag5xlegr7rUi+ek7uYit0wZoajKtgz9SyxWD4NSQczJMcNa++6ojsLbkM1EgO8hu0VBp2dDcP4puHoshFkvaTiBVT135rOh+ogUWNTezyA/rf5AMViklG -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
1.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
10, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Celsion
Corporation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">997
Lenox Drive, Suite 100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrenceville,
NJ 08648</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Michael H. Tardugno</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman,
President and Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Mr. Tardugno:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
letter (the <B>&ldquo;Agreement&rdquo;</B>) constitutes the agreement between A.G.P./Alliance Global Partners (the <B>&ldquo;Placement
Agent&rdquo;</B>) and Celsion Corporation, a Delaware corporation (the <B>&ldquo;Company&rdquo;</B>), that the Placement Agent shall
serve as the exclusive placement agent for the Company, on a <B>&ldquo;reasonable best efforts&rdquo;</B> basis, in connection with the
proposed placement (the <B>&ldquo;Placement&rdquo;</B>) of shares (the <B>&ldquo;Shares&rdquo;</B> or the <B>&ldquo;Securities&rdquo;</B>)
of the Company&rsquo;s Preferred Stock, par value $0.01 per share (the &ldquo;<B>Preferred Stock</B>&rdquo;), that are redeemable and
are convertible into shares of the Company&rsquo;s Common Stock, par value $0.01 per share (the <B>&ldquo;Common Stock&rdquo;</B>). The
Securities actually placed by the Placement Agent are referred to herein as the <B>&ldquo;Placement Agent Securities&rdquo;.</B> The
terms of the Placement shall be mutually agreed upon by the Company and the purchasers (each, a <B>&ldquo;Purchaser&rdquo;</B> and collectively,
the <B>&ldquo;Purchasers&rdquo;</B>), and nothing herein constitutes that the Placement Agent would have the power or authority to bind
the Company or any Purchaser, or an obligation for the Company to issue any Securities or complete the Placement. The Company expressly
acknowledges and agrees that the Placement Agent&rsquo;s obligations hereunder are on a reasonable best efforts basis only and that the
execution of this Agreement does not constitute a commitment by the Placement Agent to purchase the Securities and does not ensure the
successful placement of the Securities or any portion thereof or the success of the Placement Agent with respect to securing any other
financing on behalf of the Company. The Placement Agent may retain other brokers or dealers to act as sub-agents or selected-dealers
on its behalf in connection with the Placement. Certain affiliates of the Placement Agent may participate in the Placement by purchasing
some of the Placement Agent Securities. The sale of Placement Agent Securities to any Purchaser will be evidenced by a securities purchase
agreement (the <B>&ldquo;Purchase Agreement&rdquo;</B>) between the Company and such Purchaser, in a form reasonably acceptable to the
Company and the Purchaser. Capitalized terms that are not otherwise defined herein have the meanings given to such terms in the Purchase
Agreement. Prior to the signing of any Purchase Agreement, officers of the Company will be available to answer inquiries from prospective
Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
1.&#9;REPRESENTATIONS AND WARRANTIES OF THE COMPANY; COVENANTS OF THE COMPANY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
<U>Representations of the Company</U>. With respect to the Placement Agent Securities, each of the representations and warranties (together
with any related disclosure schedules thereto) and covenants made by the Company to the Purchasers in the Purchase Agreement in connection
with the Placement, is hereby incorporated herein by reference into this Agreement (as though fully restated herein) and is, as of the
date of this Agreement and as of the Closing Date, hereby made to, and in favor of, the Placement Agent. In addition to the foregoing,
the Company represents and warrants that there are no affiliations with any FINRA member firm among the Company&rsquo;s officers, directors
or, to the knowledge of the Company, any five percent (5.0%) or greater securityholder of the Company, except as set forth in the Purchase
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
<U>Covenants of the Company</U>. The Company covenants and agrees to continue to retain (i) a firm of independent PCAOB registered public
accountants for a period of at least three (3) years after the Closing Date and (ii) a competent transfer agent with respect to the Common
Stock for a period of three (3) years after the Closing Date. In addition, from the date hereof until 90 days after the Closing Date,
neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of
any shares of Preferred Stock, Common Stock or Common Stock Equivalents, except that such restriction shall not apply with respect to
an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
2.&#9;REPRESENTATIONS AND COVENANTS OF THE PLACEMENT AGENT. </U>The Placement Agent represents and warrants that it (i) is a member in
good standing of FINRA, (ii) is registered as a broker/dealer under the Exchange Act, (iii) is licensed as a broker/dealer under the
laws of the United States of America, applicable to the offers and sales of the Placement Agent Securities by the Placement Agent, (iv)
is and will be a corporate body validly existing under the laws of its place of incorporation, (v) has full power and authority to enter
into and perform its obligations under this Agreement. The Placement Agent will immediately notify the Company in writing of any change
in its status with respect to subsections (i) through (v) above. The Placement Agent covenants that it will use its reasonable best efforts
to conduct the Placement hereunder in compliance with the provisions of this Agreement and the requirements of applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
3.&#9;COMPENSATION. </U>In consideration of the services to be provided for hereunder, the Company shall pay to the Placement Agent and/or
its respective designees a flat cash fee of $1 million (the <B>&ldquo;Cash Fee&rdquo;</B>). The Cash Fee shall be paid on the Closing
Date. The Company shall not be required to pay the Placement Agent any fees or expenses except for the Cash Fee, the reimbursement of
(i) up to $100,000 for legal expenses and (ii) expenses in connection with marketing the transaction (i.e., IPREO software related expenses,
roadshow expenses, background checks, tombstones, etc.), with respect to the engagement hereunder; provided, however, that the reimbursement
of expenses of the Placement Agent shall not exceed $10,000 in the aggregate; provided, further, that this sentence in no way limits
or impairs the indemnification or contribution provisions contained herein. The Placement Agent reserves the right to reduce any item
of compensation or adjust the terms thereof as specified herein in the event that a determination shall be made by FINRA to the effect
that the Placement Agent&rsquo;s aggregate compensation is in excess of FINRA Rules or that the terms thereof require adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
4.&#9;INDEMNIFICATION.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
To the extent permitted by law, with respect to the Placement Agent Securities, the Company will indemnify the Placement Agent and its
affiliates, stockholders, directors, officers, employees, members and controlling persons (within the meaning of Section 15 of the Securities
Act or Section 20 of the Exchange Act) against all losses, claims, damages, expenses and liabilities, as the same are incurred (including
the reasonable fees and expenses of counsel), relating to or arising out of its activities hereunder or pursuant to this Agreement, except
to the extent that any losses, claims, damages, expenses or liabilities (or actions in respect thereof) are found in a final judgment
(not subject to appeal) by a court of law to have resulted primarily and directly from the Placement Agent&rsquo;s willful misconduct
or gross negligence in performing the services described herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
Promptly after receipt by the Placement Agent of notice of any claim or the commencement of any action or proceeding with respect to
which the Placement Agent is entitled to indemnity hereunder, the Placement Agent will notify the Company in writing of such claim or
of the commencement of such action or proceeding, but failure to so notify the Company shall not relieve the Company from any obligation
it may have hereunder, except and only to the extent such failure results in the forfeiture by the Company of substantial rights and
defenses. If the Company so elects or is requested by the Placement Agent, the Company will assume the defense of such action or proceeding
and will employ counsel reasonably satisfactory to the Placement Agent and will pay the fees and expenses of such counsel. Notwithstanding
the preceding sentence, the Placement Agent will be entitled to employ counsel separate from counsel for the Company and from any other
party in such action if counsel for the Placement Agent reasonably determines that it would be inappropriate under the applicable rules
of professional responsibility for the same counsel to represent both the Company and the Placement Agent. In such event, the reasonable
fees and disbursements of no more than one such separate counsel will be paid by the Company, in addition to fees of local counsel. The
Company will have the right to settle the claim or proceeding, provided that the Company will not settle any such claim, action or proceeding
without the prior written consent of the Placement Agent, which will not be unreasonably withheld. The Company shall not be liable for
any settlement of any action effected without its written consent, which will not be unreasonably withheld.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
The Company agrees to notify the Placement Agent promptly of the assertion against it or any other person of any claim or the commencement
of any action or proceeding relating to a transaction contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
If for any reason the foregoing indemnity is unavailable to the Placement Agent or insufficient to hold the Placement Agent harmless
(other than due to the express provisions thereof), then the Company shall contribute to the amount paid or payable by the Placement
Agent as a result of such losses, claims, damages or liabilities in such proportion as is appropriate to reflect not only the relative
benefits received by the Company on the one hand and the Placement Agent on the other, but also the relative fault of the Company on
the one hand and the Placement Agent on the other that resulted in such losses, claims, damages or liabilities, as well as any relevant
equitable considerations. The amounts paid or payable by a party in respect of losses, claims, damages and liabilities referred to above
shall be deemed to include any legal or other fees and expenses incurred in defending any litigation, proceeding or other action or claim.
Notwithstanding the provisions hereof, the Placement Agent&rsquo;s share of the liability hereunder shall not be in excess of the amount
of fees actually received, or to be received, by the Placement Agent under this Agreement (excluding any amounts received as reimbursement
of expenses incurred by the Placement Agent).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.
These indemnification provisions shall remain in full force and effect whether or not the transaction contemplated by this Agreement
is completed and shall survive the termination of this Agreement, and shall be in addition to any liability that the Company might otherwise
have to any indemnified party under this Agreement or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
5.&#9;ENGAGEMENT TERM. </U>The Placement Agent&rsquo;s engagement hereunder will be until the earlier of (i) March 17, 2022 and (ii)
the Closing Date. The date of termination of this Agreement is referred to herein as the <B>&ldquo;Termination Date.&rdquo;</B> In the
event, however, in the course of the Placement Agent&rsquo;s performance of due diligence it deems it necessary to terminate the engagement,
the Placement Agent may do so prior to the Termination Date. The Company may elect to terminate the engagement hereunder for any reason
prior to the Termination Date but will remain responsible for fees and expenses pursuant to, and subject to the limits set forth in,
Section 3 hereof. Notwithstanding anything to the contrary contained herein, the provisions concerning the Company&rsquo;s obligation
to pay any fees actually earned pursuant to Section 3 hereof, to pay expenses pursuant to Section 3 hereof, and the provisions concerning
confidentiality, indemnification and contribution contained herein will survive any expiration or termination of this Agreement. Subject
to the limitations set forth herein, if this Agreement is terminated prior to the completion of the Placement, all fees and expenses
due to the Placement Agent shall be paid by the Company to the Placement Agent on or before the Termination Date (in the event such fees
are earned or owed as of the Termination Date). The Placement Agent agrees not to disclose or use any confidential information concerning
the Company provided to the Placement Agent by the Company for any purposes other than those contemplated under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
6.&#9;PLACEMENT AGENT INFORMATION.</U> The Company agrees that any information or advice rendered by the Placement Agent in connection
with this engagement is for the confidential use of the Company only in their evaluation of the Placement and, except as otherwise required
by law, the Company will not disclose or otherwise refer to the advice or information in any manner without the Placement Agent&rsquo;s
prior written consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
7.&#9;NO FIDUCIARY RELATIONSHIP. </U>This Agreement does not create, and shall not be construed as creating rights enforceable by any
person or entity not a party hereto, except those entitled hereto by virtue of the indemnification provisions hereof. The Company acknowledges
and agrees that the Placement Agent is not and shall not be construed as a fiduciary of the Company and shall have no duties or liabilities
to the equity holders or the creditors of the Company or any other person by virtue of this Agreement or the retention of the Placement
Agent hereunder, all of which are hereby expressly waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
8.&#9;CLOSING. </U>The obligations of the Placement Agent, and the closing of the sale of the Placement Agent Securities hereunder are
subject to the accuracy, when made and on the Closing Date, of the representations and warranties on the part of the Company contained
herein and in the Purchase Agreement, to the performance by the Company of its obligations hereunder and in the Purchase Agreement, and
to each of the following additional terms and conditions, except as otherwise disclosed to and acknowledged and waived by the Placement
Agent:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
All corporate proceedings and other legal matters incident to the authorization, form, execution, delivery and validity of each of this
Agreement, the Placement Agent Securities, and all other legal matters relating to this Agreement and the transactions contemplated hereby
with respect to the Placement Agent Securities shall be reasonably satisfactory in all material respects to the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
The Placement Agent shall have received from outside U.S. counsel to the Company each such counsel&rsquo;s written opinion with respect
to the Placement Agent Securities, addressed to the Placement Agent and dated as of the Closing Date, in form and substance reasonably
satisfactory to the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
The Placement Agent shall have received from the Company a certificate executed by the Chief Financial Officer of the Company, dated
as of such date, in form and substance reasonably satisfactory to the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
The Placement Agent shall have received customary certificates of the Company&rsquo;s executive officers, as to the accuracy of the representations
and warranties contains in the Purchase Agreement, and a certificate of the Company&rsquo;s secretary certifying that the Company&rsquo;s
charter documents are true and complete, have not been modified and are in full force and effect; (ii) that the resolutions of the Company&rsquo;s
Board of Directors relating to the Placement are in full force and effect and have not been modified; and (iii) as to the incumbency
of the officers of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.
The Common Stock shall be registered under the Exchange Act and, as of the Closing Date, the Common Stock shall be listed and admitted
and authorized for trading on the Trading Market or other applicable U.S. national exchange and reasonably satisfactory evidence of such
action shall have been provided to the Placement Agent. Except as disclosed in reports filed under the Exchange Act, the Company shall
have taken no action designed to, or likely to have the effect of terminating the registration of the Common Stock under the Exchange
Act or delisting or suspending from trading the Common Stock from the Trading Market or other applicable U.S. national exchange, nor
has the Company received any information suggesting that the Commission or the Trading Market or other U.S. applicable national exchange
is contemplating terminating such registration or listing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.
No action or proceeding before a court of competent jurisdiction shall have been taken and no statute, rule, regulation or order shall
have been enacted, adopted or issued by any governmental agency or body which would, as of the Closing Date, prevent the issuance or
sale of the Placement Agent Securities or materially and adversely affect or potentially and adversely affect the business or operations
of the Company; and no injunction, restraining order or order of any other nature by any federal or state court of competent jurisdiction
shall have been issued as of the Closing Date which would prevent the issuance or sale of the Placement Agent Securities or materially
and adversely affect or potentially and adversely affect the business or operations of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.
The Company shall have entered into a Purchase Agreement with each of the Purchasers of the Placement Agent Securities and such agreements
shall be in full force and effect and shall contain representations, warranties and covenants of the Company as agreed upon between the
Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.
FINRA shall have raised no objection to the fairness and reasonableness of the terms and arrangements of this Agreement. In addition,
the Company shall, if requested by the Placement Agent, make or authorize Placement Agent&rsquo;s counsel to make on the Company&rsquo;s
behalf, any filing with the FINRA Corporate Financing Department pursuant to FINRA Rule 2710 with respect to the Placement and pay all
filing fees required in connection therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the conditions specified in this Section 8 shall not have been fulfilled when and as required by this Agreement, all obligations
of the Placement Agent hereunder may be cancelled by the Placement Agent at, or at any time prior to, the Closing Date. Notice of such
cancellation shall be given to the Company in writing or orally. Any such oral notice shall be confirmed promptly thereafter in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
9.&#9;GOVERNING LAW. </U>This Agreement will be governed by, and construed in accordance with, the laws of the State of New York applicable
to agreements made and to be performed entirely in such State. This Agreement may not be assigned by either party without the prior written
consent of the other party. This Agreement shall be binding upon and inure to the benefit of the parties hereto, and their respective
successors and permitted assigns. Any right to trial by jury with respect to any dispute arising under this Agreement or any transaction
or conduct in connection herewith is waived. Any dispute arising under this Agreement may be brought into the courts of the State of
New York or into the Federal Court located in New York, New York and, by execution and delivery of this Agreement, the Company hereby
accepts for itself and in respect of its property, generally and unconditionally, the jurisdiction of aforesaid courts. Each party hereto
hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by
delivering a copy thereof via overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it
under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing
contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. If either party shall
commence an action or proceeding to enforce any provisions of this Agreement, then the prevailing party in such action or proceeding
shall be reimbursed by the other party for its attorney&rsquo;s fees and other costs and expenses incurred with the investigation, preparation
and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
10.&#9;ENTIRE AGREEMENT/MISCELLANEOUS. </U>This Agreement embodies the entire agreement and understanding between the parties hereto,
and supersedes all prior agreements and understandings, relating to the subject matter hereof, including but not limited to the letter
agreement dated December 17, 2021 by and between the Placement Agent and the Company (the &ldquo;<U>Letter Agreement</U>&rdquo;), which
Letter Agreement shall terminate effective immediately as of the execution of this Agreement. If any provision of this Agreement is determined
to be invalid or unenforceable in any respect, such determination will not affect such provision in any other respect or any other provision
of this Agreement, which will remain in full force and effect. This Agreement may not be amended or otherwise modified or waived except
by an instrument in writing signed by both the Placement Agent and the Company. The representations, warranties, agreements and covenants
contained herein shall survive the Closing Date of the Placement and delivery of the Placement Agent Securities. This Agreement may be
executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become
effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need
not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or a .pdf format file, such signature
shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force
and effect as if such facsimile or .pdf signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
11.&#9;NOTICES.</U> Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be
in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is
sent to the email address specified on the signature pages attached hereto prior to 6:30 p.m. (New York City time) on a business day,
(b) the next business day after the date of transmission, if such notice or communication is sent to the email address on the signature
pages attached hereto on a day that is not a business day or later than 6:30 p.m. (New York City time) on any business day, (c) the third
business day following the date of mailing, if sent by U.S. internationally recognized air courier service, or (d) upon actual receipt
by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the
signature pages hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
12.&#9;PRESS ANNOUNCEMENTS.</U> The Company agrees that the Placement Agent shall, on and after the Closing Date, have the right to reference
the Placement and the Placement Agent&rsquo;s role in connection therewith in the Placement Agent&rsquo;s marketing materials and on
its website and to place advertisements in financial and other newspapers and journals, in each case at its own expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>The
remainder of this page has been intentionally left blank</I>.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
confirm that the foregoing correctly sets forth our agreement by signing and returning to the Placement Agent the enclosed copy of this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly
    yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>A.G.P./ALLIANCE GLOBAL
    PARTNERS</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Thomas Higgins</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas
    Higgins</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing
    Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for notice</U>:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">590
    Madison Avenue 36<SUP>th</SUP> Floor</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, New York 10022</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
    Thomas Higgins</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    <U>thiggins@allianceg.com</U></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted
and Agreed to as of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
date first written above:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CELSION CORPORATION</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Michael H. Tardugno</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    H. Tardugno</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for notice</U>:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">997
    Lenox Drive, Suite 100</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrenceville,
    NJ 08648</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
    Michael H. Tardugno</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman,
    President and Chief Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>3
<FILENAME>ex3-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Exhibit
3.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>celsion
corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATE
OF DESIGNATION OF PREFERENCES, </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RIGHTS
AND LIMITATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
<FONT STYLE="text-transform: uppercase">a </FONT>CONVERTIBLE REDEEMABLE PREFERRED STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">PURSUANT
TO SECTION 151 OF THE </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">delaware
GENERAL CORPORATION LAW</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, Jeffrey W. Church, does hereby certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">He
    is the Executive Vice President and CFO of Celsion Corporation, a Delaware corporation (the &ldquo;<U>Corporation</U>&rdquo;).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Corporation is authorized to issue 100,000 shares of preferred stock, none of which have been issued.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    following resolutions were duly adopted by the board of directors of the Corporation (the &ldquo;<U>Board of Directors</U>&rdquo;):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the certificate of incorporation of the Corporation, as amended (the &ldquo;Certificate of Incorporation&rdquo;), provides for a class
of its authorized stock known as preferred stock, consisting of 100,000 shares, $0.01 par value per share, issuable from time to time
in one or more series;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Board of Directors is authorized by resolution to provide for the issuance of preferred stock in one or more series, and to establish
from time to time the number of shares to be included in each such series, and to fix the designation, powers, privileges, preferences
and relative participating, optional or other rights, if any, of the shares of each such series and the qualifications, limitations or
restrictions thereof; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
it is the desire of the Board of Directors, pursuant to its authority as described above, to fix the rights, preferences, restrictions
and other matters relating to a series of the preferred stock, which shall consist of 50,000 shares of the preferred stock which the
Corporation has the authority to issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, BE IT RESOLVED, that the Board of Directors does hereby provide for the issuance of a series of preferred stock to be designated
&ldquo;Series A Convertible Redeemable Preferred Stock&rdquo; and does hereby fix and determine the designation, powers, privileges,
preferences and relative participating, optional or other rights, if any, of the shares of each such series and the qualifications, limitations
or restrictions thereof as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. For the purposes hereof, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Alternate
Consideration</U>&rdquo; shall have the meaning set forth in Section 7(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Amendment</U>&rdquo;
means the amendment to the Corporation&rsquo;s certificate of incorporation, as amended, to, after the date hereof, effect the Reverse
Stock Split.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Authorized
Stockholder Approval</U>&rdquo; means approval of the Amendment by the holders of a majority in voting power of the then outstanding
shares of capital stock of the Corporation entitled to vote on the matter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo; shall have the meaning set forth in Section 6(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Buy-In</U>&rdquo;
shall have the meaning set forth in Section 6(c)(iv).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Change
of Control Transaction</U>&rdquo; means the occurrence after the date hereof of any of (a) an acquisition after the date hereof by an
individual or legal entity or &ldquo;group&rdquo; (as described in Rule 13d-5(b)(1) promulgated under the Exchange Act) of effective
control (whether through legal or beneficial ownership of capital stock of the Corporation, by contract or otherwise) of in excess of
50% of the voting securities of the Corporation (other than by means of the issuance, sale, conversion or exercise of Series A Preferred
Stock or Series B Preferred Stock), (b) the Corporation merges into or consolidates with any other Person, or any Person merges into
or consolidates with the Corporation and, after giving effect to such transaction, the stockholders of the Corporation immediately prior
to such transaction own less than a majority of the aggregate voting power of the Corporation or the successor entity of such transaction,
(c) the Corporation (and all of its Subsidiaries, taken as a whole) sells or transfers all or substantially all of its assets to another
Person and the stockholders of the Corporation immediately prior to such transaction own less than a majority of the aggregate voting
power of the acquiring entity immediately after the transaction, (d) a replacement at one time or within a one year period of more than
one-half of the members of the Board of Directors which is not approved by a majority of those individuals who are members of the Board
of Directors on the Original Issue Date (or by those individuals who are serving as members of the Board of Directors on any date whose
nomination to the Board of Directors was approved by a majority of the members of the Board of Directors who are members on the Original
Issue Date), or (e) the execution by the Corporation of an agreement to which the Corporation is a party or by which it is bound, providing
for any of the events set forth in clauses (a) through (d) above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Series A Preferred Stock pursuant to Section 2.1 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto and all conditions precedent to (i) each Holder&rsquo;s obligations to pay the Subscription Amount and (ii) the Corporation&rsquo;s
obligations to deliver the Series A Preferred Stock have been satisfied or waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the Corporation&rsquo;s common stock, $0.01 par value per share, and stock of any other class of securities into
which such securities may hereafter be reclassified, converted or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Corporation or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that
is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Amount</U>&rdquo; means the Stated Value at issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Date</U>&rdquo; shall have the meaning set forth in Section 6(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Price</U>&rdquo; shall have the meaning set forth in Section 6(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Shares</U>&rdquo; means, collectively, the shares of Common Stock issuable upon conversion of the shares of Series A Preferred Stock
in accordance with the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Escrow
Agreement</U>&rdquo; means the escrow agreement to be entered into concurrently with the Purchase Agreement, by and among the Corporation,
Citibank N.A., and the other party thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Equity
Conditions</U>&rdquo; means, during the period in question, (a) the Corporation shall have paid all liquidated damages and other amounts
owing to the applicable Holder in respect of the Series A Preferred Stock, (b)(i) there is an effective registration statement pursuant
to which either (A) the Corporation may issue Conversion Shares or (B) the Holders are permitted to utilize the prospectus thereunder
to resell all of the shares of Common Stock issuable pursuant to the Transaction Documents (and the Corporation believes, in good faith,
that such effectiveness will continue uninterrupted for the foreseeable future) or (ii) all of the Conversion Shares issuable pursuant
to the Transaction Documents (and shares issuable in lieu of cash payments of dividends) may be resold pursuant to Rule 144 without volume
or manner-of-sale restrictions or current public information requirements as determined by the counsel to the Corporation as set forth
in a written opinion letter to such effect, addressed and reasonably acceptable to the Transfer Agent and the affected Holder or (iii)
all of the Conversion Shares may be issued to the Holder pursuant to Section 3(a)(9) of the Securities Act and immediately resold without
restriction, (c) the Common Stock is trading on a Trading Market and all of the shares of Common Stock issuable upon conversion of the
Series A Preferred Stock are listed or quoted for trading on such Trading Market (and the Corporation believes, in good faith, that trading
of the Common Stock on a Trading Market will continue uninterrupted for the foreseeable future), (d) there is a sufficient number of
authorized, but unissued and otherwise unreserved, shares of Common Stock for the issuance of all of the shares then issuable pursuant
to the Transaction Documents, (e) Authorized Stockholder Approval shall have been received and be effective, (f) the issuance of the
shares in question to the applicable Holder would not violate the limitations set forth in Section 6(d) herein, (g) <FONT STYLE="font-style: normal; font-weight: normal">the
shares of Common Stock have traded on the applicable Trading Market during a consecutive ten (10) day period at an average market price
per share greater than $2.00 and the average daily trading volume during such period is equal to or greater than $2,000,000, (h)</FONT>
there has been no public announcement of a pending or proposed Fundamental Transaction or Change of Control Transaction that has not
been consummated, (i) the applicable Holder is not in possession of any information provided by the Corporation, any of its Subsidiaries,
or any of their officers, directors, employees, agents or Affiliates, that constitutes, or may constitute, material non-public information
and (j) the Corporation shall have duly honored all conversions scheduled to occur or occurring by virtue of one or more Notices of Conversion
of the applicable Holder on or prior to the dates so requested or required, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Forced
Conversion Date</U>&rdquo; shall have the meaning set forth in Section 8(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Forced
Conversion Notice</U>&rdquo; shall have the meaning set forth in Section 8(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Forced
Conversion Notice Date</U>&rdquo; shall have the meaning set forth in Section 8(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Fundamental
Transaction</U>&rdquo; shall have the meaning set forth in Section 7(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
means United States generally accepted accounting principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Holder</U>&rdquo;
shall have the meaning given such term in Section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liquidation</U>&rdquo;
shall have the meaning set forth in Section 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Mandatory
Conversion</U>&rdquo; shall have the meaning set forth in Section 8(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Mandatory
Conversion Date</U>&rdquo; shall have the meaning set forth in Section 8(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Notice
of Conversion</U>&rdquo; shall have the meaning set forth in Section 6(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Original
Issue Date</U>&rdquo; means the date of the first issuance of any shares of the Series A Preferred Stock regardless of the number of
transfers of any particular shares of Series A Preferred Stock and regardless of the number of certificates which may be issued to evidence
such Series A Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchase
Agreement</U>&rdquo; means the Preferred Stock Purchase Agreement, dated as of January 10, 2022, among the Corporation and the
original Holders, as amended, modified or supplemented from time to time in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Reverse
Stock Split</U>&rdquo; means the reverse stock split of the Corporation&rsquo;s Common Stock that is effected by the Corporation&rsquo;s
filing of the Amendment with and acceptance by the Secretary of the State of Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Reverse
Stock Split Date</U>&rdquo; means the date on which the Reverse Stock Split is consummated and the Amendment is filed and accepted by
the Secretary of State of the State of Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
A Preferred Stock</U>&rdquo; shall have the meaning set forth in Section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
B Preferred Stock Certificate of Designation</U>&rdquo; means the Certificate of Designation of Preferences, Rights and Limitations of
the Series B Convertible Redeemable Preferred Stock of the Corporation, dated as of the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Share
Delivery Date</U>&rdquo; shall have the meaning set forth in Section 6(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stated
Value</U>&rdquo; shall have the meaning set forth in Section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; shall mean, as to each Holder, the aggregate amount to be paid for the Series A Preferred Stock purchased pursuant
to the Purchase Agreement as specified below such Holder&rsquo;s name on the signature page of the Purchase Agreement and next to the
heading &ldquo;Subscription Amount,&rdquo; in United States dollars and in immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Corporation as set forth on <U>Schedule 3.1(a)</U> of the Purchase Agreement and shall, where applicable,
also include any direct or indirect subsidiary of the Corporation formed or acquired after the date of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Successor
Entity</U>&rdquo; shall have the meaning set forth in Section 7(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Certificate of Designation, the Series B Preferred Stock Certificate of Designation, the Purchase Agreement,
the Escrow Agreement, all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with
the transactions contemplated pursuant to the Purchase Agreement, in each case as amended, modified or supplemented from time to time
in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means American Stock Transfer &amp; Trust Company, and any successor transfer agent of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Designation, Amount and Par Value</U>. The series of preferred stock shall be designated as &ldquo;Series A Convertible Redeemable
Preferred Stock&rdquo; (the &ldquo;<U>Series A Preferred Stock</U>&rdquo;) and the number of shares of such series shall be 50,000 (which
shall not be subject to increase without the written consent of the holders of a majority of the then outstanding shares of the Series
A Preferred Stock (each, a &ldquo;<U>Holder</U>&rdquo; and collectively, the &ldquo;<U>Holders</U>&rdquo;)). Each share of Series A Preferred
Stock shall have a par value of $0.01 per share and a stated value equal to $300.00 (the &ldquo;<U>Stated Value</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Dividends</U>. Except for stock dividends or distributions for which adjustments are to be made pursuant to Section 7, Holders
shall be entitled to receive, and the Corporation shall pay, dividends on shares of Series A Preferred Stock equal (on an as-if-converted-to-Common-Stock
basis, disregarding for such purpose any conversion limitations hereunder) to and in the same form as dividends actually paid on shares
of the Common Stock when, as and if such dividends are paid on shares of the Common Stock. No other dividends shall be paid on shares
of Series A Preferred Stock. The Corporation shall not pay any dividends on the Common Stock unless the Corporation simultaneously complies
with this provision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Voting Rights</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
purposes of determining the presence of a quorum at any meeting of the stockholders of the Corporation at which the shares of Series
A Preferred Stock are entitled to vote, the number of shares of Series A Preferred Stock and votes represented by such shares shall be
counted on an as converted to Common Stock basis, disregarding, for such purposes, any limitations on conversion set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
share of Series A Preferred Stock shall entitle the holder thereof (a) to vote exclusively with respect to the Amendment and the Reverse
Stock Split (and the Series A Preferred Stock shall not be entitled to vote on any other matter except to the extent required under the
Delaware General Corporation Law) and (b) to a number of votes equal to the number of Conversion Shares issuable upon conversion thereof
assuming the Series A Preferred Stock were then convertible into Common Stock (whether or not such shares are then convertible and disregarding
any limitations on conversion set forth herein) and shall, except as required by law, vote together with the Common Stock and any other
issued and outstanding shares of preferred stock of the Corporation, as a single class. Notwithstanding the foregoing, in addition, as
long as any shares of Series A Preferred Stock are outstanding, the Corporation shall not, without the affirmative vote of the Holders
of a majority of the then outstanding shares of the Series A Preferred Stock, (a) alter or change adversely the powers, preferences or
rights given to the Series A Preferred Stock or alter or amend this Certificate of Designation, (b) amend its certificate of incorporation
or other charter documents in a manner adverse to the Holders, (c) increase the number of authorized shares of Series A Preferred Stock,
or (d) enter into any agreement with respect to any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Liquidation</U>. Upon any liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary (a &ldquo;<U>Liquidation</U>&rdquo;),
prior and in preference to the Common Stock, the Holders shall be entitled to receive out of the assets available for distribution to
stockholders an amount equal to 105% of the Stated Value and no more. <FONT STYLE="font-weight: normal">The preference set forth in this
Section 5 with respect to distributions to the Series A Preferred Stock upon a Liquidation shall apply <I>mutatis mutandis </I>to any
distributions to be made upon the consummation of a Fundamental Transaction or Change of Control Transaction.</FONT> The Corporation
shall mail written notice of any such Liquidation, <FONT STYLE="font-style: normal; font-weight: normal">Fundamental Transaction or Change
of Control Transaction</FONT> not less than 45 days prior to the payment date stated therein, to each Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
6</U>. <U>Conversion</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Conversions at Option of Holder</U>. Subject to Section 6(d), each share of Series A Preferred Stock shall be convertible, at any
time and from time to time only after the Reverse Stock Split Date, at the option of the Holder thereof, into that number of shares of
Common Stock determined by dividing the Stated Value of such share of Series A Preferred Stock by the Conversion Price. Holders shall
effect conversions by delivering to the Corporation a conversion notice in the form attached hereto as <U>Annex A</U> (a &ldquo;<U>Notice
of Conversion</U>&rdquo;). Each Notice of Conversion shall specify the number of shares of Series A Preferred Stock to be converted,
the number of shares of Series A Preferred Stock owned prior to the conversion at issue, the number of shares of Series A Preferred Stock
owned subsequent to the conversion at issue and the date on which such conversion is to be effected, which date may not be prior to the
date the applicable Holder delivers such Notice of Conversion to the Corporation (such date, the &ldquo;<U>Conversion Date</U>&rdquo;).
If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be as of the close of business on the Business
Day that such Notice of Conversion is delivered to the Corporation, or if such day is not a Business day or if the Notice of Conversion
is delivered after regular business hours, the next Business Day. No ink-original Notice of Conversion shall be required, nor shall any
medallion guarantee (or other type of guarantee or notarization) of any Notice of Conversion form be required. The calculations and entries
set forth in the Notice of Conversion shall control in the absence of manifest or mathematical error. From and after the Conversion Date,
until presented for transfer or exchange, certificates that previously represented shares of Series A Preferred Stock shall represent,
in lieu of the number of shares of Series A Preferred Stock previously represented by such certificate, the number of shares of Series
A Preferred Stock, if any, previously represented by such certificate that were not converted pursuant to the Notice of Conversion, plus
the number of shares of Conversion Shares into which the shares of Series A Preferred Stock previously represented by such certificate
were converted. To effect conversions of shares of Series A Preferred Stock, a Holder shall not be required to surrender the certificate(s)
representing the shares of Series A Preferred Stock to the Corporation unless all of the shares of Series A Preferred Stock represented
thereby are so converted, in which case such Holder shall deliver the certificate representing such shares of Series A Preferred Stock
promptly following the Conversion Date at issue. Shares of Series A Preferred Stock converted into Common Stock shall be canceled and
shall not be reissued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Conversion Price</U>. The conversion price for the Series A Preferred Stock shall equal $0.91, subject to adjustment herein (the &ldquo;<U>Conversion
Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Mechanics of Conversion</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Delivery
    of Conversion Shares Upon Conversion</U>. Not later than the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days
    comprising the Standard Settlement Period (as defined below) after each Conversion Date (the &ldquo;<U>Share Delivery Date</U>&rdquo;),
    the Corporation shall deliver, or cause to be delivered, to the converting Holder the number of Conversion Shares being acquired
    upon the conversion of the Series A Preferred Stock, which Conversion Shares shall be free of restrictive legends and trading restrictions.
    The Corporation shall use its reasonable best efforts to deliver the Conversion Shares required to be delivered by the Corporation
    under this Section 6 electronically through the Depository Trust Company or another established clearing corporation performing similar
    functions. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number
    of Trading Days, on the Corporation&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
    of the Notice of Conversion.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Failure
    to Deliver Conversion Shares</U>. If, in the case of any Notice of Conversion, such Conversion Shares are not delivered to or as
    directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written notice to the Corporation
    at any time on or before its receipt of such Conversion Shares, to rescind such Conversion, in which event the Corporation shall
    promptly return to the Holder any original Preferred Stock certificate delivered to the Corporation and the Holder shall promptly
    return to the Corporation the Conversion Shares issued to such Holder pursuant to the rescinded Notice of Conversion.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Obligation
    Absolute; Partial Liquidated Damages</U>. Subject to Section 6(d), the Corporation&rsquo;s obligation to issue and deliver the Conversion
    Shares upon conversion of Series A Preferred Stock in accordance with the terms hereof are absolute and unconditional, irrespective
    of any action or inaction by a Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery
    of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination,
    or any breach or alleged breach by such Holder or any other Person of any obligation to the Corporation or any violation or alleged
    violation of law by such Holder or any other Person, and irrespective of any other circumstance, other than pursuant to Section 6(d),
    which might otherwise limit such obligation of the Corporation to such Holder in connection with the issuance of such Conversion
    Shares; <U>provided</U>, <U>however</U>, that such delivery shall not operate as a waiver by the Corporation of any such action that
    the Corporation may have against such Holder. In the event a Holder shall elect to convert any or all of the Stated Value of its
    Series A Preferred Stock, the Corporation may not refuse conversion based on any claim that such Holder or anyone associated or affiliated
    with such Holder has been engaged in any violation of law, agreement or for any other reason, other than pursuant to Section 6(d),
    unless an injunction from a court, on notice to Holder, restraining and/or enjoining conversion of all or part of the Series A Preferred
    Stock of such Holder shall have been sought and obtained, and the Corporation posts a surety bond for the benefit of such Holder
    in the amount of 150% of the Stated Value of the Series A Preferred Stock which is subject to the injunction, which bond shall remain
    in effect until the completion of arbitration/litigation of the underlying dispute and the proceeds of which shall be payable to
    such Holder to the extent it obtains judgment. In the absence of such injunction, subject to Section 6(d), the Corporation shall
    issue Conversion Shares and, if applicable, cash, upon a properly noticed conversion. If the Corporation fails to deliver to a Holder
    such Conversion Shares pursuant to Section 6(c)(i) by the Share Delivery Date applicable to such conversion, other than in accordance
    with Section 6(d), the Corporation shall pay to such Holder, in cash, as liquidated damages and not as a penalty, for each $5,000
    of Stated Value of Series A Preferred Stock being converted, $50 per Trading Day (increasing to $100 per Trading Day on the third
    Trading Day after the Share Delivery Date and increasing to $200 per Trading Day on the sixth Trading Day after the Share Delivery
    Date) for each Trading Day after the Share Delivery Date until such Conversion Shares are delivered or Holder rescinds such conversion.
    Nothing herein shall limit a Holder&rsquo;s right to pursue actual damages for the Corporation&rsquo;s failure to deliver Conversion
    Shares within the period specified herein and such Holder shall have the right to pursue all remedies available to it hereunder,
    at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief. The exercise of any
    such rights shall not prohibit a Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable
    law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Compensation
    for Buy-In on Failure to Timely Deliver Conversion Shares Upon Conversion</U>. In addition to any other rights available to the Holder,
    if the Corporation fails for any reason, other than due to Section 6(d), to deliver to a Holder the applicable Conversion Shares
    by the Share Delivery Date pursuant to Section 6(c)(i), and if after such Share Delivery Date such Holder is required by its brokerage
    firm to purchase (in an open market transaction or otherwise), or the Holder&rsquo;s brokerage firm otherwise purchases, shares of
    Common Stock to deliver in satisfaction of a sale by such Holder of the Conversion Shares which such Holder was entitled to receive
    upon the conversion relating to such Share Delivery Date (a &ldquo;<U>Buy-In</U>&rdquo;), then the Corporation shall (A) pay in cash
    to such Holder (in addition to any other remedies available to or elected by such Holder) the amount, if any, by which (x) such Holder&rsquo;s
    total purchase price (including any brokerage commissions) for the Common Stock so purchased exceeds (y) the product of (1) the aggregate
    number of shares of Common Stock that such Holder was entitled to receive from the conversion at issue multiplied by (2) the actual
    sale price at which the sell order giving rise to such purchase obligation was executed (including any brokerage commissions) and
    (B) at the option of such Holder, either reissue (if surrendered) the shares of Series A Preferred Stock equal to the number of shares
    of Series A Preferred Stock submitted for conversion (in which case, such conversion shall be deemed rescinded) or deliver to such
    Holder the number of shares of Common Stock that would have been issued if the Corporation had timely complied with its delivery
    requirements under Section 6(c)(i). For example, if a Holder purchases shares of Common Stock having a total purchase price of $11,000
    to cover a Buy-In with respect to an attempted conversion of shares of Series A Preferred Stock with respect to which the actual
    sale price of the Conversion Shares (including any brokerage commissions) giving rise to such purchase obligation was a total of
    $10,000 under clause (A) of the immediately preceding sentence, the Corporation shall be required to pay such Holder $1,000. The
    Holder shall provide the Corporation written notice indicating the amounts payable to such Holder in respect of the Buy-In and, upon
    request of the Corporation, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any
    other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
    injunctive relief with respect to the Corporation&rsquo;s failure to timely deliver the Conversion Shares upon conversion of the
    shares of Series A Preferred Stock as required pursuant to the terms hereof.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Reservation
    of Shares Issuable Upon Conversion</U>. From and after the Reverse Stock Split Date and until no shares of Series A Preferred Stock
    remain outstanding, the Corporation covenants that it will at all times reserve and keep available out of its authorized and unissued
    shares of Common Stock for the sole purpose of issuance upon conversion of the Series A Preferred Stock as herein provided, free
    from preemptive rights or any other actual contingent purchase rights of Persons other than the Holder (and the other holders of
    the Series A Preferred Stock), not less than the aggregate number of shares of the Common Stock as shall (subject to the terms and
    conditions set forth in the Purchase Agreement) be issuable (taking into account any adjustments under Section 7) upon the conversion
    of the then outstanding shares of Series A Preferred Stock. The Corporation covenants that all shares of Common Stock that shall
    be so issuable shall, upon issue, be duly authorized, validly issued, fully paid and nonassessable.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Fractional
    Shares</U>. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of the Series A Preferred
    Stock. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, the Corporation
    shall at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
    by the Conversion Price or round up to the next whole share. Notwithstanding anything to the contrary contained herein, but consistent
    with the provisions of this subsection with respect to fractional Conversion Shares, nothing shall prevent any Holder from converting
    fractional shares of Series A Preferred Stock.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Transfer
    Taxes and Expenses</U>. The issuance of Conversion Shares on conversion of the Series A Preferred Stock shall be made without charge
    to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion
    Shares, provided that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer involved
    in the issuance and delivery of any such Conversion Shares upon conversion in a name other than that of the Holders of such shares
    of Series A Preferred Stock and the Corporation shall not be required to issue or deliver such Conversion Shares unless or until
    the Person or Persons requesting the issuance thereof shall have paid to the Corporation the amount of such tax or shall have established
    to the satisfaction of the Corporation that such tax has been paid. The Corporation shall pay all Transfer Agent fees required for
    same-day processing of any Notice of Conversion and all fees to the Depository Trust Company (or another established clearing corporation
    performing similar functions) required for same-day electronic delivery of the Conversion Shares.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Beneficial Ownership Limitation</U>. Notwithstanding anything to the contrary set forth herein, the Corporation shall not effect any
conversion of the Series A Preferred Stock, and a Holder shall not have the right to convert any portion of the Series A Preferred Stock,
to the extent that, after giving effect to the conversion set forth on the applicable Notice of Conversion, such Holder (together with
such Holder&rsquo;s Affiliates, and any Persons acting as a group together with such Holder or any of such Holder&rsquo;s Affiliates
(such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)) would beneficially own in excess of the Beneficial Ownership Limitation (as
defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by such Holder and its
Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon conversion of the Series A Preferred
Stock with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which are issuable
upon (i) conversion of the remaining, unconverted Series A Preferred Stock beneficially owned by such Holder or any of its Affiliates
or Attribution Parties and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Corporation
subject to a limitation on conversion or exercise analogous to the limitation contained herein (including, without limitation, the Series
A Preferred Stock) beneficially owned by such Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding
sentence, for purposes of this Section 6(d), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange
Act and the rules and regulations promulgated thereunder. To the extent that the limitation contained in this Section 6(d) applies, the
determination of whether the Series A Preferred Stock is convertible (in relation to other securities owned by such Holder together with
any Affiliates and Attribution Parties) and of how many shares of Series A Preferred Stock are convertible shall be in the sole discretion
of such Holder, and the submission of a Notice of Conversion shall be deemed to be such Holder&rsquo;s determination of whether the shares
of Series A Preferred Stock may be converted (in relation to other securities owned by such Holder together with any Affiliates and Attribution
Parties) and how many shares of the Series A Preferred Stock are convertible, in each case subject to the Beneficial Ownership Limitation.
To ensure compliance with this restriction, each Holder will be deemed to represent to the Corporation each time it delivers a Notice
of Conversion that such Notice of Conversion has not violated the restrictions set forth in this Section 6(d) and the Corporation shall
have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated
above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.
For purposes of this Section 6(d), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of
outstanding shares of Common Stock as stated in the most recent of the following: (i) the Corporation&rsquo;s most recent periodic or
annual report filed with the Commission, as the case may be, (ii) a more recent public announcement by the Corporation or (iii) a more
recent written notice by the Corporation or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the
written or oral request of a Holder, the Corporation shall within one (1) Trading Day confirm orally and in writing to such Holder the
number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined
after giving effect to the conversion or exercise of securities of the Corporation, including the Series A Preferred Stock, by such Holder
or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The
&ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon election by a Holder prior to the issuance of any shares
of Series A Preferred Stock, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance
of shares of Common Stock issuable upon conversion of Series A Preferred Stock held by the applicable Holder. A Holder, upon notice to
the Corporation, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 6(d) applicable to its Series
A Preferred Stock; provided, that the Beneficial Ownership Limitation shall not in any event exceed 9.99% of the number of shares of
the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon conversion of this Series
A Preferred Stock held by the Holder and the provisions of this Section 6(d) shall continue to apply. Any such increase will not be effective
until the 61<SUP>st</SUP> day after such notice is delivered to the Corporation and shall only apply to such Holder and no other Holder.
The Beneficial Ownership Limitation shall not be waived by the Corporation or the Holder and upon issuance of the Series A Preferred
Stock by the Corporation, and the purchase thereof by the Holder, in accordance with the Purchase Agreement, each of the Corporation
and the Purchaser shall be deemed to acknowledge such limitation and to agree not to waive it. The provisions of this Section 6(d) shall
be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 6(d) to correct this Section
(or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation contained herein or
to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this Section
shall apply to a successor holder of Series A Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
7</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Stock Splits</U>. If the Corporation, at any time while the Series A Preferred Stock is outstanding: (i) pays
a stock dividend or otherwise makes a distribution or distributions that is payable in shares of Common Stock on shares of Common Stock
or any other Common Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Corporation
upon conversion of, or payment of a dividend on, the Series A Preferred Stock), (ii) subdivides outstanding shares of Common Stock into
a larger number of shares, (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller
number of shares, or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the
Corporation, then the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common
Stock (excluding any treasury shares of the Corporation) outstanding immediately before such event, and of which the denominator shall
be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section 7(a) shall
become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution
and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification. Notwithstanding
the foregoing in no event may the Conversion Price be less than the par value per share of Series A Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 7(a) above, if at any time the Corporation grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of Common Stock or any class thereof (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete conversion of such Holder&rsquo;s Series A Preferred Stock (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the
date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to
such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Distributions</U>. During such time as the Series A Preferred Stock is outstanding, if the Corporation declares or makes any dividend
or other distribution of its assets (or rights to acquire its assets) to holders of Common Stock, by way of return of capital or otherwise
(including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off,
reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have
participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of the Series A
Preferred Stock (without regard to any limitations on conversion hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the
record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, that, to
the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial
ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be
held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while the Series A Preferred Stock is outstanding, (i) the Corporation, directly or indirectly,
in one or more related transactions effects any merger or consolidation of the Corporation with or into another Person, (ii) the Corporation
(and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance
or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect,
purchase offer, tender offer or exchange offer (whether by the Corporation or another Person) is completed pursuant to which holders
of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by
the holders of at least 50% of the outstanding Common Stock, (iv) the Corporation, directly or indirectly, in one or more related transactions
effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Corporation, directly
or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including,
without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person
acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or
other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase
agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent conversion
of the Series A Preferred Stock, the Holder shall have the right to receive, for each Conversion Share that would have been issuable
upon such conversion immediately prior to the occurrence of such Fundamental Transaction (without regard to any limitation in Section
6(d) on the conversion of the Series A Preferred Stock), the number of shares of Common Stock of the successor or acquiring corporation
or of the Corporation, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which the Series A Preferred
Stock is convertible immediately prior to such Fundamental Transaction (without regard to any limitation in Section 6(d) on the conversion
of the Series A Preferred Stock). For purposes of any such conversion, the determination of the Conversion Price shall be appropriately
adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of
Common Stock in such Fundamental Transaction, and the Corporation shall apportion the Conversion Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall
be given the same choice as to the Alternate Consideration it receives upon any conversion of the Series A Preferred Stock following
such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any successor to the Corporation or surviving
entity in such Fundamental Transaction shall file a new Certificate of Designation with the same terms and conditions and issue to the
Holders new preferred stock consistent with the foregoing provisions and evidencing the Holders&rsquo; right to convert such preferred
stock into Alternate Consideration. The Corporation shall cause any successor entity in a Fundamental Transaction in which the Corporation
is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Corporation under
this Certificate of Designation and the other Transaction Documents in accordance with the provisions of this Section 7(d) pursuant to
written agreements in customary form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for the Series
A Preferred Stock a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to
the Series A Preferred Stock which is convertible for a corresponding number of shares of capital stock of such Successor Entity (or
its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion of the Series A Preferred Stock
(without regard to any limitations on the conversion of the Series A Preferred Stock) prior to such Fundamental Transaction, and with
a conversion price which applies the conversion price hereunder to such shares of capital stock (but taking into account the relative
value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number
of shares of capital stock and such conversion price being for the purpose of protecting the economic value of the Series A Preferred
Stock immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance
to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for
(so that from and after the date of such Fundamental Transaction, the provisions of this Certificate of Designation and the other Transaction
Documents referring to the &ldquo;Corporation&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power
of the Corporation and shall assume all of the obligations of the Corporation under this Certificate of Designation and the other Transaction
Documents with the same effect as if such Successor Entity had been named as the Corporation herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Calculations</U>. All calculations under this Section 7 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 7, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Corporation) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Notice of Adjustment to Conversion Price</U>. Whenever the Conversion Price is adjusted pursuant to any provision of this Section
7, the Corporation shall promptly deliver to each Holder by facsimile or email a notice setting forth the Conversion Price after such
adjustment and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
8</U>. <U>Mandatory Conversion and Forced Conversion</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Mandatory Conversion</U>. Notwithstanding anything herein to the contrary, on the Reverse Stock Split Date or, if all of the Equity
Conditions are not satisfied on the Reverse Stock Split Date, on the first such date after the Reverse Stock Split Date, if and only
if such date is within and no later than fifteen (15) Trading Days after the Reverse Stock Split Date, that all of the Equity Conditions
are satisfied (unless waived in writing by a Holder with respect to such Holder) (the &ldquo;<U>Mandatory Conversion Date</U>&rdquo;),
the Corporation may deliver written notice of the Mandatory Conversion to all Holders on the Mandatory Conversion Date and, on such Mandatory
Conversion Date, the Corporation shall convert all of each Holder&rsquo;s shares of Series A Preferred Stock (the &ldquo;<U>Mandatory
Conversion</U>&rdquo;) into Conversion Shares at the then effective Conversion Price on the Mandatory Conversion Date, it being agreed
that the &ldquo;Conversion Date&rdquo; for purposes of Section 6 herein shall be deemed to be the Mandatory Conversion Date. The Mandatory
Conversion hereunder shall not be effective, unless all of the Equity Conditions are met (unless waived in writing by a Holder with respect
to such Holder) on the Mandatory Conversion Date through and including the Share Delivery Date and the actual delivery of all of the
Conversion Shares to the Holders. For purposes of clarification, a Mandatory Conversion shall be subject to all of the provisions of
Section 6, including, without limitation, Section 6(d) and the provision requiring payment of liquidated damages. If any of the Equity
Conditions shall cease to be satisfied at any time on or after the Mandatory Conversion Date through and including the actual delivery
of all of the Conversion Shares to the Holders, a Holder may elect to nullify the Mandatory Conversion as to such Holder by notice to
the Corporation within three (3) Trading Days after the first day on which any such Equity Condition has not been satisfied (provided
that if, by a provision of the Transaction Documents, the Corporation is obligated to notify the Holders of the non-existence of an Equity
Condition, such notice period shall be extended to the third Trading Day after proper notice from the Corporation) in which case the
Mandatory Conversion shall be null and void, ab initio. Subject to the other terms hereof, the Corporation covenants and agrees that
the Corporation will honor all Notices of Conversion that are tendered by the Holder on or after the Mandatory Conversion Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Forced Conversion</U>. At any time after 120 days following the Mandatory Conversion Date, the Corporation may deliver a written notice
to all Holders (a &ldquo;<U>Forced Conversion Notice</U>&rdquo; and the date such notice is delivered to all Holders, the &ldquo;<U>Forced
Conversion Notice Date</U>&rdquo;) to cause each Holder to convert all or part of such Holder&rsquo;s Series A Preferred Stock (as specified
in such Forced Conversion Notice) pursuant to Section 6 (a &ldquo;<U>Forced Conversion</U>&rdquo;), it being agreed that the &ldquo;Conversion
Date&rdquo; for purposes of Section 6 shall be deemed to be the Forced Conversion Notice Date (such date, the &ldquo;<U>Forced Conversion
Date</U>&rdquo;), provided that the Corporation shall not deliver a Forced Conversion Notice more than once in any 60 day period. The
Corporation may not deliver a Forced Conversion Notice, and any Forced Conversion Notice delivered by the Corporation shall not be effective,
unless all of the Equity Conditions have been met on the Forced Conversion Notice Date through and including the later of the Forced
Conversion Date and the Trading Day after the date that the Conversion Shares issuable pursuant to such conversion are actually delivered
to the Holders pursuant to the Forced Conversion Notice. Any Forced Conversion Notices shall be applied ratably to all of the Holders
based on each Holder&rsquo;s initial purchases of Series A Preferred Stock hereunder, provided that any voluntary conversions by a Holder
shall be applied against such Holder&rsquo;s <U>pro rata</U> allocation, thereby decreasing the aggregate amount forcibly converted hereunder
if less than all shares of the Series A Preferred Stock are forcibly converted. For purposes of clarification, a Forced Conversion shall
be subject to all of the provisions of Section 6, including, without limitation, the provisions requiring payment of liquidated damages
and Section 6(d) on Beneficial Ownership Limitation on conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
Notwithstanding the terms of Sections 8(a) and 8(b) above, if the Corporation exercises its right to cause the conversion of Series A
Preferred Stock pursuant to Sections 8(a) or 8(b), then, within two (2) Trading Days following the receipt of a Mandatory Conversion
Notice or Forced Conversion Notice, each such Holder shall be entitled to Deliver a Redemption Notice to the Corporation to cause the
Corporation to redeem its shares of Series A Preferred Stock otherwise subject to conversion, only to the extent the right to cause such
redemption would otherwise be available to such Holder, pursuant to the terms of Section 9 below. In the event a Holder delivers a Redemption
Notice pursuant to this Section 8(c), any conversion contemplated by the applicable Mandatory Conversion Notice or Forced Conversion
Notice shall be null and void, ab initio, and the Corporation shall be obligated to redeem such Holder&rsquo;s Series A Preferred Stock
pursuant to Section 9.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
9</U>. <U>Redemption</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
After (i) the earlier of (1) the receipt of Authorized Stockholder Approval and (2) the date that is 90 days following the Original Issue
Date and (ii) before the date that is 120 days after the Original Issue Date (the &ldquo;<U>Redemption Period</U>&rdquo;), each Holder
shall have the right to cause the Corporation to redeem all or part of such Holder&rsquo;s shares of Series A Preferred Stock at a price
per share equal to 105% of the Stated Value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
Subject to the terms of Section 9(a) above, to cause the Corporation to redeem all or part of its shares of Series A Preferred Stock,
each Holder shall deliver written notice to the Corporation (each, a &ldquo;<U>Redemption Notice</U>&rdquo;) setting forth the number
of shares of Series A Preferred Stock that each such Holder wishes to redeem. The Corporation shall redeem the shares of Series A Preferred
Stock in accordance with the Redemption Notice, no later than 5 days after the date on which the Redemption Notice is delivered to the
Corporation. Upon receipt of full payment in cash for a complete redemption, each Holder will promptly submit to the Corporation such
Holder&rsquo;s Series A Preferred Stock certificates, if any, and such redeemed shares shall no longer be deemed to be outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
10</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Notices</U>. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without
limitation, any Notice of Conversion, shall be in writing and delivered personally, by facsimile or e-mail attachment, or sent by a nationally
recognized overnight courier service, addressed to the Corporation, at 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648, Attention:
Michael H. Tardugno, Chairman, President and Chief Executive Officer, e-mail address mtardugno@celsion.com, or such other e-mail address
or address as the Corporation may specify for such purposes by notice to the Holders delivered in accordance with this Section 10. Any
and all notices or other communications or deliveries to be provided by the Corporation hereunder shall be in writing and delivered personally,
by e-mail attachment, or sent by a nationally recognized overnight courier service addressed to each Holder at the e-mail address or
address of such Holder appearing on the books of the Corporation, or if no such e-mail address or address appears on the books of the
Corporation, at the principal place of business of such Holder, as set forth in the Purchase Agreement. Any notice or other communication
or deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication
is delivered via e-mail attachment at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City time) on any date,
(ii) the next Trading Day after the time of transmission, if such notice or communication is delivered via e-mail attachment at the e-mail
address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day,
(iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv)
upon actual receipt by the party to whom such notice is required to be given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Lost or Mutilated Preferred Stock Certificate</U>. If a Holder&rsquo;s Series A Preferred Stock certificate shall be mutilated, lost,
stolen or destroyed, the Corporation shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated
certificate, or in lieu of or in substitution for a lost, stolen or destroyed certificate, a new certificate for the shares of Series
A Preferred Stock so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such
certificate, and of the ownership hereof reasonably satisfactory to the Corporation (which shall not include the posting of any bond).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Severability</U>. If any provision of this Certificate of Designation is invalid, illegal or unenforceable, the balance of this Certificate
of Designation shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain
applicable to all other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder
violates the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the
maximum rate of interest permitted under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Next Business Day</U>. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment
shall be made on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Headings</U>. The headings contained herein are for convenience only, do not constitute a part of this Certificate of Designation
and shall not be deemed to limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Status of Converted Preferred Stock</U>. Shares of Series A Preferred Stock may only be issued pursuant to the Purchase Agreement.
If any shares of Series A Preferred Stock shall be converted, redeemed or reacquired by the Corporation, such shares may not be reissued
and shall automatically be retired and cancelled and shall resume the status of authorized but unissued shares of preferred stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have executed this Certificate this 10<SUP>th</SUP> day of January 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Jeffrey W. Church</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Jeffrey W. Church</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
Vice President and Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ANNEX
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
OF CONVERSION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">(To
be Executed by the Registered Holder in order to Convert Shares</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">of SERIES A Preferred Stock)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby elects to convert the number of shares of Series A Convertible Preferred Stock indicated below into shares of common
stock, par value $0.01 per share (the &ldquo;<U>Common Stock</U>&rdquo;), of Celsion Corporation, a Delaware corporation (the &ldquo;<U>Corporation</U>&rdquo;),
according to the conditions hereof, as of the date written below. If shares of Common Stock are to be issued in the name of a Person
other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto. No fee will be charged to the Holders
for any conversion, except for any such transfer taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
calculations:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
    to Effect Conversion: _____________________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares of Preferred Stock owned prior to Conversion: _______________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares of Preferred Stock to be Converted: ________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stated
    Value of shares of Preferred Stock to be Converted: ____________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares of Common Stock to be Issued: ___________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applicable
    Conversion Price:____________________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares of Preferred Stock subsequent to Conversion: ________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for Delivery: ______________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Or</U></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DWAC
    Instructions:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker
    no: _________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account
    no: ___________</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HOLDER</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>4
<FILENAME>ex3-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
3.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>celsion
corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATE
OF DESIGNATION OF PREFERENCES,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RIGHTS
AND LIMITATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
<FONT STYLE="text-transform: uppercase">B </FONT>CONVERTIBLE REDEEMABLE PREFERRED STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">PURSUANT
TO SECTION 151 OF THE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">delaware
GENERAL CORPORATION LAW</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, Jeffrey W. Church, does hereby certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">He
    is the Executive Vice President and CFO of Celsion Corporation, a Delaware corporation (the &ldquo;<U>Corporation</U>&rdquo;).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Corporation is authorized to issue 100,000 shares of preferred stock, none of which have been issued.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    following resolutions were duly adopted by the board of directors of the Corporation (the &ldquo;<U>Board of Directors</U>&rdquo;):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the certificate of incorporation of the Corporation, as amended (the &ldquo;Certificate of Incorporation&rdquo;), provides for a class
of its authorized stock known as preferred stock, consisting of 100,000 shares, $0.01 par value per share, issuable from time to time
in one or more series;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Board of Directors is authorized by resolution to provide for the issuance of preferred stock in one or more series, and to establish
from time to time the number of shares to be included in each such series, and to fix the designation, powers, privileges, preferences
and relative participating, optional or other rights, if any, of the shares of each such series and the qualifications, limitations or
restrictions thereof; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
it is the desire of the Board of Directors, pursuant to its authority as described above, to fix the rights, preferences, restrictions
and other matters relating to a series of the preferred stock, which shall consist of 50,000 shares of the preferred stock which the
Corporation has the authority to issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, BE IT RESOLVED, that the Board of Directors does hereby provide for the issuance of a series of preferred stock to be designated
&ldquo;Series B Convertible Redeemable Preferred Stock&rdquo; and does hereby fix and determine the designation, powers, privileges,
preferences and relative participating, optional or other rights, if any, of the shares of each such series and the qualifications, limitations
or restrictions thereof as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. For the purposes hereof, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Alternate
Consideration</U>&rdquo; shall have the meaning set forth in Section 7(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Amendment</U>&rdquo;
means the amendment to the Corporation&rsquo;s certificate of incorporation, as amended, to, after the date hereof, effect the Reverse
Stock Split.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Authorized
Stockholder Approval</U>&rdquo; means approval of the Amendment by the holders of a majority in voting power of the then outstanding
shares of capital stock of the Corporation entitled to vote on the matter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo; shall have the meaning set forth in Section 6(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Buy-In</U>&rdquo;
shall have the meaning set forth in Section 6(c)(iv).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Change
of Control Transaction</U>&rdquo; means the occurrence after the date hereof of any of (a) an acquisition after the date hereof by an
individual or legal entity or &ldquo;group&rdquo; (as described in Rule 13d-5(b)(1) promulgated under the Exchange Act) of effective
control (whether through legal or beneficial ownership of capital stock of the Corporation, by contract or otherwise) of in excess of
50% of the voting securities of the Corporation (other than by means of the issuance, sale, conversion or exercise of Series A Preferred
Stock or Series B Preferred Stock), (b) the Corporation merges into or consolidates with any other Person, or any Person merges into
or consolidates with the Corporation and, after giving effect to such transaction, the stockholders of the Corporation immediately prior
to such transaction own less than a majority of the aggregate voting power of the Corporation or the successor entity of such transaction,
(c) the Corporation (and all of its Subsidiaries, taken as a whole) sells or transfers all or substantially all of its assets to another
Person and the stockholders of the Corporation immediately prior to such transaction own less than a majority of the aggregate voting
power of the acquiring entity immediately after the transaction, (d) a replacement at one time or within a one year period of more than
one-half of the members of the Board of Directors which is not approved by a majority of those individuals who are members of the Board
of Directors on the Original Issue Date (or by those individuals who are serving as members of the Board of Directors on any date whose
nomination to the Board of Directors was approved by a majority of the members of the Board of Directors who are members on the Original
Issue Date), or (e) the execution by the Corporation of an agreement to which the Corporation is a party or by which it is bound, providing
for any of the events set forth in clauses (a) through (d) above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Series B Preferred Stock pursuant to Section 2.1 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto and all conditions precedent to (i) each Holder&rsquo;s obligations to pay the Subscription Amount and (ii) the Corporation&rsquo;s
obligations to deliver the Series B Preferred Stock have been satisfied or waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the Corporation&rsquo;s common stock, $0.01 par value per share, and stock of any other class of securities into
which such securities may hereafter be reclassified, converted or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Corporation or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that
is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Amount</U>&rdquo; means the Stated Value at issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Date</U>&rdquo; shall have the meaning set forth in Section 6(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Price</U>&rdquo; shall have the meaning set forth in Section 6(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Shares</U>&rdquo; means, collectively, the shares of Common Stock issuable upon conversion of the shares of Series B Preferred Stock
in accordance with the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Escrow
Agreement</U>&rdquo; means the escrow agreement to be entered into concurrently with the Purchase Agreement, by and among the Corporation,
Citibank N.A., and the other party thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Equity
Conditions</U>&rdquo; means, during the period in question, (a) the Corporation shall have paid all liquidated damages and other amounts
owing to the applicable Holder in respect of the Series B Preferred Stock, (b)(i) there is an effective registration statement pursuant
to which either (A) the Corporation may issue Conversion Shares or (B) the Holders are permitted to utilize the prospectus thereunder
to resell all of the shares of Common Stock issuable pursuant to the Transaction Documents (and the Corporation believes, in good faith,
that such effectiveness will continue uninterrupted for the foreseeable future) or (ii) all of the Conversion Shares issuable pursuant
to the Transaction Documents (and shares issuable in lieu of cash payments of dividends) may be resold pursuant to Rule 144 without volume
or manner-of-sale restrictions or current public information requirements as determined by the counsel to the Corporation as set forth
in a written opinion letter to such effect, addressed and reasonably acceptable to the Transfer Agent and the affected Holder or (iii)
all of the Conversion Shares may be issued to the Holder pursuant to Section 3(a)(9) of the Securities Act and immediately resold without
restriction, (c) the Common Stock is trading on a Trading Market and all of the shares of Common Stock issuable upon conversion of the
Series B Preferred Stock are listed or quoted for trading on such Trading Market (and the Corporation believes, in good faith, that trading
of the Common Stock on a Trading Market will continue uninterrupted for the foreseeable future), (d) there is a sufficient number of
authorized, but unissued and otherwise unreserved, shares of Common Stock for the issuance of all of the shares then issuable pursuant
to the Transaction Documents, (e) Authorized Stockholder Approval shall have been received and be effective, (f) the issuance of the
shares in question to the applicable Holder would not violate the limitations set forth in Section 6(d) herein, (g) <FONT STYLE="font-weight: normal">the
shares of Common Stock have traded on the applicable Trading Market during a consecutive ten (10) day period at an average market price
per share greater than $2.00 and the average daily trading volume during such period is equal to or greater than $2,000,000, (h)</FONT>
there has been no public announcement of a pending or proposed Fundamental Transaction or Change of Control Transaction that has not
been consummated, (i) the applicable Holder is not in possession of any information provided by the Corporation, any of its Subsidiaries,
or any of their officers, directors, employees, agents or Affiliates, that constitutes, or may constitute, material non-public information
and (j) the Corporation shall have duly honored all conversions scheduled to occur or occurring by virtue of one or more Notices of Conversion
of the applicable Holder on or prior to the dates so requested or required, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Forced
Conversion Date</U>&rdquo; shall have the meaning set forth in Section 8(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Forced
Conversion Notice</U>&rdquo; shall have the meaning set forth in Section 8(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Forced
Conversion Notice Date</U>&rdquo; shall have the meaning set forth in Section 8(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Fundamental
Transaction</U>&rdquo; shall have the meaning set forth in Section 7(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
means United States generally accepted accounting principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Holder</U>&rdquo;
shall have the meaning given such term in Section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liquidation</U>&rdquo;
shall have the meaning set forth in Section 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Mandatory
Conversion</U>&rdquo; shall have the meaning set forth in Section 8(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Mandatory
Conversion Date</U>&rdquo; shall have the meaning set forth in Section 8(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Notice
of Conversion</U>&rdquo; shall have the meaning set forth in Section 6(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Original
Issue Date</U>&rdquo; means the date of the first issuance of any shares of the Series B Preferred Stock regardless of the number of
transfers of any particular shares of Series B Preferred Stock and regardless of the number of certificates which may be issued to evidence
such Series B Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchase
Agreement</U>&rdquo; means the Preferred Stock Purchase Agreement, dated as of January 10, 2022, among the Corporation and the
original Holders, as amended, modified or supplemented from time to time in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Reverse
Stock Split</U>&rdquo; means the reverse stock split of the Corporation&rsquo;s Common Stock that is effected by the Corporation&rsquo;s
filing of the Amendment with and acceptance by the Secretary of the State of Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Reverse
Stock Split Date</U>&rdquo; means the date on which the Reverse Stock Split is consummated and the Amendment is filed and accepted by
the Secretary of State of the State of Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
B Preferred Stock</U>&rdquo; shall have the meaning set forth in Section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
A Preferred Stock Certificate of Designation</U>&rdquo; means the Certificate of Designation of Preferences, Rights and Limitations of
the Series A Convertible Redeemable Preferred Stock of the Corporation, dated as of the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Share
Delivery Date</U>&rdquo; shall have the meaning set forth in Section 6(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stated
Value</U>&rdquo; shall have the meaning set forth in Section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; shall mean, as to each Holder, the aggregate amount to be paid for the Series B Preferred Stock purchased pursuant
to the Purchase Agreement as specified below such Holder&rsquo;s name on the signature page of the Purchase Agreement and next to the
heading &ldquo;Subscription Amount,&rdquo; in United States dollars and in immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Corporation as set forth on <U>Schedule 3.1(a)</U> of the Purchase Agreement and shall, where applicable,
also include any direct or indirect subsidiary of the Corporation formed or acquired after the date of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Successor
Entity</U>&rdquo; shall have the meaning set forth in Section 7(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Certificate of Designation, the Series A Preferred Stock Certificate of Designation, the Purchase Agreement,
the Escrow Agreement, all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with
the transactions contemplated pursuant to the Purchase Agreement, in each case as amended, modified or supplemented from time to time
in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means American Stock Transfer &amp; Trust Company, and any successor transfer agent of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Designation, Amount and Par Value</U>. The series of preferred stock shall be designated as &ldquo;Series B Convertible Redeemable
Preferred Stock&rdquo; (the &ldquo;<U>Series B Preferred Stock</U>&rdquo;) and the number of shares of such series shall be 50,000 (which
shall not be subject to increase without the written consent of the holders of a majority of the then outstanding shares of the Series
B Preferred Stock (each, a &ldquo;<U>Holder</U>&rdquo; and collectively, the &ldquo;<U>Holders</U>&rdquo;)). Each share of Series B Preferred
Stock shall have a par value of $0.01 per share and a stated value equal to $300.00 (the &ldquo;<U>Stated Value</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Dividends</U>. Except for stock dividends or distributions for which adjustments are to be made pursuant to Section 7, Holders
shall be entitled to receive, and the Corporation shall pay, dividends on shares of Series B Preferred Stock equal (on an as-if-converted-to-Common-Stock
basis, disregarding for such purpose any conversion limitations hereunder) to and in the same form as dividends actually paid on shares
of the Common Stock when, as and if such dividends are paid on shares of the Common Stock. No other dividends shall be paid on shares
of Series B Preferred Stock. The Corporation shall not pay any dividends on the Common Stock unless the Corporation simultaneously complies
with this provision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Voting Rights</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
Solely for purposes of determining the presence of a quorum at any meeting of the stockholders of the Corporation at which the shares
of Series B Preferred Stock are entitled to vote, the number of shares of Series B Preferred Stock and votes represented by such shares
shall be counted on an as converted to Common Stock basis, disregarding, for such purposes, any limitations on conversion set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
Each share of Series B Preferred Stock shall entitle the holder thereof (a) to vote exclusively with respect to the Amendment and the
Reverse Stock Split (and the Series B Preferred Stock shall not be entitled to vote on any other matter except to the extent required
under the Delaware General Corporation Law) and (b) to 45,000 votes per each share of Series B Preferred Stock and shall, except as required
by law, vote together with the Common Stock and any other issued and outstanding shares of preferred stock of the Corporation, as a single
class. Notwithstanding the foregoing, in addition, as long as any shares of Series B Preferred Stock are outstanding, the Corporation
shall not, without the affirmative vote of the Holders of a majority of the then outstanding shares of the Series B Preferred Stock,
(a) alter or change adversely the powers, preferences or rights given to the Series B Preferred Stock or alter or amend this Certificate
of Designation, (b) amend its certificate of incorporation or other charter documents in a manner adverse to the Holders, (c) increase
the number of authorized shares of Series B Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Liquidation</U>. Upon any liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary (a &ldquo;<U>Liquidation</U>&rdquo;),
prior and in preference to the Common Stock, the Holders shall be entitled to receive out of the assets available for distribution to
stockholders an amount equal to 105% of the Stated Value and no more. <FONT STYLE="font-weight: normal">The preference set forth in this
Section 5 with respect to distributions to the Series B Preferred Stock upon a Liquidation shall apply <I>mutatis mutandis </I>to any
distributions to be made upon the consummation of a Fundamental Transaction or Change of Control Transaction.</FONT> The Corporation
shall mail written notice of any such Liquidation, <FONT STYLE="font-weight: normal">Fundamental Transaction or Change of Control Transaction
</FONT>not less than 45 days prior to the payment date stated therein, to each Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
6</U>. <U>Conversion</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Conversions at Option of Holder</U>. Subject to Section 6(d), each share of Series B Preferred Stock shall be convertible, at any
time and from time to time only after the Reverse Stock Split Date, at the option of the Holder thereof, into that number of shares of
Common Stock determined by dividing the Stated Value of such share of Series B Preferred Stock by the Conversion Price. Holders shall
effect conversions by delivering to the Corporation a conversion notice in the form attached hereto as <U>Annex A</U> (a &ldquo;<U>Notice
of Conversion</U>&rdquo;). Each Notice of Conversion shall specify the number of shares of Series B Preferred Stock to be converted,
the number of shares of Series B Preferred Stock owned prior to the conversion at issue, the number of shares of Series B Preferred Stock
owned subsequent to the conversion at issue and the date on which such conversion is to be effected, which date may not be prior to the
date the applicable Holder delivers such Notice of Conversion to the Corporation (such date, the &ldquo;<U>Conversion Date</U>&rdquo;).
If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be as of the close of business on the Business
Day that such Notice of Conversion is delivered to the Corporation, or if such day is not a Business day or if the Notice of Conversion
is delivered after regular business hours, the next Business Day. No ink-original Notice of Conversion shall be required, nor shall any
medallion guarantee (or other type of guarantee or notarization) of any Notice of Conversion form be required. The calculations and entries
set forth in the Notice of Conversion shall control in the absence of manifest or mathematical error. From and after the Conversion Date,
until presented for transfer or exchange, certificates that previously represented shares of Series B Preferred Stock shall represent,
in lieu of the number of shares of Series B Preferred Stock previously represented by such certificate, the number of shares of Series
B Preferred Stock, if any, previously represented by such certificate that were not converted pursuant to the Notice of Conversion, plus
the number of shares of Conversion Shares into which the shares of Series B Preferred Stock previously represented by such certificate
were converted. To effect conversions of shares of Series B Preferred Stock, a Holder shall not be required to surrender the certificate(s)
representing the shares of Series B Preferred Stock to the Corporation unless all of the shares of Series B Preferred Stock represented
thereby are so converted, in which case such Holder shall deliver the certificate representing such shares of Series B Preferred Stock
promptly following the Conversion Date at issue. Shares of Series B Preferred Stock converted into Common Stock shall be canceled and
shall not be reissued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Conversion Price</U>. The conversion price for the Series B Preferred Stock shall equal $1.00, subject to adjustment herein (the &ldquo;<U>Conversion
Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Mechanics of Conversion</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Delivery
    of Conversion Shares Upon Conversion</U>. Not later than the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days
    comprising the Standard Settlement Period (as defined below) after each Conversion Date (the &ldquo;<U>Share Delivery Date</U>&rdquo;),
    the Corporation shall deliver, or cause to be delivered, to the converting Holder the number of Conversion Shares being acquired
    upon the conversion of the Series B Preferred Stock, which Conversion Shares shall be free of restrictive legends and trading restrictions.
    The Corporation shall use its reasonable best efforts to deliver the Conversion Shares required to be delivered by the Corporation
    under this Section 6 electronically through the Depository Trust Company or another established clearing corporation performing similar
    functions. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number
    of Trading Days, on the Corporation&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
    of the Notice of Conversion.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Failure
    to Deliver Conversion Shares</U>. If, in the case of any Notice of Conversion, such Conversion Shares are not delivered to or as
    directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written notice to the Corporation
    at any time on or before its receipt of such Conversion Shares, to rescind such Conversion, in which event the Corporation shall
    promptly return to the Holder any original Preferred Stock certificate delivered to the Corporation and the Holder shall promptly
    return to the Corporation the Conversion Shares issued to such Holder pursuant to the rescinded Notice of Conversion.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Obligation
    Absolute; Partial Liquidated Damages</U>. Subject to Section 6(d), the Corporation&rsquo;s obligation to issue and deliver the Conversion
    Shares upon conversion of Series B Preferred Stock in accordance with the terms hereof are absolute and unconditional, irrespective
    of any action or inaction by a Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery
    of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination,
    or any breach or alleged breach by such Holder or any other Person of any obligation to the Corporation or any violation or alleged
    violation of law by such Holder or any other Person, and irrespective of any other circumstance, other than pursuant to Section 6(d),
    which might otherwise limit such obligation of the Corporation to such Holder in connection with the issuance of such Conversion
    Shares; <U>provided</U>, <U>however</U>, that such delivery shall not operate as a waiver by the Corporation of any such action that
    the Corporation may have against such Holder. In the event a Holder shall elect to convert any or all of the Stated Value of its
    Series B Preferred Stock, the Corporation may not refuse conversion based on any claim that such Holder or anyone associated or affiliated
    with such Holder has been engaged in any violation of law, agreement or for any other reason, other than pursuant to Section 6(d),
    unless an injunction from a court, on notice to Holder, restraining and/or enjoining conversion of all or part of the Series B Preferred
    Stock of such Holder shall have been sought and obtained, and the Corporation posts a surety bond for the benefit of such Holder
    in the amount of 150% of the Stated Value of the Series B Preferred Stock which is subject to the injunction, which bond shall remain
    in effect until the completion of arbitration/litigation of the underlying dispute and the proceeds of which shall be payable to
    such Holder to the extent it obtains judgment. In the absence of such injunction, subject to Section 6(d), the Corporation shall
    issue Conversion Shares and, if applicable, cash, upon a properly noticed conversion. If the Corporation fails to deliver to a Holder
    such Conversion Shares pursuant to Section 6(c)(i) by the Share Delivery Date applicable to such conversion, other than pursuant
    to Section 6(d), the Corporation shall pay to such Holder, in cash, as liquidated damages and not as a penalty, for each $5,000 of
    Stated Value of Series B Preferred Stock being converted, $50 per Trading Day (increasing to $100 per Trading Day on the third Trading
    Day after the Share Delivery Date and increasing to $200 per Trading Day on the sixth Trading Day after the Share Delivery Date)
    for each Trading Day after the Share Delivery Date until such Conversion Shares are delivered or Holder rescinds such conversion.
    Nothing herein shall limit a Holder&rsquo;s right to pursue actual damages for the Corporation&rsquo;s failure to deliver Conversion
    Shares within the period specified herein and such Holder shall have the right to pursue all remedies available to it hereunder,
    at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief. The exercise of any
    such rights shall not prohibit a Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable
    law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Compensation
    for Buy-In on Failure to Timely Deliver Conversion Shares Upon Conversion</U>. In addition to any other rights available to the Holder,
    if the Corporation fails for any reason, other than pursuant to Section 6(d), to deliver to a Holder the applicable Conversion Shares
    by the Share Delivery Date pursuant to Section 6(c)(i), and if after such Share Delivery Date such Holder is required by its brokerage
    firm to purchase (in an open market transaction or otherwise), or the Holder&rsquo;s brokerage firm otherwise purchases, shares of
    Common Stock to deliver in satisfaction of a sale by such Holder of the Conversion Shares which such Holder was entitled to receive
    upon the conversion relating to such Share Delivery Date (a &ldquo;<U>Buy-In</U>&rdquo;), then the Corporation shall (A) pay in cash
    to such Holder (in addition to any other remedies available to or elected by such Holder) the amount, if any, by which (x) such Holder&rsquo;s
    total purchase price (including any brokerage commissions) for the Common Stock so purchased exceeds (y) the product of (1) the aggregate
    number of shares of Common Stock that such Holder was entitled to receive from the conversion at issue multiplied by (2) the actual
    sale price at which the sell order giving rise to such purchase obligation was executed (including any brokerage commissions) and
    (B) at the option of such Holder, either reissue (if surrendered) the shares of Series B Preferred Stock equal to the number of shares
    of Series B Preferred Stock submitted for conversion (in which case, such conversion shall be deemed rescinded) or deliver to such
    Holder the number of shares of Common Stock that would have been issued if the Corporation had timely complied with its delivery
    requirements under Section 6(c)(i). For example, if a Holder purchases shares of Common Stock having a total purchase price of $11,000
    to cover a Buy-In with respect to an attempted conversion of shares of Series B Preferred Stock with respect to which the actual
    sale price of the Conversion Shares (including any brokerage commissions) giving rise to such purchase obligation was a total of
    $10,000 under clause (A) of the immediately preceding sentence, the Corporation shall be required to pay such Holder $1,000. The
    Holder shall provide the Corporation written notice indicating the amounts payable to such Holder in respect of the Buy-In and, upon
    request of the Corporation, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any
    other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
    injunctive relief with respect to the Corporation&rsquo;s failure to timely deliver the Conversion Shares upon conversion of the
    shares of Series B Preferred Stock as required pursuant to the terms hereof.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Reservation
    of Shares Issuable Upon Conversion</U>. From and after the Reverse Stock Split Date and until no shares of Series B Preferred Stock
    remain outstanding, the Corporation covenants that it will at all times reserve and keep available out of its authorized and unissued
    shares of Common Stock for the sole purpose of issuance upon conversion of the Series B Preferred Stock as herein provided, free
    from preemptive rights or any other actual contingent purchase rights of Persons other than the Holder (and the other holders of
    the Series B Preferred Stock), not less than the aggregate number of shares of the Common Stock as shall (subject to the terms and
    conditions set forth in the Purchase Agreement) be issuable (taking into account any adjustments under Section 7) upon the conversion
    of the then outstanding shares of Series B Preferred Stock. The Corporation covenants that all shares of Common Stock that shall
    be so issuable shall, upon issue, be duly authorized, validly issued, fully paid and nonassessable.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Fractional
    Shares</U>. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of the Series B Preferred
    Stock. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, the Corporation
    shall at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
    by the Conversion Price or round up to the next whole share. Notwithstanding anything to the contrary contained herein, but consistent
    with the provisions of this subsection with respect to fractional Conversion Shares, nothing shall prevent any Holder from converting
    fractional shares of Series B Preferred Stock.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Transfer
    Taxes and Expenses</U>. The issuance of Conversion Shares on conversion of the Series B Preferred Stock shall be made without charge
    to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion
    Shares, provided that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer involved
    in the issuance and delivery of any such Conversion Shares upon conversion in a name other than that of the Holders of such shares
    of Series B Preferred Stock and the Corporation shall not be required to issue or deliver such Conversion Shares unless or until
    the Person or Persons requesting the issuance thereof shall have paid to the Corporation the amount of such tax or shall have established
    to the satisfaction of the Corporation that such tax has been paid. The Corporation shall pay all Transfer Agent fees required for
    same-day processing of any Notice of Conversion and all fees to the Depository Trust Company (or another established clearing corporation
    performing similar functions) required for same-day electronic delivery of the Conversion Shares.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Beneficial Ownership Limitation</U>. Notwithstanding anything to the contrary set forth herein, the Corporation shall not effect any
conversion of the Series B Preferred Stock, and a Holder shall not have the right to convert any portion of the Series B Preferred Stock,
to the extent that, after giving effect to the conversion set forth on the applicable Notice of Conversion, such Holder (together with
such Holder&rsquo;s Affiliates, and any Persons acting as a group together with such Holder or any of such Holder&rsquo;s Affiliates
(such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)) would beneficially own in excess of the Beneficial Ownership Limitation (as
defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by such Holder and its
Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon conversion of the Series B Preferred
Stock with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which are issuable
upon (i) conversion of the remaining, unconverted Series B Preferred Stock beneficially owned by such Holder or any of its Affiliates
or Attribution Parties and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Corporation
subject to a limitation on conversion or exercise analogous to the limitation contained herein (including, without limitation, the Series
B Preferred Stock) beneficially owned by such Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding
sentence, for purposes of this Section 6(d), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange
Act and the rules and regulations promulgated thereunder. To the extent that the limitation contained in this Section 6(d) applies, the
determination of whether the Series B Preferred Stock is convertible (in relation to other securities owned by such Holder together with
any Affiliates and Attribution Parties) and of how many shares of Series B Preferred Stock are convertible shall be in the sole discretion
of such Holder, and the submission of a Notice of Conversion shall be deemed to be such Holder&rsquo;s determination of whether the shares
of Series B Preferred Stock may be converted (in relation to other securities owned by such Holder together with any Affiliates and Attribution
Parties) and how many shares of the Series B Preferred Stock are convertible, in each case subject to the Beneficial Ownership Limitation.
To ensure compliance with this restriction, each Holder will be deemed to represent to the Corporation each time it delivers a Notice
of Conversion that such Notice of Conversion has not violated the restrictions set forth in this Section 6(d) and the Corporation shall
have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated
above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.
For purposes of this Section 6(d), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of
outstanding shares of Common Stock as stated in the most recent of the following: (i) the Corporation&rsquo;s most recent periodic or
annual report filed with the Commission, as the case may be, (ii) a more recent public announcement by the Corporation or (iii) a more
recent written notice by the Corporation or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the
written or oral request of a Holder, the Corporation shall within one Trading Day confirm orally and in writing to such Holder the number
of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving
effect to the conversion or exercise of securities of the Corporation, including the Series B Preferred Stock, by such Holder or its
Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. &ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon election by a Holder prior to the issuance of any shares of Series B Preferred
Stock, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common
Stock issuable upon conversion of Series B Preferred Stock held by the applicable Holder. A Holder, upon notice to the Corporation, may
increase or decrease the Beneficial Ownership Limitation provisions of this Section 6(d) applicable to its Series B Preferred Stock;
provided, that the Beneficial Ownership Limitation shall not in any event exceed 9.99% of the number of shares of the Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock upon conversion of this Series B Preferred Stock held by the
Holder and the provisions of this Section 6(d) shall continue to apply. Any such increase will not be effective until the 61<SUP>st</SUP>
day after such notice is delivered to the Corporation and shall only apply to such Holder and no other Holder. The Beneficial Ownership
Limitation shall not be waived by the Corporation or the Holder and upon issuance of the Series B Preferred Stock by the Corporation,
and the purchase thereof by the Holder, in accordance with the Purchase Agreement, each of the Corporation and the Purchaser shall be
deemed to acknowledge such limitation and to agree not to waive it. The provisions of this Section 6(d) shall be construed and implemented
in a manner otherwise than in strict conformity with the terms of this Section 6(d) to correct this Section (or any portion hereof) which
may be defective or inconsistent with the intended Beneficial Ownership Limitation contained herein or to make changes or supplements
necessary or desirable to properly give effect to such limitation. The limitations contained in this Section shall apply to a successor
holder of Series B Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
7</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Stock Splits</U>. If the Corporation, at any time while the Series B Preferred Stock is outstanding: (i) pays
a stock dividend or otherwise makes a distribution or distributions that is payable in shares of Common Stock on shares of Common Stock
or any other Common Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Corporation
upon conversion of, or payment of a dividend on, the Series B Preferred Stock), (ii) subdivides outstanding shares of Common Stock into
a larger number of shares, (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller
number of shares, or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the
Corporation, then the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common
Stock (excluding any treasury shares of the Corporation) outstanding immediately before such event, and of which the denominator shall
be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section 7(a) shall
become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution
and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification. Notwithstanding
the foregoing in no event may the Conversion Price be less than the par value per share of Series B Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 7(a) above, if at any time the Corporation grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of Common Stock or any class thereof (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete conversion of such Holder&rsquo;s Series B Preferred Stock (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the
date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to
such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Distributions</U>. During such time as the Series B Preferred Stock is outstanding, if the Corporation declares or makes any dividend
or other distribution of its assets (or rights to acquire its assets) to holders of Common Stock, by way of return of capital or otherwise
(including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off,
reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have
participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of the Series B
Preferred Stock (without regard to any limitations on conversion hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the
record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, that, to
the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial
ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be
held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while the Series B Preferred Stock is outstanding, (i) the Corporation, directly or indirectly,
in one or more related transactions effects any merger or consolidation of the Corporation with or into another Person, (ii) the Corporation
(and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance
or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect,
purchase offer, tender offer or exchange offer (whether by the Corporation or another Person) is completed pursuant to which holders
of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by
the holders of at least 50% of the outstanding Common Stock, (iv) the Corporation, directly or indirectly, in one or more related transactions
effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Corporation, directly
or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including,
without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person
acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or
other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase
agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent conversion
of the Series B Preferred Stock, the Holder shall have the right to receive, for each Conversion Share that would have been issuable
upon such conversion immediately prior to the occurrence of such Fundamental Transaction (without regard to any limitation in Section
6(d) on the conversion of the Series B Preferred Stock), the number of shares of Common Stock of the successor or acquiring corporation
or of the Corporation, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which the Series B Preferred
Stock is convertible immediately prior to such Fundamental Transaction (without regard to any limitation in Section 6(d) on the conversion
of the Series B Preferred Stock). For purposes of any such conversion, the determination of the Conversion Price shall be appropriately
adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of
Common Stock in such Fundamental Transaction, and the Corporation shall apportion the Conversion Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall
be given the same choice as to the Alternate Consideration it receives upon any conversion of the Series B Preferred Stock following
such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any successor to the Corporation or surviving
entity in such Fundamental Transaction shall file a new Certificate of Designation with the same terms and conditions and issue to the
Holders new preferred stock consistent with the foregoing provisions and evidencing the Holders&rsquo; right to convert such preferred
stock into Alternate Consideration. The Corporation shall cause any successor entity in a Fundamental Transaction in which the Corporation
is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Corporation under
this Certificate of Designation and the other Transaction Documents in accordance with the provisions of this Section 7(d) pursuant to
written agreements in customary form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for the Series
B Preferred Stock a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to
the Series B Preferred Stock which is convertible for a corresponding number of shares of capital stock of such Successor Entity (or
its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion of the Series B Preferred Stock
(without regard to any limitations on the conversion of the Series B Preferred Stock) prior to such Fundamental Transaction, and with
a conversion price which applies the conversion price hereunder to such shares of capital stock (but taking into account the relative
value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number
of shares of capital stock and such conversion price being for the purpose of protecting the economic value of the Series B Preferred
Stock immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance
to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for
(so that from and after the date of such Fundamental Transaction, the provisions of this Certificate of Designation and the other Transaction
Documents referring to the &ldquo;Corporation&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power
of the Corporation and shall assume all of the obligations of the Corporation under this Certificate of Designation and the other Transaction
Documents with the same effect as if such Successor Entity had been named as the Corporation herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Calculations</U>. All calculations under this Section 7 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 7, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Corporation) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Notice of Adjustment to Conversion Price</U>. Whenever the Conversion Price is adjusted pursuant to any provision of this Section
7, the Corporation shall promptly deliver to each Holder by facsimile or email a notice setting forth the Conversion Price after such
adjustment and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
8</U>. <U>Mandatory Conversion and Forced Conversion</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Mandatory Conversion</U>. Notwithstanding anything herein to the contrary, on the Reverse Stock Split Date or, if all of the Equity
Conditions are not satisfied on the Reverse Stock Split Date, on the first such date, after the Reverse Stock Split Date, if and only
if such date is within and no later than fifteen (15) Trading Days after the Reverse Stock Split Date, that all of the Equity Conditions
are satisfied (unless waived in writing by a Holder with respect to such Holder) (the &ldquo;<U>Mandatory Conversion Date</U>&rdquo;),
the Corporation may deliver written notice of the Mandatory Conversion to all Holders on the Mandatory Conversion Date and, on such Mandatory
Conversion Date, the Corporation shall convert all of each Holder&rsquo;s shares of Series B Preferred Stock (the &ldquo;<U>Mandatory
Conversion</U>&rdquo;) into Conversion Shares at the then effective Conversion Price on the Mandatory Conversion Date, it being agreed
that the &ldquo;Conversion Date&rdquo; for purposes of Section 6 herein shall be deemed to be the Mandatory Conversion Date. The Mandatory
Conversion hereunder shall not be effective, unless all of the Equity Conditions are met (unless waived in writing by a Holder with respect
to such Holder) on the Mandatory Conversion Date through and including the Share Delivery Date and the actual delivery of all of the
Conversion Shares to the Holders. For purposes of clarification, a Mandatory Conversion shall be subject to all of the provisions of
Section 6, including, without limitation, Section 6(d) and the provision requiring payment of liquidated damages. If any of the Equity
Conditions shall cease to be satisfied at any time on or after the Mandatory Conversion Date through and including the actual delivery
of all of the Conversion Shares to the Holders, a Holder may elect to nullify the Mandatory Conversion as to such Holder by notice to
the Corporation within three (3) Trading Days after the first day on which any such Equity Condition has not been satisfied (provided
that if, by a provision of the Transaction Documents, the Corporation is obligated to notify the Holders of the non-existence of an Equity
Condition, such notice period shall be extended to the third Trading Day after proper notice from the Corporation) in which case the
Mandatory Conversion shall be null and void, ab initio. Subject to the other terms hereof, the Corporation covenants and agrees that
the Corporation will honor all Notices of Conversion that are tendered by the Holder on or after the Mandatory Conversion Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Forced Conversion</U>. At any time after 120 days following the Mandatory Conversion Date, the Corporation may deliver a written notice
to all Holders (a &ldquo;<U>Forced Conversion Notice</U>&rdquo; and the date such notice is delivered to all Holders, the &ldquo;<U>Forced
Conversion Notice Date</U>&rdquo;) to cause each Holder to convert all or part of such Holder&rsquo;s Series B Preferred Stock (as specified
in such Forced Conversion Notice) pursuant to Section 6 (a &ldquo;<U>Forced Conversion</U>&rdquo;), it being agreed that the &ldquo;Conversion
Date&rdquo; for purposes of Section 6 shall be deemed to be the Forced Conversion Notice Date (such date, the &ldquo;<U>Forced Conversion
Date</U>&rdquo;), provided that the Corporation shall not deliver a Forced Conversion Notice more than once in any 60 day period. The
Corporation may not deliver a Forced Conversion Notice, and any Forced Conversion Notice delivered by the Corporation shall not be effective,
unless all of the Equity Conditions have been met on the Forced Conversion Notice Date through and including the later of the Forced
Conversion Date and the Trading Day after the date that the Conversion Shares issuable pursuant to such conversion are actually delivered
to the Holders pursuant to the Forced Conversion Notice. Any Forced Conversion Notices shall be applied ratably to all of the Holders
based on each Holder&rsquo;s initial purchases of Series B Preferred Stock hereunder, provided that any voluntary conversions by a Holder
shall be applied against such Holder&rsquo;s <U>pro rata</U> allocation, thereby decreasing the aggregate amount forcibly converted hereunder
if less than all shares of the Series B Preferred Stock are forcibly converted. For purposes of clarification, a Forced Conversion shall
be subject to all of the provisions of Section 6, including, without limitation, the provisions requiring payment of liquidated damages
and Section 6(d) on Beneficial Ownership Limitation on conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
Notwithstanding the terms of Section 8(a) and 8(b) above, if the Corporation exercises its right to cause the conversion of Series Preferred
Stock pursuant to Sections 8(a) or 8(b), then, within two (2) Trading Days following the receipt of a Mandatory Conversion Notice or
Forced Conversion Notice, each such Holder shall be entitled to Deliver a Redemption Notice to the Corporation to cause the Corporation
to redeem its shares of Series B Preferred Stock otherwise subject to conversion, only to the extent the right to cause such redemption
would otherwise be available to such Holder, pursuant to the terms of Section 9 below. In the event a Holder delivers a Redemption Notice
pursuant to this Section 8(c), any conversion contemplated by the applicable Mandatory Conversion Notice or Forced Conversion Notice
shall be null and void, ab initio, and the Corporation shall be obligated to redeem such Holder&rsquo;s Series B Preferred Stock pursuant
to Section 9.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
9</U>. <U>Redemption</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
After (i) the earlier of (1) the receipt of Authorized Stockholder Approval and (2) the date that is 90 days following the Original Issue
Date and (ii) before the date that is 120 days after the Original Issue Date (the &ldquo;<U>Redemption Period</U>&rdquo;), each Holder
shall have the right to cause the Corporation to redeem all or part of such Holder&rsquo;s shares of Series B Preferred Stock at a price
per share equal to 105% of the Stated Value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
Subject to the terms of Section 9(a) above, to cause the Corporation to redeem all or part of its shares of Series B Preferred Stock,
each Holder shall deliver written notice to the Corporation (each, a &ldquo;<U>Redemption Notice</U>&rdquo;) setting forth the number
of shares of Series B Preferred Stock that each such Holder wishes to redeem. The Corporation shall redeem the shares of Series B Preferred
Stock in accordance with the Redemption Notice, no later than 5 days after the date on which the Redemption Notice is delivered to the
Corporation. Upon receipt of full payment in cash for a complete redemption, each Holder will promptly submit to the Corporation such
Holder&rsquo;s Series B Preferred Stock certificates, if any, and such redeemed shares shall no longer be deemed to be outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
10</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Notices</U>. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without
limitation, any Notice of Conversion, shall be in writing and delivered personally, by facsimile or e-mail attachment, or sent by a nationally
recognized overnight courier service, addressed to the Corporation, at 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648, Attention:
Michael H. Tardugno, Chairman, President and Chief Executive Officer, e-mail address mtardugno@celsion.com, or such other e-mail address
or address as the Corporation may specify for such purposes by notice to the Holders delivered in accordance with this Section 10. Any
and all notices or other communications or deliveries to be provided by the Corporation hereunder shall be in writing and delivered personally,
by e-mail attachment, or sent by a nationally recognized overnight courier service addressed to each Holder at the e-mail address or
address of such Holder appearing on the books of the Corporation, or if no such e-mail address or address appears on the books of the
Corporation, at the principal place of business of such Holder, as set forth in the Purchase Agreement. Any notice or other communication
or deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication
is delivered via e-mail attachment at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City time) on any date,
(ii) the next Trading Day after the time of transmission, if such notice or communication is delivered via e-mail attachment at the e-mail
address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day,
(iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv)
upon actual receipt by the party to whom such notice is required to be given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Lost or Mutilated Preferred Stock Certificate</U>. If a Holder&rsquo;s Series B Preferred Stock certificate shall be mutilated, lost,
stolen or destroyed, the Corporation shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated
certificate, or in lieu of or in substitution for a lost, stolen or destroyed certificate, a new certificate for the shares of Series
B Preferred Stock so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such
certificate, and of the ownership hereof reasonably satisfactory to the Corporation (which shall not include the posting of any bond).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Severability</U>. If any provision of this Certificate of Designation is invalid, illegal or unenforceable, the balance of this Certificate
of Designation shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain
applicable to all other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder
violates the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the
maximum rate of interest permitted under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Next Business Day</U>. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment
shall be made on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Headings</U>. The headings contained herein are for convenience only, do not constitute a part of this Certificate of Designation
and shall not be deemed to limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Status of Converted Preferred Stock</U>. Shares of Series B Preferred Stock may only be issued pursuant to the Purchase Agreement.
If any shares of Series B Preferred Stock shall be converted, redeemed or reacquired by the Corporation, such shares may not be reissued
and shall automatically be retired and cancelled and shall resume the status of authorized but unissued shares of preferred stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have executed this Certificate this 10<SUP>th</SUP> day of January 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Jeffrey W. Church</I></FONT></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 45%">Jeffrey W. Church</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
Vice President and Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ANNEX
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
OF CONVERSION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">(To
be Executed by the Registered Holder in order to Convert Shares of SERIES B Preferred Stock)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby elects to convert the number of shares of Series B Convertible Preferred Stock indicated below into shares of common
stock, par value $0.01 per share (the &ldquo;<U>Common Stock</U>&rdquo;), of Celsion Corporation, a Delaware corporation (the &ldquo;<U>Corporation</U>&rdquo;),
according to the conditions hereof, as of the date written below. If shares of Common Stock are to be issued in the name of a Person
other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto. No fee will be charged to the Holders
for any conversion, except for any such transfer taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
calculations:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
    to Effect Conversion: _____________________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares of Preferred Stock owned prior to Conversion: _______________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares of Preferred Stock to be Converted: ________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stated
    Value of shares of Preferred Stock to be Converted: ____________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares of Common Stock to be Issued: ___________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applicable
    Conversion Price:____________________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares of Preferred Stock subsequent to Conversion: ________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
                                            for Delivery: ______________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Or</U></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DWAC
    Instructions:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker
    no: _________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account
    no: ___________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HOLDER</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>5
<FILENAME>ex5-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
5.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR>
    <TD ROWSPAN="10" STYLE="font: bold 9pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 70%"><FONT STYLE="font-size: 10pt"><IMG SRC="ex5-1_001.jpg" ALT="" STYLE="height: 87px; width: 225px"></FONT></TD>
    <TD STYLE="font: bold 9pt Times New Roman, Times, Serif; vertical-align: top; width: 30%">Baker &amp; McKenzie LLP</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: bold 9pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 9pt/103% Times New Roman, Times, Serif">452 Fifth <FONT STYLE="letter-spacing: -0.15pt">Avenue </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 9pt Times New Roman, Times, Serif">New <FONT STYLE="letter-spacing: -0.2pt">York, </FONT>NY 10018</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 9pt Times New Roman, Times, Serif">United States</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 9pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 9pt Times New Roman, Times, Serif">Tel: +1 212 626 4100</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 9pt Times New Roman, Times, Serif">Fax: +1 212 310 1600</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 11pt Times New Roman, Times, Serif">www.bakermckenzie.com</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 11pt Times New Roman, Times, Serif"></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1.25in"><IMG SRC="ex5-1_002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
                                            10, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Celsion
Corporation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">997
Lenox Drive, Suite 100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrenceville,
NJ 08648</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have acted as special counsel for Celsion Corporation, a Delaware corporation (the &ldquo;Company&rdquo;), in connection with the sale
of 50,000 shares (the &ldquo;Shares&rdquo;) of Series A Convertible Redeemable Preferred Stock (the &ldquo;Series A Preferred Stock&rdquo;),
$0.01 par value per share and the shares of Common Stock, $0.01 par value per share, issuable upon the conversion of the Series A Preferred
Stock s (the &ldquo;Common Stock&rdquo;) pursuant to that certain Securities Purchase Agreement, dated as of January 10, 2022,
by and among the Company and the investors named therein (the &ldquo;Securities Purchase Agreement&rdquo;). The offer and sale of the
Shares are registered pursuant to the Company&rsquo;s Registration Statement on Form S-3 (Registration Number 333-254515), as amended
through the date hereof (the &ldquo;Registration Statement&rdquo;), which was declared effective by the Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) on March 30, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have reviewed the Securities Purchase Agreement and the Registration Statement and we have examined the originals, or photostatic or
certified copies, of such records of the Company, of certificates of officers of the Company and of public documents, and such other
documents as we have deemed relevant and necessary as the basis of the opinions set forth below. In such examination, we have assumed
the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents
of all documents submitted to us as photostatic or certified copies and the authenticity of the originals of such copies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this opinion, we have assumed that (a) the Company will effect, in accordance with the Delaware General Corporation Law,
an amendment to its Certificate of Incorporation, as amended, prior to the time any Shares are converted into Common Stock to increase
the number of authorized but unissued shares of Common Stock to a number which is sufficient to accommodate the conversion of all of
the Shares into shares of Common Stock and (b) the Company, in accordance with the Delaware General Corporation Law, reserves a sufficient
number of authorized but unissued shares of Common Stock for purposes of effectuating the conversion of all of the Shares into shares
of Common Stock in accordance with the Certificates of Designation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon and subject to the foregoing, we are of the opinion that the Shares have been duly and validly authorized and, when such Shares
are issued against payment thereof in accordance with the Securities Purchase Agreement, the Common Stock issuable upon conversion of
the Series A Preferred Stock in accordance with the terms of the Certificate of Designation of Preferences, Rights and Limitations of
the Series A Preferred Stock when so issued will be validly issued, fully paid and non-assessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
opinion expressed above is limited to the General Corporation Law of the State of Delaware, and the federal laws of the United States
of America.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
opinion letter is limited to the matters stated herein, and no opinion is implied or may be inferred beyond the matters expressly stated.
We hereby consent to the use of our opinion as herein set forth as an exhibit to the Registration Statement and to the use of our name
under the caption &ldquo;Legal Matters&rdquo; in the prospectus forming a part of the Registration Statement. In giving this consent,
we do not hereby admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act or
the rules and regulations of the Securities and Exchange Commission promulgated thereunder or Item 509 of Regulation S-K.</FONT></P>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Baker &amp; McKenzie LLP</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BAKER
    &amp; McKENZIE LLP</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1.25in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Baker
&amp; McKenzie LLP is a member of Baker &amp; McKenzie International.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex5-1_001.jpg
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !7 .$# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#V+''-<_=^
M-=+L+V6UF:7S(CM;"9&:Z(UXYXD_Y&/4,?\ /8UE5FX+0[\NPL,14<9[)7/0
MH?'&BRL%-T4)Z;D('YUN0SQ7$:O"ZNK#((.0:\PU7P;=:;IIO5G2:-5#.H&"
M :T?AUJ$HOIK$N3"T9D4'^$YJ8U9<W+)&^(P%+V3K4)72W/0Q3J9NVBLR?Q/
MI-LY26^A#C@J&R1^5;-I;GEQA*?PJYK5%,VU&;&=HS55-9L9+5KF.ZA:!?O2
M!QA?K42:S8WZ2QVMW#,X0DJC@G%%T/V<NJ,/3?'D.H:E#9BQD0R/L#%Q@>]=
M>*\=\.'_ (JBR_Z[U[ SA%+,0%'4FLZ4W):G=F.&A0G&-/JAU+65_P )-I&2
M/[1M<YQ_K!5RXO[>UB\V>6../^\[8%:71P.$D[-%FBL8>+=&+[?M\/USQ^=:
M<-U%<('@=)$/1E.10FGL.5.<-9*Q-15*\U>ST\H+RYB@+YVAVQG'I44_B#3;
M:WCGENXECE&4.[.X>U%T)0D]D:5%06MW#>VZ3VTBR1/]UU.0:GIDM6W"BBB@
M HHHH **** "BBB@ HHHH **** &FO&_$O/B/4 >GFG^E>R&O&_$W_(QZ@1U
M\TUA7V1[.2_Q9>A?U7QE=:EI?V!($AB*@.V[)8"MGX=VD"_:+L2J]P1L\L'E
M![_6K[>!-)GLE,:2Q2M&"&60G!QZ&N'T^XFT+Q"A5L-#-Y<F.C#."*S?-":E
M(ZDZ.(H3I8?W7OZG5>/?$$L#KIMK*4)7=,RG!P>B_P"-<_HWA*_UF#ST\N&
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=,L)_.L[&W@EQC?'&%./3-%% E)I61?Q1110(_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex5-1_002.jpg
<TEXT>
begin 644 ex5-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (? $@# 2(  A$! Q$!_\0
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MR+]B6XGS'$F!GY,=<@_GUK0TRW\;/K%M+JMQ:K91W$GF1P8&^(I\N>.S>^:
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M#@5QNG>,- TW3;6UMDNU@"8@!AR7 7<3@?7'U/XU?7QOI)F*,)TPQ1F9!\C
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MI<6OV,>H6,\NZ%B98Y,*BY_B7OSWK+-SX1GU%Y([:_GG:3S'=78@Y!&22V"
M%_+IFNFU1[A-3M3'9K+&$;+_ &7S6)[KG(V<<Y/7I6);ZOKJP0R_\(O$K,XB
M\I8"I" 'YL_PCI@?6@";1;[PX=<)M$N(;I;=^99/D6,$%L#<1SP?YX/%6$\>
M:<;(736]VJ;&9E,8W( <?,"0>>,?[PJO%JNK"[C1?#@\HF-7E6V9>')\S /;
MH>??/-=8UM"X;=#&V\8;*@[A[^M %+2-=M-:CG>UW_N)/+<.NT@X!Z?CWK4J
M*.".$-Y<:)N.3M4#)]34M !1110 4444 <UKD"7&K6D1OX()7B=8XY2P(/\
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M9'4G./>K^G66NR/,FIWKK$% B:!UR200?X>V0>>X].*S= 33+?7%>VU&X<&
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I!& >AQD'MCWKLJ3% &1H7]M;;G^VOL^_S3Y/D?=V8_Q]>:*V** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>8
<FILENAME>ex5-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 5.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="10" STYLE="font: bold 9pt Times New Roman, Times, Serif; text-align: left; width: 70%"><FONT STYLE="font-size: 10pt"><IMG SRC="ex5-2_001.jpg" ALT="" STYLE="width: 225px; height: 87px"></FONT></TD>
    <TD STYLE="font: bold 9pt Times New Roman, Times, Serif; width: 30%">Baker &amp; McKenzie LLP</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: bold 9pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 9pt/103% Times New Roman, Times, Serif">452 Fifth <FONT STYLE="letter-spacing: -0.15pt">Avenue </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 9pt Times New Roman, Times, Serif">New <FONT STYLE="letter-spacing: -0.2pt">York, </FONT>NY 10018</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 9pt Times New Roman, Times, Serif">United States</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 9pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 9pt Times New Roman, Times, Serif">Tel: +1 212 626 4100</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 9pt Times New Roman, Times, Serif">Fax: +1 212 310 1600</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 11pt Times New Roman, Times, Serif">www.bakermckenzie.com</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 11pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify; width: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex5-2_002.jpg" ALT="" STYLE="width: 100px; height: 753px">&#8239;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">January
    10, 2022</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">Celsion Corporation</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">997 Lenox Drive,
    Suite 100</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">Lawrenceville,
    NJ 08648</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">Ladies and Gentlemen:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">We have
    acted as special counsel for Celsion Corporation, a Delaware corporation (the &ldquo;Company&rdquo;), in connection with the sale
    of 50,000 shares (the &ldquo;Shares&rdquo;) of Series B Convertible Redeemable Preferred Stock (the &ldquo;Series B Preferred Stock&rdquo;),
    $0.01 par value per share and the shares of Common Stock, $0.01 par value per share, issuable upon the conversion of the Series B
    Preferred Stock s (the &ldquo;Common Stock&rdquo;) pursuant to that certain Securities Purchase Agreement, dated as of January 10,
    2022, by and among the Company and the investors named therein (the &ldquo;Securities Purchase Agreement&rdquo;). The offer and
    sale of the Shares are registered pursuant to the Company&rsquo;s Registration Statement on Form S-3 (Registration Number 333-254515),
    as amended through the date hereof (the &ldquo;Registration Statement&rdquo;), which was declared effective by the Securities and
    Exchange Commission (the &ldquo;SEC&rdquo;) on March 30, 2021.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">We have reviewed
    the Securities Purchase Agreement and the Registration Statement and we have examined the originals, or photostatic or certified copies,
    of such records of the Company, of certificates of officers of the Company and of public documents, and such other documents as we have
    deemed relevant and necessary as the basis of the opinions set forth below. In such examination, we have assumed the genuineness of all
    signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted
    to us as photostatic or certified copies and the authenticity of the originals of such copies.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">For purposes
    of this opinion, we have assumed that (a) the Company will effect, in accordance with the Delaware General Corporation Law, an amendment
    to its Certificate of Incorporation, as amended, prior to the time any Shares are converted into Common Stock to increase the number of
    authorized but unissued shares of Common Stock to a number which is sufficient to accommodate the conversion of all of the Shares into
    shares of Common Stock and (b) the Company, in accordance with the Delaware General Corporation Law, reserves a sufficient number of authorized
    but unissued shares of Common Stock for purposes of effectuating the conversion of all of the Shares into shares of Common Stock in accordance
    with the Certificates of Designation.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">Based upon
    and subject to the foregoing, we are of the opinion that the Shares have been duly and validly authorized and, when such Shares are
    issued against payment thereof in accordance with the Securities Purchase Agreement, the Common Stock issuable upon conversion of
    the Series B Preferred Stock in accordance with the terms of the Certificate of Designation of Preferences, Rights and Limitations
    of the Series B  Preferred Stock when so issued will be validly issued, fully paid and non-assessable.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">The opinion
    expressed above is limited to the General Corporation Law of the State of Delaware, and the federal laws of the United States of America.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">This opinion
letter is limited to the matters stated herein, and no opinion is implied or may be inferred beyond the matters expressly stated. We
hereby consent to the use of our opinion as herein set forth as an exhibit to the Registration Statement and to the use of our name under
the caption &ldquo;Legal Matters&rdquo; in the prospectus forming a part of the Registration Statement. In giving this consent, we do
not hereby admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act or the rules
and regulations of the Securities and Exchange Commission promulgated thereunder or Item 509 of Regulation S-K.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Baker &amp; McKenzie LLP</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BAKER &amp; McKENZIE LLP</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1.25in; margin-top: 0pt; margin-bottom: 0pt">Baker &amp; McKenzie LLP is a member of Baker &amp;
McKenzie International.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex5-2_001.jpg
<TEXT>
begin 644 ex5-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !7 .$# 2(  A$! Q$!_\0
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M(ZDZ.(H3I8?W7OZG5>/?$$L#KIMK*4)7=,RG!P>B_P"-<_HWA*_UF#ST\N&
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=,L)_.L[&W@EQC?'&%./3-%% E)I61?Q1110(_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ex5-2_002.jpg
<TEXT>
begin 644 ex5-2_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (? $@# 2(  A$! Q$!_\0
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MR+]B6XGS'$F!GY,=<@_GUK0TRW\;/K%M+JMQ:K91W$GF1P8&^(I\N>.S>^:
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M#@5QNG>,- TW3;6UMDNU@"8@!AR7 7<3@?7'U/XU?7QOI)F*,)TPQ1F9!\C
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MI<6OV,>H6,\NZ%B98Y,*BY_B7OSWK+-SX1GU%Y([:_GG:3S'=78@Y!&22V"
M%_+IFNFU1[A-3M3'9K+&$;+_ &7S6)[KG(V<<Y/7I6);ZOKJP0R_\(O$K,XB
M\I8"I" 'YL_PCI@?6@";1;[PX=<)M$N(;I;=^99/D6,$%L#<1SP?YX/%6$\>
M:<;(736]VJ;&9E,8W( <?,"0>>,?[PJO%JNK"[C1?#@\HF-7E6V9>')\S /;
MH>??/-=8UM"X;=#&V\8;*@[A[^M %+2-=M-:CG>UW_N)/+<.NT@X!Z?CWK4J
M*.".$-Y<:)N.3M4#)]34M !1110 4444 <UKD"7&K6D1OX()7B=8XY2P(/\
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M9'4G./>K^G66NR/,FIWKK$% B:!UR200?X>V0>>X].*S= 33+?7%>VU&X<&
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I!& >AQD'MCWKLJ3% &1H7]M;;G^VOL^_S3Y/D?=V8_Q]>:*V** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>11
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit 10.1</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITIES
PURCHASE AGREEMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Securities Purchase Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of January 10, 2022, between Celsion Corporation, a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including its successors
and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities
Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), the Company desires to issue and sell to each Purchaser, and each
Purchaser desires to purchase from the Company, securities of the Company as more fully described in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE, IN CONSIDERATION</B> of the mutual covenants contained in this Agreement, and for other good and valuable consideration the
receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEFINITIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1 <FONT STYLE="color: #0D0D0D"><U>Definitions</U>.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings
set forth in this Section 1.1:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Ballard</U>&rdquo;
means Ballard Spahr LLP with offices located at 1735 Market Street, 51st Floor, Philadelphia, PA 19103-7599.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the second (2nd) Trading
Day following the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.01 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Counsel</U>&rdquo; means Baker &amp; McKenzie LLP, 452 Fifth Avenue, New York, NY 10018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the
date hereof, and (ii) if this Agreement is signed between midnight (New York City time) and 9:00 a.m. (New York City time) on any Trading
Day, no later than 9:01 a.m. (New York City time) on the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock or options or other awards to employees, officers, service providers
or directors of the Company pursuant to any stock or option plan or arrangement duly adopted for such purpose, by a majority of the non-employee
members of the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose
for services rendered to the Company (or shares of Common Stock issued upon exercise of any such options or awards), (b) securities upon
the exercise or exchange of or conversion of any Securities issued hereunder and/or other securities exercisable or exchangeable for
or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not
been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price
or conversion price of such securities (other than in connection with stock splits or combinations), (c) securities in connection with
the acquisition or license by the Company of the securities, business, property, technology or other assets of another person or business
entity or pursuant to any employee benefit plan assumed by the Company in connection with any such acquisition, and (d) securities in
connection with any merger, joint venture, strategic alliance, commercial or other collaborative transaction; provided that, in the case
of immediately preceding clauses (c) and (d), the aggregate number of securities issued in connection with all such acquisitions and
other transactions does not exceed 10% of the number of shares outstanding on a fully diluted basis after giving effect to the consummation
of the offering pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FDA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(hh).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FDCA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(hh).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(aa).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Issuer
Covered Person</U>&rdquo; means the Company, any of its predecessors, any affiliated issuer, nor, to its knowledge, any director, executive
officer, other officer of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s
outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405
under the Securities Act) connected with the Company in any capacity at the time of sale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b). &ldquo;Material Permits&rdquo; shall have the
meaning ascribed to such term in Section 3.1(n).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Per
Share Purchase Price</U>&rdquo; equals, with respect to each share of Series A Stock and each share of Series B Stock, $285.00 per share,
subject, in each case, to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions
of the Common Stock that occur after the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pharmaceutical
Product</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(hh).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agent</U>&rdquo; means A.G.P./Alliance Global Partners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agent Agreement</U>&rdquo; means that certain placement agent agreement dated as of the date hereof between the Company and the Placement
Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Preferred
Stock</U>&rdquo; means the Series A Stock and Series B Stock of the Company, each par value $0.01 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition) pending or, to the Company&rsquo;s knowledge, threatened in writing against or affecting the Company, any Subsidiary
or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority
(federal, state, county, local or foreign).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus filed for the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed with the
Commission and delivered by the Company to each Purchaser at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement with Commission File No. 333-254515 which registers the sale of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Minimum</U>&rdquo; means, as of any date, the maximum aggregate number of shares of Common Stock then issued or potentially issuable
in the future pursuant to the Transaction Documents, including the conversion in full of all shares of Preferred Stock, ignoring any
conversion or exercise limits set forth therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Reverse
Stock Split Amendment</U>&rdquo; means the amendment to the Company&rsquo;s certificate of incorporation that effects the Reverse Stock
Split.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Reverse
Stock Split</U>&rdquo; means a reverse stock split of the outstanding shares of Common Stock that is effected by the Company&rsquo;s
filing of an amendment to its certificate of incorporation with the Secretary of State of the State of Delaware and the acceptance thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Reverse
Stock Split Date</U>&rdquo; means the date on which the Reverse Stock Split is consummated and deemed effective by the State of Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
A Stock</U>&rdquo; means the Company&rsquo;s Series A Redeemable Convertible Preferred Stock, stated value $300.00 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
B Stock</U>&rdquo; means the Company&rsquo;s Series B Redeemable Convertible Preferred Stock, stated value $300.00 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval</U>&rdquo; means the Company&rsquo;s stockholders approval of the Reverse Stock Split, pursuant to the Delaware General Corporation
Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shares</U>&rdquo;
means the shares of Preferred Stock issued or issuable to each Purchaser pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares purchased hereunder as specified below such
Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo; in United States
dollars and in immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on Schedule 3.1(a), and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Placement Agent Agreement, all exhibits and schedules thereto and hereto and any other
documents or agreements executed in connection with the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means American Stock Transfer &amp; Trust Company, LLC, the current transfer agent of the Company, with a mailing address
of 6201 15th Avenue, Brooklyn, New York 11219, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PURCHASE
AND SALE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1 <FONT STYLE="color: #0D0D0D"><U>Closing</U>.
On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the Purchasers, severally
and not jointly, agree to purchase, 50,000 shares of Series A Stock and 50,000 shares of Series B Stock. The Amount as set forth on the
signature page hereto executed by each Purchaser shall be made available for &ldquo;Delivery Versus Payment&rdquo; settlement with the
Company or its designees. The Company shall deliver to each Purchaser its Shares as determined pursuant to Section 2.2(a), and the Company
and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants
and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of Ballard or such other location as the parties
shall mutually agree. Unless otherwise directed by the Placement Agent, settlement of the Shares shall occur via &ldquo;Delivery Versus
Payment (i.e., on the Closing Date, the Company shall issue the Shares registered in the Purchasers&rsquo; names and addresses and released
by the Transfer Agent or the Company directly to the account(s) at the Placement Agent identified by each Purchaser; upon receipt of
such Shares, the Placement Agent shall promptly electronically deliver such Shares to the applicable Purchaser, and payment therefor
shall be made by the Placement Agent (or its clearing firm) by wire transfer to the Escrow Agent).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2 <FONT STYLE="color: #0D0D0D"><U>Deliveries</U>.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <FONT STYLE="color: #0D0D0D">On
or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <FONT STYLE="color: #0D0D0D">this
Agreement duly executed by the Company;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <FONT STYLE="color: #0D0D0D">a
legal opinion of Company Counsel, in a form reasonably acceptable to the Purchaser and the Placement Agent;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) <FONT STYLE="color: #0D0D0D">the
Company shall have provided each Purchaser with the Company&rsquo;s wire instructions, on Company letterhead and executed by the Company&rsquo;s
Chief Executive Officer or Chief Financial Officer;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) <FONT STYLE="color: #0D0D0D">a
certificate executed by the Chief Financial Officer of the Company, dated as of such date, in form and substance reasonably satisfactory
to the Purchaser and the Placement Agent;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) <FONT STYLE="color: #0D0D0D">subject
to the last sentence of Section 2.1, at the Company&rsquo;s option, (a) stock certificates in the name of the Purchaser representing
the Shares or (b) a certified copy of the Company&rsquo;s stock ledger including entries whereby the Purchaser is recorded as owner of
the Shares; and</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi) <FONT STYLE="color: #0D0D0D">the
Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <FONT STYLE="color: #0D0D0D">On
or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <FONT STYLE="color: #0D0D0D">this
Agreement duly executed by such Purchaser; and</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <FONT STYLE="color: #0D0D0D">such
Purchaser&rsquo;s Subscription Amount, which shall be made available for &ldquo;Delivery Versus Payment&rdquo; settlement with the Company
or its designees.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3 <FONT STYLE="color: #0D0D0D"><U>Closing
Conditions</U>.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <FONT STYLE="color: #0D0D0D">The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <FONT STYLE="color: #0D0D0D">the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) when made and on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as
of a specific date therein in which case they shall be accurate as of such date);</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <FONT STYLE="color: #0D0D0D">all
obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed;
and</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) <FONT STYLE="color: #0D0D0D">the
delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <FONT STYLE="color: #0D0D0D">The
respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <FONT STYLE="color: #0D0D0D">the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of
a specific date therein in which case they shall be accurate as of such date);</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <FONT STYLE="color: #0D0D0D">all
obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed
in all material respects;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) <FONT STYLE="color: #0D0D0D">the
delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) <FONT STYLE="color: #0D0D0D">there
shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) <FONT STYLE="color: #0D0D0D">from
the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such
magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of
such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPRESENTATIONS
AND WARRANTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1 <FONT STYLE="color: #0D0D0D"><U>Representations
and Warranties of the Company</U>. Except as set forth in the SEC Reports, or in the Disclosure Schedules, which Disclosure Schedules
shall be deemed a part hereof and shall qualify any representation or warranty otherwise made herein to the extent of the disclosure
contained in the corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties
to each Purchaser:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <FONT STYLE="color: #0D0D0D"><U>Subsidiaries</U>.
All of the direct and indirect subsidiaries of the Company are set forth on <U>Schedule 3.1(a)</U>. The Company owns, directly or indirectly,
all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding
shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights
to subscribe for or purchase securities.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <FONT STYLE="color: #0D0D0D"><U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority
to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary
is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational
or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing, as the case may be, would not have or reasonably be expected
to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material
adverse effect on the results of operations, assets, business, or financial condition of the Company and the Subsidiaries, taken as a
whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis its obligations
under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;); provided that a change in
the market price or trading volume of the Common Stock alone shall not be deemed, in and of itself, to constitute a Material Adverse
Effect. Except as disclosed in filings by the Company under the Exchange Act, no Proceeding has been instituted in any such jurisdiction
revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <FONT STYLE="color: #0D0D0D"><U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. Subject
to the Stockholder Approval, the execution and delivery of this Agreement and each of the other Transaction Documents by the Company
and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the
part of the Company and no further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection
herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which
it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms
hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with
its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and
other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the
availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <FONT STYLE="color: #0D0D0D"><U>No
Conflicts</U>. Subject to the Stockholder Approval, the execution, delivery and performance by the Company of this Agreement and the
other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions
contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s
certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) except as set forth on <U>Schedule
3.1(d)</U>, conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under,
result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights
of termination, amendment, anti-dilution or similar adjustments, acceleration or cancellation (with or without notice, lapse of time
or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other
understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is
bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order,
judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject
(including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound
or affected; except in the case of each of clauses (ii) and (iii), such as would not have or reasonably be expected to result in a Material
Adverse Effect.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <FONT STYLE="color: #0D0D0D"><U>Filings,
Consents and Approvals</U>. Except as set forth on <U>Schedule 3.1(d)</U>, the Company is not required to obtain any consent, waiver,
authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other
governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents,
other than: (i) the filings required pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission of the Prospectus
Supplement, (iii) application(s) to each applicable Trading Market for the listing of the Shares for trading thereon in the time and
manner required thereby, (iv) the Stockholder Approval and (v) the filing of the amendment to the Company&rsquo;s certificate of incorporation
with the Secretary of State of the State of Delaware in connection with the Reverse Stock Split (collectively, the &ldquo;<U>Required
Approvals</U>&rdquo;).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <FONT STYLE="color: #0D0D0D"><U>Issuance
of the Securities; Registration</U>. The Securities have been duly authorized and, subject to Stockholder Approval, when issued and paid
for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and
clear of all Liens imposed by the Company. Subject to the Stockholder Approval and the consummation of the Reverse Stock Split, the Company
has reserved from its duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to this Agreement.
The Company has prepared and filed the Registration Statement in conformity with the requirements of the Securities Act, which became
effective on March 30, 2021, including the Prospectus, and such amendments and supplements thereto as may have been required to the date
of this Agreement. The Company was at the time of the filing of the Registration Statement eligible to use Form S-3. The Company is eligible
to use Form S-3 under the Securities Act and it meets the transaction requirements as set forth in General Instruction I.B.1 of Form
S-3. The Registration Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness of
the Registration Statement or suspending or preventing the use of the Prospectus has been issued by the Commission and no proceedings
for that purpose have been instituted or, to the knowledge of the Company, are threatened by the Commission. The Company, if required
by the rules and regulations of the Commission, shall file the Prospectus Supplement with the Commission pursuant to Rule 424(b). At
the time the Registration Statement and any amendments thereto became effective, at the date of this Agreement and at the Closing Date,
the Registration Statement and any amendments thereto conformed and will conform in all material respects to the requirements of the
Securities Act and did not and will not contain any untrue statement of a material fact or omit to state any material fact required to
be stated therein or necessary to make the statements therein not misleading; and the Prospectus and any amendments or supplements thereto,
at the time the Prospectus or any amendment or supplement thereto was issued and at the Closing Date, conformed and will conform in all
material respects to the requirements of the Securities Act and did not and will not contain an untrue statement of a material fact or
omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were
made, not misleading.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <FONT STYLE="color: #0D0D0D"><U>Capitalization</U>.
The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule 3.1(g)</U> shall
also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof.
Except as set forth on <U>Schedule 3.1(g)</U>, the Company has not issued any capital stock since its most recently filed periodic report
under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&rsquo;s stock option plans, the
issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion
and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange
Act. No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions
contemplated by the Transaction Documents other than as has been duly waived. Except as a result of the purchase and sale of the Securities
and as set forth on <U>Schedule 3.1(g)</U>, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments
of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or
giving any Person any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts,
commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares
of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate
the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Purchasers and the Placement
Agent) and will not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange or reset price
under any of such securities. There are no outstanding securities or instruments of the Company or any Subsidiary with any provision
that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities by the Company
or any Subsidiary. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or
similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is
or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or
&ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock of the
Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all applicable federal
and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to
subscribe for or purchase securities. Except for the Required Approvals, no further approval or authorization of any stockholder, the
Board of Directors or others is required for the issuance and sale of the Securities. There are no stockholders agreements, voting agreements
or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge of
the Company, between or among any of the Company&rsquo;s stockholders.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <FONT STYLE="color: #0D0D0D"><U>SEC
Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be
filed by the Company under the Securities Act and Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years
preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing
materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus and the Prospectus
Supplement, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received a valid
extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective
dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable,
and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required
to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading. Additionally, any further documents so filed and incorporated by reference in the Prospectus and Prospectus Supplement,
when such documents are filed with the Commission, will conform in all material respects to the requirements of the Exchange Act and
the applicable rules and regulations, as applicable, and will not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements therein, in light of the circumstances under which they were made not misleading. No post-effective
amendment to the Registration Statement reflecting any facts or events arising after the date thereof which represent, individually or
in the aggregate, a fundamental change in the information set forth therein is required to be filed with the Commission. The Company
has never been an issuer subject to Rule 144(i) under the Securities Act. The financial statements of the Company included in the SEC
Reports complied in all material respects with applicable accounting requirements and the rules and regulations of the Commission with
respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally
accepted accounting principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be
otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain
all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated
Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the
case of unaudited statements, to normal, immaterial, year-end audit adjustments. The agreements and documents described in the Registration
Statement, the Prospectus, the Prospectus Supplement, and the SEC Reports conform in all material aspects to the descriptions thereof
contained therein and there are no agreements or other documents required by the Securities Act and the rules and regulations thereunder
to be described in the Registration Statement, the Prospectus, the Prospectus Supplement or the SEC Reports or to be filed with the Commission
as exhibits to the Registration Statement, that have not been so described or filed. Each agreement or other instrument (however characterized
or described) to which the Company is a party or by which it is or may be bound or affected and (i) that is referred to in the Registration
Statement, the Prospectus, the Prospectus Supplement or the SEC Reports, or (ii) is material to the Company&rsquo;s business (each, a
&ldquo;Material Agreement&rdquo;), has been duly authorized and validly executed by the Company, is in full force and effect in all material
respects and is enforceable against the Company and, to the Company&rsquo;s knowledge, the other parties thereto, in accordance with
its terms, except (x) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo;
rights generally, (y) as enforceability of any indemnification or contribution provision may be limited under the federal and state securities
laws, and (z) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable
defenses and to the discretion of the court before which any proceeding therefore may be brought. No Material Agreement has been assigned
by the Company, and neither the Company nor, to the best of the Company&rsquo;s knowledge, any other party is in default thereunder and,
to the best of the Company&rsquo;s knowledge, no event has occurred that, with the lapse of time or the giving of notice, or both, would
constitute a default thereunder that has had or that could reasonably be expected to result in a Material Adverse Effect. To the best
of the Company&rsquo;s knowledge, performance by the Company of the material provisions of the Material Agreements will not result in
a violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental agency or court, domestic
or foreign, having jurisdiction over the Company or any of its assets or businesses, including, without limitation, those relating to
environmental laws and regulations. The other financial and statistical information included in the SEC Reports present fairly, in all
material respects, the information included therein and have been prepared on a basis consistent with that of the financial statements
that are included in the SEC Reports and the books and records of the respective entities presented therein.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <FONT STYLE="color: #0D0D0D"><U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the SEC Reports (i) there has been no event, occurrence or development that has had or that would reasonably be expected to result in
a Material Adverse Effect, (ii) the Company has not incurred any material liabilities (contingent or otherwise) other than (A) trade
payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required
to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii)
the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash
or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock
and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company equity
compensation or stock option plans. The Company does not have pending before the Commission any request for confidential treatment of
information. Except for the issuance of the Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence
or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or
their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed
by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed
at least 1 Trading Day prior to the date that this representation is made.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) <FONT STYLE="color: #0D0D0D"><U>Litigation</U>.
Except as reported in the SEC Reports or on <U>Schedule 3.1(j)</U>, there is no material action, suit, inquiry, notice of violation,
proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary
or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority
(federal, state, county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth in the SEC Reports
(i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or
(ii) except for the matters set forth on <U>Schedule 3.1(j)</U>, would, if there were an unfavorable decision, have or reasonably be
expected to result in a Material Adverse Effect. Except as reported in the SEC Reports or on <U>Schedule 3.1(j)</U>, neither the Company
nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or
liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of
the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former
director or officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration
statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) <FONT STYLE="color: #0D0D0D"><U>Labor
Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company,
which would reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees
is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company
nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their
relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary,
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all applicable U.S. federal, state,
local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages
and hours, except where the failure to be in compliance would not, individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) <FONT STYLE="color: #0D0D0D"><U>Compliance</U>.
Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived
that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or
any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement
or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default
or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority
or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation
all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality
and safety and employment and labor matters, except in each case as would not have or reasonably be expected to result in a Material
Adverse Effect.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) <FONT STYLE="color: #0D0D0D"><U>Environmental
Laws</U>. The Company and its Subsidiaries (i) are in material compliance with all applicable federal, state, local and foreign laws
relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface
or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants,
or toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise
relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials,
as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters,
orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;);
(ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective
businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i),
(ii) and (iii), the failure to so comply would be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) <FONT STYLE="color: #0D0D0D"><U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except
where the failure to possess such permits would not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or
modification of any Material Permit.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) <FONT STYLE="color: #0D0D0D"><U>Title
to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good
and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in
each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries, and (ii) Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of
which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance, except
where the failure to be in compliance would not reasonably be expected to have a Material Adverse Effect.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p) <FONT STYLE="color: #0D0D0D"><U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to
so have would have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither
the Company nor any Subsidiary has received a written notice that any of, the Intellectual Property Rights has expired, terminated or
been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement. Neither
the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC Reports,
a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights
of any Person, except as would not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company,
all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual
Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and
value of all of their intellectual properties, except where failure to do so would not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect. The Company has no knowledge of any facts that would preclude it from having valid license
rights or clear title to the Intellectual Property Rights. The Company has no knowledge that it lacks or will be unable to obtain any
rights or licenses to use all Intellectual Property Rights that are necessary to conduct its business.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) <FONT STYLE="color: #0D0D0D"><U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in
such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not
limited to, directors and officers insurance coverage.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r) <FONT STYLE="color: #0D0D0D"><U>Transactions
With Affiliates and Employees</U>. Except as disclosed in the SEC Reports, none of the officers or directors of the Company or any Subsidiary
and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction
with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement
or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from,
providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or
such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
employee benefits, including stock option agreements under any stock option plan of the Company.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s) <FONT STYLE="color: #0D0D0D"><U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance in all material respects with the applicable requirements
of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated
by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain
a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance
with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with
management&rsquo;s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets
at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and
designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it
files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s
rules and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of
the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act
(such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange
Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations
as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as
such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely
to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t) <FONT STYLE="color: #0D0D0D"><U>Certain
Fees</U>. Except as set forth in the Prospectus Supplement, no brokerage or finder&rsquo;s fees or commissions are or will be payable
by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or
other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation with
respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section
that may be due in connection with the transactions contemplated by the Transaction Documents.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u) <FONT STYLE="color: #0D0D0D"><U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be
or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The
Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) <FONT STYLE="color: #0D0D0D"><U>Registration
Rights</U>. No Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any
securities of the Company or any Subsidiary.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w) <FONT STYLE="color: #0D0D0D"><U>Listing
and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company
has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common
Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.
Except as set forth on <U>Schedule 3.1(w)</U>, the Company has not, in the 12 months preceding the date hereof, received notice from
any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with
the listing or maintenance requirements of such Trading Market. Except as disclosed in the SEC Reports, the Company is, and has no reason
to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements.
The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation
and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in
connection with such electronic transfer.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x) <FONT STYLE="color: #0D0D0D"><U>Application
of Takeover Protections</U>. The Company and its Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state
of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their
obligations or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s
issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y) <FONT STYLE="color: #0D0D0D"><U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms
that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information
that it believes constitutes or might constitute material, nonpublic information which is not otherwise disclosed in the Prospectus Supplement.
The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities
of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries,
their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and
correct in all material respects and does not contain any untrue statement of a material fact or omit to state any material fact necessary
in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. The press
releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain any
untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which they were made and when made, not misleading. The Company acknowledges
and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby
other than those specifically set forth in Section 3.2 hereof.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z) <FONT STYLE="color: #0D0D0D"><U>No
Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, neither
the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or
sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions of any Trading Market
on which any of the securities of the Company are listed or designated.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa) <FONT STYLE="color: #0D0D0D"><U>Tax
Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local
income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is
subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to
be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment
of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no
unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company
or of any Subsidiary know of no basis for any such claim.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #0D0D0D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb) <U>Foreign
Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or
other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any
unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or
campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by
any person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated in any material
respect any provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc) <U>Accountants</U>.
The Company&rsquo;s independent registered public accounting firm is set forth in the SEC Reports. To the knowledge and belief of
the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) has expressed
its opinion with respect to the financial statements included in the Company&rsquo;s Annual Report for the fiscal year ended
December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd) <U>Acknowledgment
Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting
solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions
contemplated thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the
Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any
advice given by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and
the transactions contemplated thereby is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further
represents to each Purchaser that the Company&rsquo;s decision to enter into this Agreement and the other Transaction Documents has
been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its
representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee) <U>Acknowledgment
Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for Sections 3.2(e) and 4.14 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has
been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short,
securities of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the
Securities for any specified term; (ii) past or future open market or other transactions by any Purchaser, specifically including,
without limitation, Short Sales or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private
placement transactions, may negatively impact the market price of the Company&rsquo;s publicly-traded securities; (iii) any
Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to which any such Purchaser is a party, directly or
indirectly, presently may have a &ldquo;short&rdquo; position in the Common Stock; and (iv) each Purchaser shall not be deemed to
have any affiliation with or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo; transaction. The
Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities (in material
compliance with applicable laws) at various times during the period that the Securities are outstanding, and (z) such hedging
activities (if any) could reduce the value of the existing stockholders&rsquo; equity interests in the Company at and after the time
that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not
constitute a breach of any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff) <U>Regulation
M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any
action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of,
any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other
securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection
with the placement of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg) <U>FDA</U>.
As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (&ldquo;<U>FDA</U>&rdquo;) under the Federal
Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (&ldquo;<U>FDCA</U>&rdquo;) that is manufactured, packaged,
labeled, tested and/or distributed by the Company or any of its Subsidiaries (each such product, a &ldquo;<U>Pharmaceutical
Product</U>&rdquo;), such Pharmaceutical Product is being manufactured, packaged, labeled, tested and/or distributed by the Company
in compliance with all applicable requirements under FDCA and similar laws, rules and regulations relating to registration,
investigational use, licensure, or application approval, good manufacturing practices, good laboratory practices, good clinical
practices, product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure to be in
compliance would not have a Material Adverse Effect. Except as set forth in the SEC Reports, there is no pending, completed or, to
the Company&rsquo;s knowledge, threatened, action (including any lawsuit, arbitration, or legal or administrative or regulatory
proceeding, charge, complaint, or investigation) against the Company or any of its Subsidiaries, and none of the Company or any of
its Subsidiaries has received any notice, warning letter or other communication from the FDA or any other governmental entity, which
(i) contests the licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the
testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the
recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to,
any Pharmaceutical Product, (iii) imposes a clinical hold on any clinical investigation by the Company or any of its Subsidiaries,
(iv) enjoins production at any facility of the Company or any of its Subsidiaries, (v) enters or proposes to enter into a consent
decree of permanent injunction with the Company or any of its Subsidiaries, or (vi) otherwise alleges any violation of any laws,
rules or regulations by the Company or any of its Subsidiaries, and which, either individually or in the aggregate, would have a
Material Adverse Effect. The properties, business and operations of the Company have been and are being conducted in all material
respects in accordance with all applicable laws, rules and regulations of the FDA. The Company has not been informed by the FDA that
the FDA will prohibit the marketing, sale, license or use in the United States of any product proposed to be developed, produced or
marketed by the Company nor has the FDA expressed any concern as to approving or clearing for marketing any product being developed
or proposed to be developed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh) <U>Stock
Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance
with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of
the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted
under the Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been
no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock
options with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their
financial results or prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <U>Office
of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer,
agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office
of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj) <U>U.S.
Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the
meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk) <U>Bank
Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of
1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;), and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or
indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of
the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company
nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity
that is subject to the BHCA and to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll) <U>Money
Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as
amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money
Laundering Laws</U>&rdquo;), and no Action or Proceeding by or before any court or governmental agency, authority or body or any
arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the
Company or any Subsidiary, threatened in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm) <U>Other
Covered Persons</U>. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person)
that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of
any Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2 <U>Representations
and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of
the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall
be accurate as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Organization;
Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good
standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction
Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction
Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized
by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser.
Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in
accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it
in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as
limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii)
insofar as indemnification and contribution provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Understandings
or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect
arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this
representation and warranty not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement
or otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring such Securities as
principal for his, her or its own account and not with a view to or for distributing or reselling such Securities or any part
thereof in violation of the Securities Act or any applicable state securities law, has no present intention of distributing any of
such Securities in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement
or understandings with any other persons to distribute or regarding the distribution of such Securities in violation of the
Securities Act or any applicable state securities law (this representation and warranty not limiting such Purchaser&rsquo;s right to
sell such Securities pursuant to a registration statement or otherwise in compliance with applicable federal and state securities
laws).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Purchaser
Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, either: (i) an
&ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a
&ldquo;qualified institutional buyer&rdquo; as defined in Rule 144A(a) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and
experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in
the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an
investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Access
to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all
exhibits and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has
deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering
of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its
financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its
investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without
unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment. Such
Purchaser acknowledges and agrees that neither the Placement Agent nor any Affiliate of the Placement Agent has provided such
Purchaser with any information or advice with respect to the Securities nor is such information or advice necessary or desired.
Neither the Placement Agent nor any Affiliate has made or makes any representation as to the Company or the quality of the
Securities and the Placement Agent and any Affiliate may have acquired non-public information with respect to the Company which such
Purchaser agrees need not be provided to it. In connection with the issuance of the Securities to such Purchaser, neither the
Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Certain
Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor
has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any
purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such
Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth
the material terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding
the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage
separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions
made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall
only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the
Securities covered by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser&rsquo;s
representatives, including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents and
Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction
(including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing
contained herein shall constitute a representation or warranty against, or a prohibition of, any actions with respect to the
borrowing of, arrangement to borrow, identification of the availability of, and/or securing of, securities of the Company in order
for such Purchaser (or its broker or other financial representative) to effect Short Sales or similar transactions in the
future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <U>General
Solicitation</U>. Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication
regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at
any seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order
to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IV. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
AGREEMENTS OF THE PARTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1 <U>Removal
of Legends</U>. The Shares shall be issued free of legends.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2 <U>Integration</U>.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in
Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations
of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction unless shareholder
approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3 <U>Securities
Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time issue a press release disclosing the material terms of the
transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto,
with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company represents
to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the
Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents in connection with the transactions
contemplated by the Transaction Documents. In addition, effective upon the issuance of such press release, the Company acknowledges and
agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any
of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates on the one hand, and any of the Purchasers
or any of their Affiliates on the other hand, shall terminate. The Company and each Purchaser shall consult with each other in issuing
any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue
any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press
release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent
shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall
promptly provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing, the Company
shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any
regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a) as required by federal securities
law in connection with the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required
by law or Trading Market regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted
under this clause (b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4 <U>Shareholder
Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, by any other Person, that any
Purchaser is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill (including
any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company,
or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under
the Transaction Documents or under any other agreement between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5 <U>Non-Public
Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its
behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes
constitutes, material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information
and agreed with the Company to keep such information confidential. The Company understands and confirms that any Purchaser shall be relying
on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company delivers any material,
non-public information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser
shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, agents,
employees or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees
or Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to
applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public
information regarding the Company or any Subsidiaries, the Company shall simultaneously file such material non-public information with
the Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that the Purchaser shall be relying on
the foregoing covenant in effecting transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6 <U>Use
of Proceeds</U>. The Company shall use the net proceeds from the sale of the Securities hereunder as set forth in the Prospectus Supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7 <U>Indemnification
of Purchasers</U>. Subject to the provisions of this Section 4.7, the Company will indemnify and hold each Purchaser and its directors,
officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning
of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members,
partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack
of such title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any and all
losses, liabilities, obligations, claims, contingencies, damages, costs and reasonable expenses, including all judgments, amounts paid
in settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer
or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the
Company in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity,
or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with
respect to any of the transactions contemplated by the Transaction Documents (unless such action is based upon a material breach of such
Purchaser Party&rsquo;s representations, warranties or covenants under the Transaction Documents or any agreements or understandings
such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws
or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct),
the Company will indemnify each Purchaser Party, to the fullest extent permitted by applicable law, from and against any and all losses,
claims, damages, liabilities, costs (including, without limitation, reasonable attorneys&rsquo; fees) and expenses, as incurred, arising
out of or relating to (i) any untrue or alleged untrue statement of a material fact contained in such registration statement, any prospectus
or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to
any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the
case of any prospectus or supplement thereto, in the light of the circumstances under which they were made) not misleading, except to
the extent, but only to the extent, that such untrue statements or omissions are based solely upon information regarding such Purchaser
Party furnished in writing to the Company by such Purchaser Party expressly for use therein, or (ii) any violation or alleged violation
by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder in connection
therewith. If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement,
such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof
with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate
counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense
of such Purchaser Party except to the extent that (x) the employment thereof has been specifically authorized by the Company in writing,
(y) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (z) in such action there
is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the position
of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such
separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (1) for any settlement or compromise of,
or consent to the entry of judgement in, any action, claim or proceeding by a Purchaser Party effected without the Company&rsquo;s prior
written consent, which shall not be unreasonably withheld or delayed; or (2) to the extent, but only to the extent that a loss, claim,
damage or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations, warranties, covenants or agreements
made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification required by this Section 4.7
shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received
or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser
Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8 <U>Reservation
of Common Stock</U>. Subject to the Stockholder Approval and the consummation of the Reverse Stock Split, from and after the consummation
of the Reverse Stock Split, the Company shall reserve and keep available at all times, free of preemptive rights, a sufficient number
of shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9 <U>Listing
of Common Stock</U>. The Company hereby agrees to use commercially reasonable best efforts to maintain the listing or quotation of the
Common Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list
or quote all of the Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded
on any other Trading Market, it will then include in such application all of the Shares, and will take such other action as is necessary
to cause all of the Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all
action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects
with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. For so long as the
Company maintains a listing or quotation of the Common Stock on a Trading Market, the Company agrees to maintain the eligibility of the
Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without
limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection with
such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10 <U>Reservation
and Listing of Securities</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) On
and after the Reverse Stock Split Date, the Company shall maintain a reserve from its duly authorized shares of Common Stock for issuance
pursuant to the Transaction Documents in such amount as may then be required to fulfill its obligations in full under the Transaction
Documents. If, at any date after the Reverse Stock Split Date, the number of authorized but unissued (and otherwise unreserved) shares
of Common Stock is less than the Required Minimum on such date, then the Board of Directors shall use commercially reasonable efforts
to amend the Company&rsquo;s certificate or articles of incorporation to increase the number of authorized but unissued shares of Common
Stock to at least the Required Minimum at such time, as soon as possible, and in any event not later than the 90<SUP>th</SUP> day after
such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) For
as long as the Company has Shares outstanding, the Company shall hold a special meeting of stockholders (which may also be at the annual
meeting of stockholders) on or prior to April 30, 2022, for the purpose of obtaining the Stockholder Approval with the recommendation
of the Company&rsquo;s Board of Directors that such proposals are approved, and the Company shall solicit proxies from its stockholders
in connection therewith in the same manner as all other management proposals in such proxy statement and all management-appointed proxyholders
shall vote their proxies in favor of such proposals. The Company shall use its best efforts to obtain the Stockholder Approval. If the
Company does not obtain the Stockholder Approval at the first meeting, the Company shall call a meeting every sixty (60) days thereafter
to seek the Stockholder Approval until the date on which the Stockholder Approval is obtained. When the Company obtains the Stockholder
Approval, the Company shall file the Reverse Stock Split Amendment with the State of Delaware as soon as practicable, but in no event
later than one (1) Business Day following the Stockholder Approval. On the Reverse Stock Split Date, the Company shall file a Form 8-K
disclosing that the Reverse Stock Split Amendment has been filed with and accepted by the State of Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) The
Company shall, if applicable: (i) in the time and manner required by the principal Trading Market, prepare and file with such Trading
Market an additional shares listing application covering a number of shares of Common Stock at least equal to the Required Minimum on
the date of such application, (ii) take all steps necessary to cause such shares of Common Stock to be approved for listing or quotation
on such Trading Market as soon as possible thereafter, (iii) provide to the Purchasers evidence of such listing or quotation and (iv)
maintain for two (2) years the listing or quotation of such Common Stock on any date at least equal to the Required Minimum on such date
on such Trading Market or another Trading Market. The Company agrees to maintain for two (2) years the eligibility of the Common Stock
for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation,
by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic
transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11 <U>Subsequent
Equity Sales</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) To
the extent shares of Preferred Stock are outstanding, from the date hereof until thirty (30) days thereafter, neither the Company nor
any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common
Stock or Common Stock Equivalents or (ii) file any registration statement or amendment or supplement thereto, other than the Prospectus
Supplement (other than a registration statement or amendment or supplement thereto relating to the issuance or resale of the Common Stock
issuable or issued on conversion of shares of Preferred Stock). In addition, to the extent shares of Preferred Stock are outstanding,
from the Closing Date until one hundred twenty (120) days thereafter, neither the Company nor any Subsidiary shall issue any shares of
preferred stock or other securities having rights senior to or <I>pari passu</I> with the Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) From
the date hereof until one (1) year following the Reverse Stock Split Date, the Company shall be prohibited from effecting or entering
into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a
combination of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction
in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or
include the right to receive, additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or
other price that is based upon, and/or varies with, the trading prices of or quotations for the shares of Common Stock at any time after
the initial issuance of such debt or equity securities or (B) with a conversion, exercise or exchange price that is subject to being
reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent
events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects
a transaction under, any agreement, including, but not limited to, an equity line of credit, whereby the Company may issue securities
at a future determined price. Any Purchaser shall be entitled to obtain injunctive relief against the Company to preclude any such issuance,
which remedy shall be in addition to any right to collect damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Until
the Reverse Stock Split Date, neither the Company nor any Subsidiary shall make any issuance whatsoever of Common Stock or Common Stock
Equivalents. The Purchaser shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy
shall be in addition to any right to collect damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Notwithstanding
the foregoing, this Section 4.11 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall be
an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12 <U>Restrictions
on Conversion and Voting of Preferred Stock</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) From
the date hereof up to and including the Reverse Stock Split Date, each Purchaser, severally and not jointly with the other Purchasers,
covenants that such Purchaser will not convert any shares of Preferred Stock and such Purchaser will not transfer, offer, sell, contract
to sell, hypothecate, pledge or otherwise dispose of (or enter into any transaction which is designed to, or might reasonably be expected
to, result in the disposition (whether by actual disposition or effective economic disposition due to cash settlement or otherwise))
any shares of Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Each
Purchaser covenants to (i) vote, and shall cause its Affiliates to vote, all shares of Series A Stock owned by such Purchaser or its
Affiliates, as applicable, in favor of any resolution presented to the shareholders of the Company for the purpose of obtaining the Stockholder
Approval, (ii) attend (with respect to all shares of Series A Preferred Stock held thereby), including, for purposes of attendance, by
delivering a proxy, any meeting of the stockholders of the Company held for purposes of obtaining the Stockholder Approval and (iii)
promptly upon request by the Company, grant the Company (or its designee) an irrevocable proxy, in form and substance reasonably satisfactory
to such Purchaser, to vote all shares of Series A Preferred Stock in accordance with clause (i) above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Each
Purchaser covenants to (i) vote, and shall cause its Affiliates to vote, the shares of Series B Stock on any resolution presented to
the stockholders of the Company for purposes of obtaining the Stockholder Approval and agrees that such shares of Series B Stock, shall
automatically and without further action of the Purchaser be voted in a manner that &ldquo;mirrors&rdquo; the proportions on which the
shares of Common Stock (excluding any shares of Common Stock that are not voted) and Series A Stock are voted on the Reverse Stock Split
Amendment; (ii) attend (with respect to all shares of Series B Preferred Stock held thereby), including, for purposes of attendance,
by delivering a proxy, any meeting of the stockholders of the Company held for purposes of obtaining the Stockholder Approval; and (iii)
promptly upon request by the Company, grant the Company (or its designee) an irrevocable proxy to vote all shares of Series B Preferred
Stock in accordance with clause (i) above. For the avoidance of doubt, and for illustrative purposes only, if 30% of the aggregate votes
cast by Common Stock and Series A Stock voting in connection with the Reverse Stock Split Amendment are voted against such resolutions
and 70% of the aggregate votes cast by Common Stock and Series A Stock voting in connection with the Reverse Stock Split Amendment are
voted in favor thereof, then 30% of the votes cast by the shares of Series B Stock voting in connection with the Reverse Stock Split
Amendment shall vote against the approval of the Reverse Stock Split Amendment and 70% of such votes shall be cast in favor of such Reverse
Stock Split Amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13 <U>Equal
Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is
also offered to all of the parties to such Transaction Documents. For clarification purposes, this provision constitutes a separate right
granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers
as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition
or voting of Securities or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14 <U>Certain
Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it
nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short
Sales of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such time
that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described
in Section 4.4. Each Purchaser, severally and not jointly with the other Purchasers covenants that until such time as the transactions
contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4,
such Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included in the Disclosure
Schedules. Notwithstanding the foregoing, and notwithstanding anything contained in this Agreement to the contrary (including Section
4.12), the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that
it will not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated by this
Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4, (ii) no Purchaser shall be
restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities laws
from and after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press
release as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade in the securities
of the Company to the Company or its Subsidiaries after the issuance of the initial press release as described in Section 4.4. Notwithstanding
the foregoing, and except as set forth in Section 4.12, in the case of a Purchaser that is a multi-managed investment vehicle whereby
separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge
of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set
forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision
to purchase the Securities covered by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15 <U>Capital
Changes</U>. Except for the Reverse Stock Split, until the one year anniversary of the Closing Date, the Company shall not undertake
a reverse or forward stock split or reclassification of the Common Stock without the prior written consent of the Purchasers holding
a majority in interest of the Shares, provided that no consent shall be required in the event the Company undertakes a reverse stock
split for purposes of maintaining the listing of the Common Stock on the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MISCELLANEOUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1 <FONT STYLE="font-weight: normal">Termination.
This Agreement may be terminated by any Purchaser, by written notice to the Company, if the Closing has not been consummated on or before
the fifth (5th) Trading Day following the date hereof.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2 <U>Fees
and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses
of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without
limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered
by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3 <U>Entire
Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus Supplement,
contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements
and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents,
exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4 <U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via facsimile
at the facsimile number or email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30
p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication
is delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached
hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd)Trading
Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the
party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature
pages attached hereto. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material,
non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission
pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5 <U>Amendments;
Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in
the case of an amendment prior to Closing by each individual Purchaser, and after Closing, by the Company and Purchasers which purchased
a majority in interest of the Shares based on the initial Subscription Amounts hereunder or, in the case of a waiver, by the party against
whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately and
adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers)
shall also be required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed
to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement
hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6 <U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7 <U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser
(other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns
or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities,
by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8 <U>No
Third-Party Beneficiaries</U>. The Placement Agent shall be the third party beneficiary of the representations and warranties of the
Company in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit
of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof
be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9 <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts
sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with
any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents),
and hereby irrevocably waives, and agrees not to assert in any action or proceeding, any claim that it is not personally subject to the
jurisdiction of any such court, that such action or proceeding is improper or is an inconvenient venue for such Proceeding. Each party
hereby irrevocably waives personal service of process and consents to process being served in any such action or proceeding by mailing
a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect
for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.
If any party shall commence an action or proceeding to enforce any provisions of the Transaction Documents, then, in addition to the
obligations of the Company under Section 4.8, the prevailing party in such action or proceeding shall be reimbursed by the non-prevailing
party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation and prosecution
of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10 <U>Survival</U>.
The covenants, representations and warranties contained herein shall survive the Closing and the delivery of the Securities for a period
of five (5) years from the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11 <U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery
of a &ldquo;.pdf&rsquo; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rsquo; signature page were an original
thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12 <U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or
unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13 <U>Rescission
and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any
of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document
and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind
or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in
whole or in part without prejudice to its future actions and rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14 <U>Replacement
of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of
and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company
of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable
third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15 <U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers
and the Company will be entitled to seek specific performance under the Transaction Documents. The parties agree that monetary damages
may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents
and hereby agree to waive and not to assert in any action for specific performance of any such obligation the defense that a remedy at
law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16 <U>Payment
Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a
Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or
any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or
are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17 <U>Independent
Nature of Purchasers&rsquo; Obligations and Rights</U>. The Purchasers have been represented by its own separate legal counsel in its
review and negotiation of the Transaction Documents. For reasons of administrative convenience only, the Purchasers and their counsel
have chosen to communicate with the Company through the legal counsel of the Placement Agent. The legal counsel of the Placement Agent
does not represent the Purchasers and only represents the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18 <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19 <U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20 <B><U>WAIVER
OF JURY TRIAL</U></B>. <B><U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE
PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<I>Signature
Pages Follow</I>)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CELSION
    CORPORATION</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice: </U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Michael H. Tardugno </I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:
    609-896-9100</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    H. Tardugno</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
    mtardugno@celsion.com</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<FONT STYLE="font-variant: small-caps">REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK<BR>
SIGNATURE PAGE FOR PURCHASER FOLLOWS</FONT>]</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[PURCHASER
SIGNATURE PAGES TO CELSION SECURITIES PURCHASE AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Purchaser: ______________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Purchaser</I>: _______________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _____________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ______________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
Address of Authorized Signatory: ______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile
Number of Authorized Signatory: ___________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Notice to Purchaser: ____________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DWAC
for Shares: _______________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
Amount for Series A Stock: $ ____________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of Series A Stock: __________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
Amount for Series B Stock: $ ____________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of Series B Stock: __________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EIN
Number: ___________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>12
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Celsion
Corporation Announces Pricing of $30 Million Registered Direct Offerings of Convertible</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Redeemable Preferred Stock </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LAWRENCEVILLE,
N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) &ndash; Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based
immunotherapy and next-generation vaccines, today announced that it has entered into a securities purchase agreement with certain institutional
investors to purchase 50,000 shares of Series A convertible redeemable preferred stock and 50,000 shares of Series B convertible redeemable
preferred stock. Each share of Series A and Series B preferred stock has a purchase price of $285, representing an original issue discount
of 5% of the $300 stated value of each share. . Each share of Series A preferred stock is convertible into shares of Celsion&rsquo;s common
stock at an initial conversion price of $0.91 per share. Each share of Series B preferred stock is convertible into shares of Celsion&rsquo;s
common stock at an initial conversion price of $1.00 per share. Shares of the Series A and Series B preferred stock are convertible at
the option of the holder at any time following the Company&rsquo;s receipt of stockholder approval for a reverse stock split of the Company&rsquo;s
common stock. Celsion will be permitted to compel conversion of the Series A and Series B preferred stock after the fulfillment of certain
conditions and subject to certain limitations. Total net proceeds from the offerings, before deducting the placement agent&rsquo;s fees and
other estimated offering expenses, is approximately $28.5 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series A and Series B preferred stock permit the holders thereof to vote together with the holders of the Company&rsquo;s common stock
on a proposal to effectuate a reverse stock split of the Company&rsquo;s common stock at a special meeting of Company stockholders. The
Series A preferred stock permits the holder to vote on such proposal on an as-converted to common stock basis. The Series B preferred
stock permits the holder to cast 45,000 votes per share of Series B preferred stock on such proposal. The Series A and Series B preferred
stock will not be permitted to vote on any other matter . The holders of the Series A and B preferred stock agreed not to transfer their
shares of preferred stock until after the special meeting of Company stockholders. The holders of the Series A preferred stock agreed
to vote their shares in favor of that proposal and the holders of the Series B preferred stock agreed to vote their shares in the same
proportions as the shares of common stock and Series A preferred stock are voted on that proposal. The holders of the Series A and Series
B preferred stock have the right to require the Company to redeem their shares of preferred stock for cash at 105% of the stated value
of such shares commencing after the earlier of the Company&rsquo;s stockholders&rsquo; approval of the reverse stock split and 90 days after the
closing of the issuances of the Series A and Series B preferred stock and until 120 days after such closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing of the offerings is expected to occur on or about January 13, 2022, subject to the satisfaction of customary closing conditions.
Additional information regarding the securities described above and the terms of the offering are included in a Current Report on Form
8-K to be filed with the United States Securities and Exchange Commission (&ldquo;SEC&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.G.P.
/Alliance Global Partners is acting as the sole placement agent in connection with the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series A and Series B preferred stock and shares of common stock into which such preferred stock are convertible are being offered pursuant
to a registration statement on Form S-3 (333-254515), which was declared effective by the Securities and Exchange Commission on March
30, 2021. The offerings will be made only by means of prospectus supplements and a prospectus that form a part of the registration statement.
Copies of the final prospectus supplements and accompanying prospectus relating to the registered direct offering may be obtained from
A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, NY 10022 at (212) 624-2060.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale
of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration
or qualification under the securities laws of any such state or other jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Celsion Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Celsion
is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of innovative cancer treatments, including
immunotherapies and DNA-based therapies, and a platform for the development of nucleic acid vaccines currently focused on SARS-CoV-2.
The Company&rsquo;s product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer. Celsion
also has two feasibility-stage platform technologies for the development of novel nucleic acid-based immunotherapies and other anticancer
DNA or RNA therapies. Both are novel synthetic, non-viral vectors with demonstrated capability in nucleic acid cellular transfection.
For more information on Celsion, visit <U>www.celsion.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Celsion
GmbH is Celsion&rsquo;s wholly owned, special purpose subsidiary based in Zug, Switzerland. Celsion GmbH is responsible for supporting
studies of ThermoDox<SUP>&reg;</SUP>, a proprietary heat-activated liposomal encapsulation of doxorubicin, is under investigator-sponsored
development for several cancer indications. For more information on Celsion GmbH, visit <U>www.celsiongmbh.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-looking
Statements:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Forward-looking
statements in this news release are made pursuant to the &ldquo;safe harbor&rdquo; provisions of the Private Securities Litigation Reform
Act of 1995. These statements are based upon current beliefs, expectation, and assumptions and include statements regarding the platform
having the potential to provide broad protection against coronavirus disease 2019 (COVID-19), and possible future mutations of SARS-CoV-2
or other coronaviruses. These statements are subject to a number of risks and uncertainties, many of which are difficult to predict,
including the ability of the Company&rsquo;s platform to provide broad protection against COVID-19, and possible future mutations of
SARS-CoV-2 or other coronaviruses, the issuance of a patent to the Company for use of its technology platform for treating or preventing
infection with the SARS-CoV-2 virus that causes COVID-19, unforeseen changes in the course of research and development activities and
in clinical trials; the uncertainties of and difficulties in analyzing interim clinical data, particularly in small subgroups that are
not statistically significant; FDA and regulatory uncertainties and risks; the significant expense, time and risk of failure of conducting
clinical trials; the need for Celsion to evaluate its future development plans; possible acquisitions or licenses of other technologies,
assets or businesses; possible actions by customers, suppliers, competitors or regulatory authorities; and other risks detailed from
time to time in the Celsion&rsquo;s periodic filings with the Securities and Exchange Commission. Celsion assumes no obligation to update or
supplement forward-looking statements that become untrue because of subsequent events, new information or otherwise.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONTACTS:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Celsion
Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
W. Church</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
Vice President and CFO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">609-482-2455</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>jchurch@celsion.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LHA
Investor Relations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kim
Sutton Golodetz 212-838-3777</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>kgolodetz@lhai.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>13
<FILENAME>clsn-20220110.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaOECbP9z5Z8uekhvWB0bdm63ysglDyg9iss+PtmEUEH -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:CLSN="http://celsion.com/20220110" elementFormDefault="qualified" targetNamespace="http://celsion.com/20220110">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://celsion.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="clsn-20220110_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="clsn-20220110_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>clsn-20220110_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>clsn-20220110_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://celsion.com/role/Cover" xlink:href="clsn-20220110.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://celsion.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139620870121608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jan. 10, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 10,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-15911<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Celsion
Corporation<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000749647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-1256615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">997 Lenox Drive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lawrenceville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(609)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">896-9100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CLSN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="clsn-20220110.xsd" xlink:type="simple"/>
    <context id="From2022-01-10to2022-01-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
        </entity>
        <period>
            <startDate>2022-01-10</startDate>
            <endDate>2022-01-10</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-01-10to2022-01-10">0000749647</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-01-10to2022-01-10">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2022-01-10to2022-01-10">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="From2022-01-10to2022-01-10">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-01-10to2022-01-10">2022-01-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-01-10to2022-01-10">Celsion Corporation</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-01-10to2022-01-10">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-01-10to2022-01-10">001-15911</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-01-10to2022-01-10">52-1256615</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-01-10to2022-01-10">997 Lenox Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-01-10to2022-01-10">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-01-10to2022-01-10">Lawrenceville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-01-10to2022-01-10">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-01-10to2022-01-10">08648</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-01-10to2022-01-10">(609)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-01-10to2022-01-10">896-9100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-01-10to2022-01-10">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-01-10to2022-01-10">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-01-10to2022-01-10">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-01-10to2022-01-10">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-01-10to2022-01-10">Common     stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-01-10to2022-01-10">CLSN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-01-10to2022-01-10">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-01-10to2022-01-10">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>18
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M61_V]X>&56F^IUXJ"SOT_'##&;P.[@:XOE+*GAINFU[\RS+\%U!+ P04
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M%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " "J@"M4!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    ( *J *U0ON7QZ[@   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( *J *U297)PC$ 8  )PG   3
M          "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
MJH K5(8-TP)=!   <1$  !@              ("!#0@  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( *J *U2?H!OPL0(  .(,   -
M          "  : ,  !X;"]S='EL97,N>&UL4$L! A0#%     @ JH K5)>*
MNQS     $P(   L              ( !? \  %]R96QS+RYR96QS4$L! A0#
M%     @ JH K5*K$(A8S 0  (@(   \              ( !91   'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( *J *U0D'INBK0   /@!   :
M      "  <41  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( *J *U1ED'F2&0$  ,\#   3              "  :H2  !;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /03      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>122</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://celsion.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-k.htm">form8-k.htm</File>
    <File>clsn-20220110.xsd</File>
    <File>clsn-20220110_lab.xml</File>
    <File>clsn-20220110_pre.xml</File>
    <File>ex1-1.htm</File>
    <File>ex10-1.htm</File>
    <File>ex3-1.htm</File>
    <File>ex3-2.htm</File>
    <File>ex5-1.htm</File>
    <File>ex5-2.htm</File>
    <File>ex99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>23
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "clsn-20220110_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "clsn-20220110_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "clsn-20220110.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 122,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "CLSN",
   "nsuri": "http://celsion.com/20220110",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2022-01-10to2022-01-10",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://celsion.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2022-01-10to2022-01-10",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>24
<FILENAME>0001493152-22-000935-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-22-000935-xbrl.zip
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M5/]YV#60ETNCY>6:9OD'4$L#!!0    ( *J *U3YKCU/_PH  &R'   5
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MM,545<^UM#"JN6VH5<O%]UMH?'VAY<HRZ=TCH_##!6V)J]J&S.D:-].#J'7
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MEQ&2"A "*9$1<9HE_(69"CP2V:WE:=HMQ3H/O$P$ P\Y#B_"!"""'?&V ::
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M0>,T5#-%ZQ!GA[W3U_#86&= )^BC+(:1#M#=$20%J 8X/CI5)')KG81DH.1
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M$:A-!&HM> =&H,Z \\Z0!7,4!/BQTK.E::/ UM&SQYY'<N&AR+&YG9AVBH?
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M,U#A)<PGXP,?E>E!>/9ADKW"@Q=UY":F:%O:QKAA!@1K/KA^)*'4B)R(45[
MB1C&#\N(C<4?_G5Z&B4GRY/HR"4VGJ0UGY[':)>.1^S$1\MTEN-IW/]+?"@(
MJWI(C#<_VW!SJ7/1XTJ7A'JHL1 E"+*-1RK*%OM8X:9UL.4[FP>.M]JR"N'<
M* 088]10Q0MWF^I=CQ3NW23=MKTDG#X:J=T0_E^!C%4'R-A>3-(+BG@;5/C4
M;Q2HP)(+*ODJJ0>Z2HHU(5Y4DNF ?Y7FNLD2FZ4IEDUV3? <<EH(RW40J7V8
MI!(ILUS5X]'S"A/%TX'T82K?HA@=)<<<>2)C4WNNY/MRNL8[V5CE.J.T&SPH
M*]8&Q\7HK[+"6KCR!OZ)PG:#%4J8K2L'X3RMLL&U#9;9YT:K#,Y3-%#0U;_F
M0QT,XW64S. 7AJND2&$*XC_&'&8"+^OWHL0C5YZ7%_D].UZ,XBXGQ@_FL44=
M/?7#+'MNHBY+*+J7UK6A-=2W5Y,U59U,LK1:] QT/*)/>+DJV*BX&?D T MT
M5)1#;X=*&F=1LRIR&\:@P= ZXI/4N^.W=@SVXN18!W_P8LKMJCOX* C>#2.&
M%#>AJF>YO=)*,@JG3U#M?..D13UJ2Z2%Y*03H=D\==1P15/#*N=D-6K+JJ?P
M0V1RQK8P+9$:'YW)8!VCC0N&HBT]K5+<)\.WI>+2?%H:A&Z0J#4H)12Q;3T!
M0VN8K58_=JN^*D$,8K_R]+=:$UI]^K#OSD>\VF1]I@3YS<5N(' F[ZIJE6%Y
M.-UR.4ES/A90)J;'872Y?0.6$(KM55R9 S?)8"PYC%PP RY^.+?Y<I>'GPC*
MB][ "MXO6,RUF2YRT(?7:Z5:JLK4O+UR_F3%6&7XQ<0AQ2@&1U>UE8?;@1.3
MFWE:L_: NS9+CVVPX^Q9)K=QU$S%O9BU5@C+_+L7+TUYC:7$OQ<@O!'""!H,
MZ%/YL[E.IXB;2%'OQJ0^\-4GF9\_I3 GQ!V YJ&'<#P*13>V.#0$-A"L4KM*
M#,; [3#-D@9KH/#]RBRX^BFY!NE%0T +:V=+]ZT0V*[M%:K8,10)](.NHEEA
MV-]$_)Y!IHS_<OK8/U=V>+B-$ULRG68$4YDD%:+ZR$V]3F_P5UQB;O4E M:;
MY5*L;GD*'$L&"WL"2?G,A==_-\O@PT$:YP<\QH?B,3X&C7%^0&,<T!@'KV8G
MK^;9D]<7 SB,9R#%,$CDXRD;&/[K$H^?*5<EL9O\W7?:3;Z3&G_O)NE%X^G%
M)ZO)7"P.$;:]F*22CB<'\3B(QY!X_'QQ\?K3B<=!.O9BDDXZGN<(1#(SC#M\
M,BE)DH.8[,4DE9C4AC@3FR0;CUY+B"MZ@]Y9]:ER?ZN#U.S%)+W48)"M1!@9
MXWFZU#/>QW&H80FP8AAW!1<9X?GD+Q)+0#'C"%Z)N 3X'PQ0PP6.]4TPEI*E
MB*46++VA4"+E<6()2,J?G:0-UH1-TU52<X%L&&MSF0!^#L=B.=!YF_/-SC$0
M*/06X;U5C9<*"-X4]"2LJ*W706AYFF133'!ZIE2.%,)=Y:)5<2LK0</!)&B!
M4<2CI.(\ .\VSR\%\[%L%^/1$-W%L0V-P@44&6V%EO$_TV253'' ^!"DL4(,
M*D8\D^Q0Z+L7DW2;^45J\JJ/]R7*X)L8,?<E;KR5;$ 1X363NYBJAEV83YOE
MI.3L $7V4%;F:5G546GF#4@-0:(QO4N\JOP3FSO FY0IG1<'V=J'23K9^A6!
M92F:%A<S3 2:Z)(R'SM9%H)^VV193(Y/++6N?10>1DLX,_IOS\*]L^62'RR7
MO9BDIP%'L^4*TW:>;OTU9J:U1"(!;59QB0<JIY7DZJ@@FW)^J-[P87B@2EK?
M$="V?_#8%H_\[_/O'YZ<GJIR*4=?W:[WQJ3P#!>+LO1SHN3@_2/LN@B)"%+C
ML?PU2S'7FL_<!SI?SJ #!C>DL)1)F/1TN<< KT"&1C$%I2\YS&$\P6&S[,,D
M]6:I>FM(":E!DM8P!F"J&PJ@B0W&<K5(5R#)95.1>-N?<"%?DP>?@+(OP,SF
MZUL(!"JP@M^ >S !'Z%>(WY!? K^J1-T_M"3U! ""6$4UV"A$.P"]AN.NQ+J
M:00P'WM#Q,(S&"CT#N9XD.A]F*27:%"[RV1J&LK64L!CUNQHCAR"['=18#*0
M%E0E8,%>AWU7),9Q<?+SR>N3;RX$'17]G!43M$)%"=Y)>=B,T;E_P.A\"8S.
M_0-&YX#1.:CYCU+S45^C+1?4!G]H"L*4I(3QGTHCH6O^7PNMUAVY6B5SKJ"O
MW<"$J,=:0[F3!\C>3=)+FB6&V$B_TA-;"*,)'4X6[L(V1,QR$*)]F*02H@)!
MZ?WTG.CO3MF3GF9)NHS!7TG)!;\Q,&[F'J02!'>7Z&@KL0E<#N?Y$BS;[GTP
MI09?^/M18 N1]IA%F)E5P6C[8Q!(0<ES:J\G>:93??4"+(G:2&+K%C-8Z(E=
M)TB6PJ7?U*E-Z N#3*/C@%E3(8JO[DA+&]+#3(04=>#.DNIPK-=8<PZL:$KL
M9U5.4BR"P#$'_+=XV]DRS:5%W(U1<0:I72S*M:76Q;C%D1#[QMQ,#BLIFAPK
M2I!YG&XX9T3HP8W<BTGJ#4LBU_0EVJBG3YKS#I*?P0>9%-[AUV]T(\(KVXCP
M("3[,,D>(0';H%FMLD$#U(!*M]];/>JOIDAHMD:U2!D,1@2</\#RR2XM,R+-
M+;\&"YW%!""^PS( ]G/M6MNUTY'2P@:$#?@@J/LPR6XOW?$(PUSK3Q$^?7!R
M8(_:BTDZ*=%G%CH[<FCUZ[.M/7=)*2E]] Q45?2R.(GNW[]_[_SA@X=G#X7J
MCV^ M>ZD*#49/95K'L1L'R:IQ(Q[58Q'%RNL-$ZR3X9;-0<S?"\FV2,KOX+;
MMFR6/:1D267SOS-RT4AJDO?XZ_[:\WZ6![@LM\7HZ",7-2:7$ZP+)P*320;V
ME<!/YPUFNEN%W@-]$!0'J:T=MPP+<#<L/*?A8ZV[&YB+.3D:T^N\(+PKD4%J
MBHS2LSJ0_Z^;IU.^/#U ]/9BDFI/$+#(LN]>(9HHNL!RT^'3.K%?#P5Q,#R>
MSM.IH(0\UB.5+H)RX%?BW3*VB48  \$A'*1L'R:Y4<IZV)T=S$U!VZSUID'U
M@TJ7_5@6KHZ?Z@'Z6&S W8N2/)1F5'D;I=<AYJ^0"Z=.2@HLNJY:08NMIR9#
M\B+CDCO)%)N!)<+*<Z!/W)=);M:FPZV0&$9I>R!U=*%<SYU2F2+&M3TRR OD
MW2:1]([H'>1K'R;IY:M!N_'LP8.N/%&8#[X)N!*] K2.<]O*#$.!L>NM2[?#
MA@P3X_C$J.$O>$HK4'QH1<_A25P:A#>#_\:V'Z&%%R.;H\J'X !\@P?+@]<=
M)/AKI.:;":I\L9O9G5\:RT+'D&O: >.1'O9!YO=@DNWI;0"4/3@ RKX$H.S!
M 5"VWX"ROYD&N)-J;L^FU[9<'IP/62[PS<%R.5@N^S!))_-7ET_&HS=F592?
MCDSC4&*R'Y/T0N+4V  VZ)"VW)])]KSUW1HH^+X)]P]]$PZRU)*EDN4HV@ I
M;Z=H',3\C<%@(E'9/U$4]IVD(6$Q9A9??O_T-*AE/XC4/DRR(U*//T*D'A]$
MZB!2/2*%[YS[CGJLSFZ"5?E+X8B32VVVK2=C$G=\19>)^]GDB,!'RF6;TAN/
M7B2W!V';ATEZ82.;><"@'D3&*,".!>GT8)L/#1GV>Y)*B,!Q'X^NDMZVI^C"
MRV\K_"%!31WM5-(EY3N'PPUD[HT/*%W]\BKR+'U!C[2C25-+G" OZFB"C2,Y
MY\L]>[)F9JALB&NBN&_1I"A+[C39#Y XA [V8I)>0)L)AHQ6?(I=++&:K!_2
MV-%B[68Z"5V,OYN8:)6D7'O$:A0U'ET5M,J"8WEEIND\I0ZE67%+,:OQR#W"
M'=\YACZ%XA))W1*&.R;7?2VIT(/-83WMR;TPW%559JVG'/&,8SM=V&B_Y<05
M1# (,%]GF-4IV2V&;W6KH>0F23-NX 43.H17]F*2P<[@\L_>"MDU!>CY!VV&
MV$1C7E%S2C]K9L ^YH@+:>8XNL7]@!9IEDY1EN#+K/+ZV7/5<@*"_TVL;P,/
MQQI;-D"H2Q5:)BW2M0-L;'\FZ<15=V3N@T5B$^P )K8J0<;2%3@RMNOTKTGY
MSA!6K%B9G"M'^:N#K.S#)+NRPF^\1UQ\)T/?>GQ)/ZYT]\HJ%*E6D\HHPRHJ
M4D5P;]NN5$1*=ZND,H8_&N0$*! % 1^__)^K2\20EZ 5<[8T7B;5+/DC>I*L
M4JR=Y[$'7PEQUO W5P:)ZL,?&&E1+M!Q9T(?V6QN,Q6><=MHT:T,&#X%3.5@
M$^_%)/7VL%4SH$YMV4Q?G"ELL!IP[T0M%J"8O#WS?I%.$"!.%H"8!17G54BZ
MV#Z6?Y*PX7=HALHPZ&"W-ZV$O;Z_726QKNN.E/"#&KN$4LCT;J=R-L,!'Q[@
M@%\"#OCP  ?<;SC@X5#ZM(?2G!(? RRB8BR)^65_'_TS68(4O4429<]O].+%
M$SZOIDU94MV2_3F3T+6YP;C],2P55STELUE)W:CA=]^>GYY%9P_A^XL;DS?@
MP#XNB^)=MH;9.>/J[.S\[(?8'6K.IMK\W#MY,GV"3=>G%<*9I?DG1: ^_NGB
MS=OG3UY<CD?/GY]$/W[S^).C4G>;U>=\6Z]_>_/DEXLKF./%2U# %R\N]V^.
M7T(B-VRV3SF5\Y.S*+A;9]5^^TG(A5"9GHQ'KW+-.$0U=W'4K,11122EV.W<
M<4'U7I])*W@?]>-"]S@,"Z+93EYD93#TY_@Z;;B[PM8X-YA<SM;C$86QBYH9
MZC,DI</K\7(;3(^CAZ?QZ>FIRM4X3(ZG?1SZC0 S3J*W, :.@W<BE\3AU JX
MBX/B/(_)NIW>Y*33!"'4&,+T87)0^'*B/64BJ'7TWS#MI@*C<(T.C8.WFKK.
M%&V+Y9*B=<1 :(W),6KO8BJ>@?V6'RY$4SVY5[Q4DA*48</W2DDVG92U<-GS
MDW,7L%6ODE].[ZS=@['>F%H"I.!SZ655:%RXO;V %JC%>17]AL)7)75:S87%
M00[(:0%G+8RUXI'TBJ!_3D4/PA^>G]R/ R'G04MOCMJV,J,&TO"HQPDF/V;<
M]@ FRQ/BG"$R>G$RG-@;,5?"-ULVV HP$WF'2>3@XE9\[2W20G ,VV/?6SYS
MK-]^P+L3C/8F30:$"3FEUMR\(3TQ)[$--84;N^[(#*7N]>,L#Q"[U^%6E=04
M9:98+8A1Y""4F<%\UW@DLW0&&0<&A);/CH#7)%M;I9),B=CQJ#JVKZ4=6< >
M+;7DSMH[\!&K+;BE25>XB,*FR?/JCU3P&B#:<X7CH$A96>3HC\"?5JS5;=Q0
M7>Y"YP9Q#5;R&BB\ 4)I)<1JAO[W3Y$W*J*'%22.D7E:+H_QU[>P2MYDE.=?
M5M.RN.5K52CN/W2$'4[G'4_G\ZVGLVQK@;4?WNR7<'<^Y:3@Y-S\CE_EQ*R[
M*M/"[>9M2MHJ(FP9E#25$;R!)Y;LGOA!&N-?GTF,[H1K2?][]I\2IW2+.&$\
M'L,CCC^_P7-,F:E*FAY]3C'XD!4Z",$'"L$V*4C&H\Q<([AWE>9B,EL5\@1L
M*O"]J%=>0D@)L)&2JLC!>EE;:AV!; ;F7K>W ML;!S'Z:L5HNS91+J<JMT3H
M>(H%P:U3IMT'V6'7R&A%OOFR86^,'!)[YPQ\'5,B1(U+>OO5E>>=>K)(S3RZ
MM$VKHU>V2749\5?/4G ,J>&T?'60T:]51F^VJSI---:1G7YYZ 3W=9\9\N^8
MMC+-64-*R*MBTC&E+UU@HL 6"0>5N>?BN$T:)2SJ)"%+JCJJ,(B-<D-Q1QOU
M.HM=J*NE+(L5MPM!WT&:<GH)KVP8AN' \Y; E695&GP@89M4' =T(S+7)_9>
M!B-FJS9R,JP5BJB#2*FX4N'&%#<EQ*8-7?BP(H:+II@$YJUTF]-.T^-XA%OB
MSDK_9L3%MP?$Q9= 7'Q[0%SL-^+B<(AM.<1V,OM5)Q2T8M2?OJM*=,3 5Z$)
M\@$H]"VG>!*0O>3[IYQ]=ZY*M4)BAL\6M_[[GPM??91S\I>CG!L3B9L"G4$'
MG4.4<R\TU%^.<I(+IU*!=]GH_-IE89LP#-5+]M4X2J'&9P%G>&!$!YQQD+VO
M+#%[?U?8%(9'+>[DD*']*FV7;1G:MV@-%Y-,>K56[6)37\P]4']B#1TD3FGA
MYGQEF8(O30R5FIGZ8,%\O:?6+BY6@B"N9+HF=PE18V )EQBEEM:Z%<* 7(M?
M&# >-R["9Z6QC&Z3LD265(1=@8S]T<!D+2C*WC.M"33XJWW$Q8SY?BZ)/S6F
M\D,<@WWT,<;X<CD@P?_KP8_9C= >$?Y<#:D=H^0:K(3PA@P1C8X:QL<E#*=/
M+"?"E(NUI642M2^F\WN:5/3IVI_DO)9(P1#&\(\/L?:O=0MMS7)G6:"88P\)
M93"B+Q$$B6@YF*4T,;-<':84TH"DCC9YJCH-.C&P0]R5CPB'>I"VKU7:=E+9
M,^L6=!'?HN<V0YU=]^!^PJN#T'QEQN.VP!<9CW*F(E2AQXY4!^/!E/S["MG!
ME/S;F)+6\]I@1U+:^6!''O;/)[<CM0!^>B/2;9[.!C[(WU<K?Q]L66H9V\VL
M3'K,RH/$?*T2LPUF1@>9K23S6B0OA@YEMB!%E;2SIJ"6N).JIL:[VSFSS4"M
M[PY K2\!U/KN -0Z +7N\CFP[1C ]FL,KE6*>Z"(4!@'!3P<L!1Z?FQ_E%0-
M'!74\ZW;G"TLV_9E&4-LFE0(36AGPNBD2[.QW-&/M/+XL&MN.) 1L6Q)O<!X
M;(^SHEA.3'D=O3AY?<)S&8^&)@,/S=(EDAM3I[IEFJ?+9HG#F;K2^O!:4V$U
M5%HM##FN:DBW"^Q!A\,59UD/BT$)E2EOX,[T+.0*@.FWER8O+-@IB29)_H[B
M-=A2H2A3&)D?R,Q,LP1]#9,2 X&\EX"J&9^CR!S)C6WJ16%;)/F'D07!=R<J
M :+(S;V/CWWB20T2U64%6B>QW LP[3K-> UP7C2:G+[&ZZ1%H/L +UU2R& N
MJ[),KF'0R.R+OGAM&\U'B'D7PDDWC$3,&"&D1#H1(OAU!1W,R,G^/-5K4%1V
M2LP@(NRN7,/ SIU="Z>"T &H<OUE\@[A]764+E<E<DUP03_-",:15K8LSG*/
MM$&,+>J*.VL]??7T37O+W_3F\O6;RZO+EV\OWCY_]?**:9S^??'FS<7+M\\O
MK_9OPGN$2KJ_ YG3FS!^RLPX_QX*H!)@"1MFF%6+]D@TY]7EDT@:;\:L![D-
M4%I-0<<A&Y*E=:\LM*[O.\5Y(MTW$B+,L1:+HX*7>/,ZXN":GHL*3J\5CPX%
ME26L&P:W9:HS-Y[QR,>+92+3HD2?&/,ER -D GZA_EFVD3\4%\=S(\S!; YD
M4WU8F#[\7 F:/3XE_M.YOVW ,=U P1*X@,;-,B^;U-2 VVK('Y6ZHM-3 ;-^
MFIH,GQ#V5> MK;G BEN,:#MN)=5!(5O'H"#\<*;"*LZU?\ZTPQAWO6:K#JQA
M#Z;PW2&B.;*R$0L7\A5%M*?7T8O44.,4C*'[QTAW*,H$-366U#(1NR=G:PVD
M^SA<B!MXVS.8D+H=?CQOT$G UBMH6^?W$F2C8LL-?T(#A3NN,$:ZHI0L:1_;
MKAH#!KP]*X8/3Q@57)3>ZO,^P&<U\>Y$5O5OG+J'S?6JO$[R],^$:=!14/X_
M3H@R^5MWLSE*/,O9IG=SBL< EM#B=J*2!?"7I8$>^Z;^7"OXR>BG6D$W[].*
MRWJE#\]U4<PBNW]46566W#K5\3M(:C5+W<&&[I9_JIRKA9IF[,$&E-VJP+V,
M5L6M%+-;=Y*+W4&WT*=8FH-W7I7%RI3L"^&/8>])#@U^/(7CC_IOX"\G#;A(
MDJH5_MV,$KJS!FGQ3N!%LINK]5\NWJ'7!.-12@71-VDA#BK^9F;F29/55@W)
M4A!I1661%S@(A<O0' +X%(RT9:R-@N6*P>_F];7J42]>DA'X']1$B=UF'&$]
M&%E**+2P] D)B8;/O./2\;JH54,)J+I"@"V-J2D#["2T=\+7S.J<Y<]ZRH&
MI+J3A?!=RJ#=H]T[X@PGO7 Z93CP >XSVT/D7?^AM\MXE!ND/(;W%F/[#+0Z
MN?4/V4Y)FN'S.)5:%6H%V/(,9AI;XD5*X7/](8ANT60S'\ I2DW5,$'3<$6L
MBR2\\/912% ?(<8BZ08=7%R"MQ4RZL#2R8X4%(3)8;FG)IFDF00Y),IC6PY$
MMGM"'%$JVC\'-G+O@WA@)'NXNC8IS;LI=F^"+'(?"'&HGUW$#.Q8>$G$7IF,
M1[>+(N,@%2<KMRY%FRW SAYC(YS))AR*#N38W!.&P2@&B&\DJ5"(<:H^^SX>
M26>T@66,CF1/PTN3);4#AS6*/%OX0"I,L88?/_),-O4"XY,^SL1Q58DN47PP
M4HU;;HJL\?0+030UR8K<!#T'Q>EAQB6T>DC[F&P>R]X&M5XW&*OKI._&(QZT
M]M+$HV$O9DYDY%4[:=S?#A$M(BSDG1I#LP!KAF.+J1W"S+XWVKU:-R"*[:9X
M1UN/0JC4OZ9$Y5T+(SH&%XVA""9M+_BYD1^K7_*M>TX4[I&C],5=MJXV)R"_
M/R0@OT0"\OM# O*0@+S;3M)TNY-TP0J<+>!'<&*Q1;24#AVA@[00L\W[%LX#
MZCT3,$Z&8H/AA\)Y$G!D-LNE0#J'^SL)[W2G,:KVT-@H[C,TV,KV+IEW89JZ
M;;3HCJYL;MG&4FAV!910JH%[9/NWQQ*X)$*[@JT$AP?K;^ZZZQQ"PX!]1PY]
MRAKBS]ENE[MM;I<U6?L93M8Z/XE>B[RX/]D7(!/(FOR196\71GT* />8JF"B
MS,%2P!G)%40K)4#+<#J\;H\+XF>?1T\IK(5=ZOI3U!Q0XK6O0HC]>(03(M>7
MK[5_B!.:Y$.0_#=V:/9E$A?_P/L:?%$H7>1Z@4=+[2<Y0K[V-AHR@A.CN1.,
MVU2COXXW<KUR"IYPV!M96D@ L,L#+X@$YVO^=\R/5!8K_IR\(?K9)&4OU&^,
M]@MVWA*&XZX3M#N#[[LCPO6H>$C.:21WK;*9?)RIP ,X5DEW%S!"9D,1GJ =
ML^QELZJG:[3(P0BZ@5,=_@TS#.(@*@L/=P#'GEZ>#:[8)\J->=N2K<X\:4X'
M4D 35CM%P;2,^1QG]*@&ZQL&DZ)'E08#&VQ2,]*?V0J<N^D@[N)YX<KAQ'YO
M<@YMP!V0 S&,Y])*E.B6V& -NWZX(/.$^E+CH;+,G34>29.%NDPG#6\9%5$1
M!B U>K7B,)&[;,M_]4; ;+L1\+(@)H0YO')N$^D.OFCW<R_VNHU:)WB![@5%
M=W0L[8]-AZ%5LE&@8V.7EJ!'43X@R9QWKP$>'W1X<L)QT^DY*RA$0,G!5.(%
MJ-RFLI*1/9 XOLFML-VN&^)N[$1)/43K4X4YH[XHIXT@'5L]W>ZDH])5XQ'F
MJV:4KXK#^=)M@JB(C>=R.]K(W'!#C436!U9-PC/DT-"R(,@,/@"W=R%1P8F9
M%DMUMV,.DL14GL>!0'ZWX'O9H\LFL?C@#6/)-M"-8^(X=^NLZ[P&FM@UJF0,
MG>.J<I=AFW3"ZZD1C[P"\$;SF?1-S>OTWBS-&AO+M0FK9(9*0)8?R;LSXP.^
M4Y3G3 +C1U:6\+]HPO*RQ>&B4?P:5PWK"1AKE?CVK7R.1?-DFG(D=&8FM9<1
M)GCF()W!L!J<P!B4UDNBLGC!Q6AB'[N_) CHXMINXVY<8&TW%820XXMDUTBD
M6M[7UM<5(<?4I&AR;B1/9[O@!OFL;!5@=@W!N+N1O:PE*FDAH@8[#LR0!F.Q
MI;EN,I$#\MQ!3BUXS9_NK#*GE-.T+P%SM*5/^'"=7%/22E\7H%QSO =:+MK)
MZE_=UMHZ=MLCSP@[-S.V@W(*SM<Z/<H6#'<"LM.ICN./>S>ML="+(6FU;^:1
M53MV(R<LUM93FF9((5>)I64MGICCD:"J=DT>1#IWH&*VXU$8:+[+)L_F\.4/
MA_#EEPA?_G (7Q["EW?;<S';/9=GG$&+R7^I7-S/'>+#(,D> )8U:(.81D6'
MBJX5+B:(0Y2SF1X:1[<)>CZ(R-+Q5(9GS(A>)&;CD9$09/+6!9<Q).^,P.)M
M(H[;]HDIR%9U8 FPK2"'=\PG=TQ=#3-EA W8"^[ZUW#<%8.1L8_UZTR_]Q9;
MWPZC<9RS)]R 9$#=^O;UL'QP\J#K,TK0Q=\DH')TU2["TN'XC\<C3X <VXRY
MCP)ANT*+[E0QD+#N@S!E!"I@3$^KQ^-<I9HY]I9;JX8\&XI'P0+F 9$1.Y4X
MI)OC09>;+9^;8-KR<.=OM I$G6,9>(\MCW$\<HMWA19IG7#HFJM0[/3L'T\-
MF(8)]809"*JR)<4I]2M817 I4.4S7"<3G]TG^ZWQ#4:8WK@VT7^7;;&O7HG/
MMROQYQ*\82<Z"-H\ F'RNM!GI%189SB)05%SY>?U![$HK*YPJ(@^'8_F#%OJ
MB["'>J%'U7$X"*$C-""X9PAWC17.5;(FN4>ZQ@Z/.QYY0"[<D "Y6-Y$\)%0
M]^X4L.N/@,F:]VS:X"0<CQ94O(=5<0:AN,62>7);BQ["?QF&\Y[J]/(&2_TH
MZNW P@'XAH)X%/Y7AT"+;&L\:B<D5Z59):6\/-")K$P#N6'51<J151:>8'@6
MAFC),N0)"0GN;8G$Q$P3C+0PIHI8H7(\%^"K^Z=Q='YZ?A:KGBOAZ1-++R(\
M7:R^MBVY[:E4\5F "5..S'L!UU9(+86CLFF"10J2MK>)JVWCP-J\Y_086"TX
M^*]3J9M#F.@S!(==W;L?/@&>;7](B5+]R\&& 8R"K*.E,3QE'7T-WT>[N.5G
MR=X\]RW)HN<GCT_.<#;X8#CD[1B'Q,#6+>(+W#C$O$!17HD=!\)VP_UYN*4T
ME:;:]^SN2%!+VSIG8 3AY45P:[RLJ4S7>E&@+U98W?I>&?/* <4J5F84<86-
MA=I#B90"CRF*J7=Y<4OM@SJMMA("?&*4U>1]SP\D S;"W FMZR.-,;).8$FC
M\?A.L<#P<$NWET$UL>BS^K3^H,X5#\X?'$V.3Z*+FM\);80-+X>2CA@]]9O4
M;DK>__Y=NT90,V<J=5(;86DIETIO%(X-SQ?M)?K.IG0=:K.7/4S>:H^2@YW2
M%?E9.NMF-J3\*F* (NP[PWZ'S9(JV"EV5",W [&#6(Q1V^Q'^!.ESD XY'YB
M"J?D/'G\ =R&'"6<AWMNY7Z+(X2W#\<EBOPCW[HM[(/26E/:@QV]BUZ<TI>M
MVTBDV9O;P4W<:T*MJXM;>B1@^ZM$-V'W=]FGO;:\RAW?))PQX:ML_<*_)GIM
M,VYMON%]N>KN#&-4KH0I+<&$XC9]E6AE%]J&@XQH<[!F,&Z][[OL(&P.UIZ=
M'J*U7R):>W9Z"-<>PK5WV]._WN[I/V'G4,*C4E/[=N&J5UW<M(4L=$><ILI)
MJZT1W6N)Z/(ITO^M99U)LJH0QXV/K:W^JI1-@2$\3[&*!P-;4B+"G301B!%=
MS-'58H*7':8%"[)CN/JZ)UR-_@&>C<[T6+<<<J:+0\=]651H@DVY>(\=YQ6\
MVV*63H4-QU;SU)U2%(6L#)UU"AR7TU2RM\M55JR-L<7 *[;U_5W[.Y?R[Z)5
MEN1<M(^5@@+P&7X=&+>5YU6=4;4?U!J9*P^F9W(<J'4'L)HP0F*+2;_!\C$U
MU6 HEV"<W209&V>^3+K]QN7?.[R)GIJ@\>@"2XO@_)% /KY[ATC!>\_3DFX\
M;RH,=*FJ:?I)['^Y(BQ1NG*8!2XCTG755![F?F9<1'L8,B7N7C^82PE0HMQ:
MBB91,F6FTS:)S=E;!(]]7<-P+P9+?\ > L<6G5OPG?4;$Y&-+?\#_(OZ4ED0
M:%!KCAD=./.RBD%0X(\RN(?[8N!>!,F%I2"[-JFK F-N&B0:<QF6G4-LGX+.
ME,*KLRC6%)DA:+V714MZ9$1*;&>LF,SXZ_2&Q!"&(D+C!::O:CZ9DI?!Z:<A
M+5@*8*-5]M\#GR( *LP?LT%J>>(HP NQCX6K?6T<#'Y' !'ET]86+L;X'Y@8
MJ<,HF7&-)8Z2YD+OI3V9X8U<;ILD!S]VP2(Z7TQ>J^%PP/#<W"2&WP)O*07@
MH9H+]Z:/U)8CG]8SUW<:G6-[/OC/<>@W:MR,4QUTZG"<F<?$K*3A* CG%IP.
ML=*GL9-6 5G9HDU=36KIO!5_ ZYV_ZY5CR\TLFT[S(_C20%2$U\-EI?2)*H/
MGT5[Z.MP3!:>& 5'G)] NP:D,^3/LPXT9QWT*<V,C@]*:X]']G#P,/+8HV/M
M6/R&CS[+?J?5Z-OP.%BSQ%Y$;LT[$Z9WTMZ\]OM982H/)R.1Y@+A%1RC8.QQ
ME-IJY_%(DIDK$ #PGOG'MMT@VQ0X?L5%'AZQ^)/@%R>1HIH)7NDPT0H92IIN
MII6;B3\P#Z6BQ&Q.4O($CO?4)\2(^] GQ 23P(=O+Z(PMD_R^Z)G>BI\%A!$
MB,)IFS*51M6ZDQE) G>@@;%VALWJ]T%!=5V3S:;AZPK1'G,O**P2Q7CMKW$2
M$+$ND+)#V.$(:>WZH#C*RQF\\H)L"_\1[1DY*RP.V<OE!JIICR0(4WQ]^-,
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M=^7A>D^45>RTA3S(73ZHW6BW=!:&V2,<IU:;1 O6I<NBM:81]9,RMPFM+)Q
M^*P4L4YK]-[0VL1V,1[YY-31GR+S?. LS6R0JTL<'D?7Y<,U%,HA#)1B["(N
M+QE?BX#$_0R;R<[!A;:,1:*GTPKK,M7ARM7 '"X-Z3@L0S )!'UMMWA9-+#H
M9,UW=X??% DHN^M<E6SX\@_TE_O)W9W03DS5Y@#I$V!*\#@!7LNFLFQ!_@R@
M#>$(&'>\.1Q03#2$<W(]TO"E*HK\#N$0?B@0&?C44NP(IXX0E-/AV&4W4N,5
MO8]6ZRRRE3=3XB?Y,$Z2%O<U6!9^#5RMY(9%V%ZJ[91K2*^/7W7EH^I!@F";
M]DYVUO8Z:+'(];'C>%8<J9,O'24.WRLL8K]&K<-;'X0_!H-C"6N13ND<%.9\
MREOCT\/N"3<MB2T<K"2E$C,F@2K=>6)TZ#!VO$ND563P-?405/"M\<CD-VE9
MV/'V,>BP?2@ZPEG.5B7APF$5O_92>_P\%9%C YWM]7BX;B3N.+_NMMK$ZW&T
MR"MB5TCY1K*)$K<9^WP/BYRA4O'A25AK<%(4[^QZX?'E9%&U>L *.3KM9.9^
M_'<Y$[PE=7I^2)U^D=3I^2%U>DB=WNW4:;H]=>HIUYY09+9Z%/V6^[X8ES<<
M>7F1L@<@X,6G8,]EQ4JE5J]2R<L%8'K$GH.)N#$DY@XC/,5LMQ!](@D]#379
M%9O86I2Q-2=S9JV<^7'U6WZWNUI^:$L-F'Z*[*93Z9'W-0#.U.(=H9\$!HH.
M+0AA8^T0P4<7Q]P-&;F]UVBR2<7L=%HB"@]'3#Z)>YX<Y* F8(E+9B=B<UIW
M&PKLA552(2:6NO.RKW3T^#@8J^9:LL$?R1_X1[9-WMYWK%/9&->D=]77?(72
M';W9)&('"H'9=M63K&82;@RP&C $"=[GP\N*QZ=]J6L%3:&7&8-+*:5A./XR
MPXB*=6L)YUDM%&C/\2UB%*9NT:(KB.,L%A1LZU$J<*>[(5.:G4&S =:?XK8:
M\,=)TZ.!V:G"(VD]V 6D%W/PHA$<.1,X)#[<E4FY (5^@\ZE<%SD=',J(T#!
M].&'3@'1)EROI5\0+[J5R6#4,QSB%8-#,:2*;ZFF<!1R(+ANU,JP[N!)-:Z[
M%0OMULN$%%=>Z=A- C8^)M#B().G=9*$!+U2"CQ@J@Q)*W9U**3GU)+62?1[
M]^--H%"Z3UV%;= P*U>WTOZ!8[622"#_4\AXXYZ&61PD[7;)4IIU8MHI.[?-
MV_$+B04IM[1#=QH4_M,"!7UL4]$7M,:TM>A/I_A=I'?53. 9V5H/!GZ3&52!
M9XY0[&FR#E$5DOND<0P^_BZ[.E^]A?3[=@OI!4CDM2Z1]95PC!KK]Z-1D79+
MW'X/2MR(SU!E@X2'N&I22HGA/EK'CI1[[H,[,74,L*%%JB:YP=B+M(KP1#8[
MD,@H AD; 7=Y!YMK52''L&>D#]QT5(PB]A:-S@D/1YZ(_#63M*;6$'$86\+;
MSI9I+ND,C.6Z:).$;XIRK5MH'K4)&.GP7RLB1HE(';?9[\#>\HGCBZE]T8[O
M+GJI($D7TLQE4W]O)'4^MNW^,*%!2\DE:UC=;-#,9O/X _H@;N)S=&D;76&$
MP_ $\O;\ V&KT3;96(AII91T.O$&L;P2(H6(2N;)35&2T@8+*F4+K9?K&;%N
M'QA8_13[JR<LCF"J+H^\_4Q;/V(2V0QL''DH'QTG>%.;,)"W<V&[?B(6@9G:
MP;!,E\&NI3PYO!=G/L@1:%,A9#'U\7[C&/W],+[ /-Q@ #53)H!O:E=ZIH^^
M6*<M-E1\*'U4*_41V$2QI'ZTINE27ODEZ GP2G]:V8Y+S"GW+7RHHIS-:!_1
M8]XJ5C!GF_.?6VC!Q*[4B5./!^O%\G9+W_KK\GLVY<6!RGQ#8/3^(3#Z10*C
M]P^!T4-@]&Z;_>]V,/N3"9[5;XRD"CG,"5LHPR_0DUQATMDY\#M8VIA4AT,L
M=R$XY<4K$\_SIK1N@"AL1!;L',3<9&5IJ[:G[5$[C&#;K;G!4;_X)%H:R\N3
MP#GHH@&4AS7"R(&8%KG,/:*TZ[I(5T' ;Z @?!#MX,TZB8^U>\!;N!4NLBKV
MB"8@D.#N!/6X'KW71DL&=YT@=N3&A0; \4%DD9^0+XX E\B_3DR]8NMUAQT8
M%A6,-3'G.]K4O691UQ")\9W$$DR"6P=",:%6=EU\@(=TF7+I0 ,T9K*!+&M
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MWC88I2T1:@_PDXUEL^A'2O))#+Z(Z/=,+J!:^H#9T2YJMWG[Z$V$-=*VC_C
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M^&MM0FR?(F:VDC6J,$P 5Q(,*_'^K7_+;7(0&N!0!9)^\>RQVU?O274'WU\
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MN6$'1[+PW^"JH??=XRW3[&B4E$B5\2E_,0@'<_:T,8&DD0J7YTL8JRUG26>
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MG@/UFI9#.L*QL#I+Y0C".6?E^(Q")[^9=Z"9,(2Q4S"%346[LO!#FN4:2'
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MX\(<,M8^A43>;Z5@B()@U2KR?T\Z!9'_!7[NE"Z"--#=77R#AI*2-7R2V&]
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M/8J.>^!RM7A8B5<5X?EF%8_-+XSO4\[,<L+;Q%Y[;AT0Z=6-5H"$YWSZ7;'
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MUJU?E*4KXV*54[S.4U2@#A=H-L>IRV)$.91OM&IE*%-'H7B$DLWK>?P?]K0
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M:4-E"65SLM_@.J[Z/702.%.9.(GWVF$J?EG2-.B?? NX3C O1IX'6:^_[-@
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MA:EEC!G;:X$KR04/A(K/=9%@9\A* YE/V[6!;3\65=XNU(3]36.5YK><@-5
MS<WBN>F0Q[*QQO+O^,I87J&Q049FL.M2 =3O72NN6)/-"F#NCO0NP07PLP.G
M&(DH6/ F?E.+^"9.4JG<S*;W[_?:97_^^1M!!77+8+1@2<U/^ <A.$JW.!QI
M$$>4.K;H^=[!(![BL&OHD&[=*+JEZD9;KS;"*N\R%T1*Q="35-;GMBM?,T$L
MT&-OK6!?3IO-E[[LE@!;ORB'DJ554+]W0M&@!Y6E_G=OT^,^^TL-.Q#N.DF%
MWI[C4S+6N1#:+1A/P+);*.(;T5B:67X1Q+ Z^^/%+OMCE_VQR_YXT+>ZS0V9
MIX5AQG5V'Y 1(V$QYD7I8FR7/M-L8MJLPY31*A:A!FG(D1_IX[-_7YQ@2*D
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M,GR<)Q??QK?L-1F,V<1PQ!O++6.X^[)O1>^.9FL$V=A^+X9?S+5P[]R*6TQ
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MU](FCG1PRLX3Z"TGI[F>*1D:=_55!JQV^U:V@9V*%TH7]M$]'-OCNT'LV#Q
MC8Z5''@/!R?0RF/'FJX:;\6NZ-1UN74(/(MC# [;<ID26X+Z+#>:E?V>)M9L
M J=O+WNR^=89H[E03WQ*;V48L1O%9G0DZ'"2NX(F6)"(QZI1/;Z("ZQ1K@D4
M60JE_DI+Y4$V^M[R18U%%\#**K2^JN@]8Q.< T%BBF_9"4+I%NB'0!SI;E+(
MC*&]'*6AZ?FY*K#,?M3O,3<G\URE:4E/=(KCW$!@NA5XI30RC@L>U'/FBWHA
M9GU%6=,13"+63C'F#OV>A5IH\+%"-]>@F\&NI$:3:.,SXJWL@$1L!&]=)B-]
MG$>B"5C72P"(O_$RU@4LSD/CZW9AX\1"O^GVT1KWS33^P/U ;^=&G)Y'<=WE
MU VB6:(92B'HU" 'DI:#4;8K[&LL).@Z7# 0H4,XNC^154JZ\GK6>).&(1G)
MN2;4LUA#]\5:K(!LJD!MS8QH(=(>.4[,@F'@]!:TS@_#*G  F9QO8]R1&Q6B
MF(4]4?FI0[I=1U38WN,FA!V8\-K91H-F^Q[B)JW^/::S>3/3IQ,=#0-ADV0A
MLM!4NOCOEZ1(6"*H65IFZF ;1QATD&[-.;?OI>>S]DI]_:F%IJ7O)J^6?:#!
M_"N_VB84/H_UZL(GT'C5T+8E:/U.4F#E!(RB21<;MWBLED2@,]\-[_1[0-9-
MM(F'2_%T:M+*X^.50V\UG0BW)VJ?2F0.A362=;?OBU AUKA"G^]<H3M7Z,X5
M^I"O]825Z&/7+\5J\W%-97*&?>HDI U]9:,0!.\4_1H"FB$N,JR3%5N4?%FL
MY/I^,\%6*TN%<MO3G47Q<WY  ;T.'7CD>'BD8[7C+W$]>"#YU@&3TLS]:7+#
MIU*KV\VLSY%5WO';!6M_KM-);P4,LL#XWVPVHO0LST8>F=I%5)S(6+B2^&XY
MN59SMKOMQ\Y4=/&QQ8@?^E#H+B%XVC])O<SFB3)0B,EV6M58/:1VN.^Q!:GS
M+C7+@7GN]YSQ)+\01FTI_M&]Z_TN]?=[78I^M%+/=T:\/TT?C,^@JL_*ME&T
MPYI^ZSCNI,=[7C8BU7O0X^T!4\%*B&0&-I]'5':KKK."]F?U=>]UW=IZU*6L
M]WN?05MO7AM7+QXPK#(./79FX:GL*YSZ(8U]Q>ML^K-3%M-^2#,$,<-#VKK3
M+O+1*N]_3Z;"MBLG4ICZILZF,0%I"+( 2RX=Y/N30;U1*'=[!)(8,X+2):?U
MZ'^AGX^3C%&#X=1K*1ZP$RO%)<[:S5Q1&$H:5*,M8USU3?6(,H;H?20\_([*
M% EKQ=L&&A1!E"3TAB8@"0HN+2(NSQV&$?AJV+DN;\KH-QF!7D_2/4TFB*V"
M]ZZ$PV<]0\-^C%B@+24-U5'?")9!%^BD*:<MC7'3*RXW<R8MFIW=V1B4ID)2
MF$,;K&-XU N%U^"N!T[)=A28T30I ZO@?W'*M%0S\"<#7?$3SNWSSV+(=5>L
M(_CX[2P*1?Q)/4I#ZBU0VE$W#62H"M%5]>2<:<'KDD*SZEE0ER2 M=QQ"%,=
MD(;IB"=8AT?!.^9YCDQ&&'XXW"IR>N^Z42Y?9:98Y:;W(]K@>O1[+K&UM5M0
MBXJK.$O^GQ,F$AW=?!;*H!;_-AQ,G9:YCB7:/6T=5"!%-REM/(L:A>B*+KJ3
MS@E--SP5#O>NVD%.KK_;%A(OJ>=SK@RS%@>OV!"_U\Z:YSJN2XQZEUXDSK%U
M^KUP%P;_4$:M(V&+Y0E<)T9$#-@A0UW7YC6IOT4)KLL-W&_Z/3'N2MX'"N9U
M4&R'3C.P"0TZT-S5D\5)B?:FARF8[@<E&JZ$5,-MMS$/DLZXJR>YS0-=/PQ[
M5,.'"=NQV6F"14<6FFO6K1"A?GQ'-W8F+=@$UERHZC65A0%SL(W'(*%HI]]Q
M$RTGZFSNX]2:-_L-^>U?G"*.'$OL"J]C=L>.K#?C\'J:3#)*(,XWQ_$T>2V;
M91[P,#;'%@F+[D0+P"@O @H%*<T)I1CQ.,4-UQA,FFGF'!3E("D#OX,6H40
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M";5M\[??[FXGL4:FVV#+"DZXDM\*.=2Y?:EU85YU0J]RQ16Q0-CDN7(+@\5
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ME[/YB+,5G[X^/_XWDO+3GR]_>?OJ_P-02P,$%     @ JH K5%(?;A?X30
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M!(R'F!G9M!S2:9+O&<3AU-M#3B_]X0?C#;S.TQI!N+ :/,XR$ #Y["$E:G@
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MW94(N3W(@_F"Y#J#P$0539Z,8JP@<;+HV_$3#J#:J.-R31G/R/AC^ 7AR%$
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M7#+AL$ONNJR8SYW_0:JO7[YX_4CC^5$G:X^..6R@8DS>,:%<YC%Q^&@C=\>
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M%B*K$0UYPA<T$& 5:'A,89.#5C1BKC\ODZXP_(QE;+>+&5&HX)XI HQ,F8C
M=@+8(%GJNB2$,* JDF@=7$(C^"W @EPMXC5+#<)HY'&%I1=J5Z0U2KG ]@<0
MSL/=L"3^<$E"M\VM1+.>)*N.3.)E5=I,3"3>-IM^%90'JMX9YC(TS< /F4T'
M3 N3#]<BW<"(9_1Y)EOG,,C9AJ51'76P % 8\9:H+H&',"8P"4&;@H\$)D+
M%528KJJK$D0KA_ ]718,%*XKG SJ3/IPD0220S#;KJ] :8*BI4"" 5>8"5S
MLC1BTMR$(QD43I/,PG1]3"?( HCZ[[!O%"D2"81M\+ >\"$E&N\V;9UC$F*=
MXU8O- _LT&#A.NK#]/4G1@HKO99W S],UF>CY]E*>U<?0,D,F;Q$@Z5DSN?N
M; V<%]+!98(D HX6.J[3G:Q771>W#/4-:IZN-)DV,W48F/PJ4P]4O1/(3.BS
M>E(R&&#T!2(ISG>(,S;U(:ATQ<(0SS9V4[=2<:6+VH@Q0<:1:_ &S&=\C'\O
M0QQ>(SAG%@,,;!PB?1OW= KS5*A@P%N8LF71_X;0W#)XV21.17AF1,PDBZT0
M&V;730+ D.0MT5:VN*;R!!\-13RH [_T\2:&@08]#H!"KPJWBV&,Y\?FTIUB
MQ!);F]=%,HE<> HH'QNPYHL2=!P$;*#\KZ1]H.H-<4R/,Y!=!9 \(>;,R+_$
M!"(N1I)!IAA$&[I2TA%4$J>FC143I#IA8[T3WB?!G;EPH7M'RP,Y'?HKG!ZH
M>D- ILMX,K=\UH211_$# %U*'V.9LZ>BK2M)0X!]W M<''L HWAT@66)"UN\
M1FSAV]B*R=GXA3)E")?SN4_FL&>TP,H<LN6A4Q3J0/4CF? #J&I/P98C)L)7
M3 Q]1S/>>\.4?ITZGJ]!5P0$+ V<HH'>9\^ >FP*6?'!:&!/@[ SX-) ^GBZ
MJV FU#,E #**YY0J3J#U@NB)>,HO#8 #*UK5 ;]#YQW[8&,56X6./=0+6^\<
MH9YG&I$5 -O.U)=ZM Q /NPG\QD@Q<2:0%VR;Q%'CQ@=!_:P^-7R?#1IJ"V
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M.1R?#?]Y)$XOQI>/.T***-&9CF32=5[.E(C50B4F3Z%;(C)I+K-;D!45#FJ
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MT.[>CWE"?Y,B_)$*^EL6_P902P,$%     @ JH K5-AHIORC(@  "!L!  L
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M&R)7JF](Z_"2U.J5,A1,.&;F+$5I'A?:G)+UTGK'DEE>FJQQ&-Y7,-P&P\2
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M0D;IF#B*(.KUE<(8%9+*6ZC+5BL8HN[&0M'YG PT#JW DQYY$:X.OZ"@30W
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M%BUSBY:Y1?.VEA\2Y1;@JT6<(;>E)(\B8S([0F:VX)Y4X: %6;!'<2/4?^@
M6./4.&;V#\[(R<E%MG=0@+-R#F9E@<!(JH&=V7RM:/&4D3P>NB6%L(X?A?#
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M[IK;;>Z>?N0WUGLY'/\/4$L! A0#%     @ JH K5"OY6(8W P  \@L  !$
M             ( !     &-L<VXM,C R,C Q,3 N>'-D4$L! A0#%     @
MJH K5/FN/4__"@  ;(<  !4              ( !9@,  &-L<VXM,C R,C Q
M,3!?;&%B+GAM;%!+ 0(4 Q0    ( *J *U3$7WYM4@<  +]8   5
M      "  9@.  !C;'-N+3(P,C(P,3$P7W!R92YX;6Q02P$"% ,4    " "J
M@"M45%I7^N4D  !1Z   "0              @ $=%@  97@Q+3$N:'1M4$L!
M A0#%     @ JH K5-?-V&I1F0  ^MH#  H              ( !*3L  &5X
M,3 M,2YH=&U02P$"% ,4    " "J@"M4Q4O72[)-  !@'@( "0
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MPX0! &5X.3DM,2YH=&U02P$"% ,4    " "J@"M4V&BF_*,B   (&P$ "P
M            @ %/DP$ 9F]R;3@M:RYH=&U02P4&      L "P"! @  &[8!
#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
